Medications for human use with a single active ingredient starting with the letter D-G.

Médicaments à usage humain contenant un seul ingrédient actif commençant par la lettre D-G.

Last Update: 2021-05-03
Product Name;
DIN;
Active ingredient(s) and concentration;
Number of active ingredients: Number of active ingredients;
Original market date;
Route(s) of administration;
Dosage form(s);
AHFS;
Schedule;
Company
Monograph
RED-COTE;
00690112;
d&c red no. 28 5 mg;
1995-12-31;
Dental;
Tablet;
34:00.00 – DENTAL AGENTS;
Otc;
SUNSTAR AMERICAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18692
PRADAXA;
02312441;
dabigatran etexilate (dabigatran etexilate mesilate) 110 mg;
2008-07-03;
Oral;
Capsule;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79795
PRADAXA;
02358808;
dabigatran etexilate (dabigatran etexilate mesilate) 150 mg;
2010-11-03;
Oral;
Capsule;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84384
APO-DABIGATRAN;
02468913;
dabigatran etexilate (dabigatran etexilate mesilate) 150 mg;
2019-02-04;
Oral;
Capsule;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95756
PRADAXA;
02312433;
dabigatran etexilate (dabigatran etexilate mesilate) 75 mg;
2008-07-03;
Oral;
Capsule;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79794
APO-DABIGATRAN;
02468891;
dabigatran etexilate (dabigatran etexilate mesilate) 75 mg;
2019-08-14;
Oral;
Capsule;
20:12.04.12 – DIRECT THROMBIN INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95754
TAFINLAR;
02409607;
dabrafenib (dabrafenib mesylate) 50 mg;
2013-08-28;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89429
TAFINLAR;
02409615;
dabrafenib (dabrafenib mesylate) 75 mg;
2013-08-28;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89430
DACARBAZINE FOR INJECTION BP;
02241445;
dacarbazine 600 mg / vial;
2000-04-04;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65081
VIZIMPRO;
02486024;
dacomitinib (dacomitinib monohydrate) 15 mg;
2019-04-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97625
VIZIMPRO;
02486032;
dacomitinib (dacomitinib monohydrate) 30 mg;
2019-04-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97626
VIZIMPRO;
02486040;
dacomitinib (dacomitinib monohydrate) 45 mg;
2019-04-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97627
COSMEGEN;
00213071;
dactinomycin 0.5 mg / vial;
1963-12-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
RECORDATI RARE DISEASES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=250
FRAGMIN;
02132664;
dalteparin sodium 10000 unit / ml;
1995-12-31;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18235
FRAGMIN;
02352656;
dalteparin sodium 10000 unit / 0.4 ml;
2011-02-01;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83791
FRAGMIN;
02352664;
dalteparin sodium 12500 unit / 0.5 ml;
2011-02-01;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83792
FRAGMIN;
02352672;
dalteparin sodium 15000 unit / 0.6 ml;
2011-02-01;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83793
FRAGMIN;
02494582;
dalteparin sodium 16500 unit / 0.66 ml;
2020-06-08;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98458
FRAGMIN;
02352680;
dalteparin sodium 18000 unit / 0.72 ml;
2011-02-01;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83794
FRAGMIN;
02132621;
dalteparin sodium 2500 unit / 0.2 ml;
1995-12-31;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18307
FRAGMIN;
02231171;
dalteparin sodium 25000 unit / ml;
1997-11-27;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50478
FRAGMIN;
02430789;
dalteparin sodium 3500 unit / 0.28 ml;
2015-03-25;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91522
FRAGMIN;
02132648;
dalteparin sodium 5000 unit / 0.2 ml;
1995-12-31;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18306
FRAGMIN;
02352648;
dalteparin sodium 7500 unit / 0.3 ml;
2011-02-01;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83790
ORGARAN;
02129043;
danaparoid sodium 750 unit / 0.6 ml;
1995-12-31;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18868
CYCLOMEN;
02018152;
danazol 100 mg;
1976-12-31;
Oral;
Capsule;
68:08.00 – ANDROGENS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15163
CYCLOMEN;
02018160;
danazol 200 mg;
1972-12-31;
Oral;
Capsule;
68:08.00 – ANDROGENS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14747
CYCLOMEN;
02018144;
danazol 50 mg;
1980-12-31;
Oral;
Capsule;
68:08.00 – ANDROGENS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15897
DANTRIUM INTRAVENOUS;
01997572;
dantrolene sodium 20 mg / vial;
1993-12-31;
Intravenous;
Powder For Solution;
12:20.08 – DIRECT-ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
ENDO PAR INNOVATION COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14017
DANTRIUM CAPSULES;
01997602;
dantrolene sodium 25 mg;
1993-12-31;
Oral;
Capsule;
12:20.08 – DIRECT-ACTING SKELETAL MUSCLE RELAXANTS;
Prescription;
ENDO PAR INNOVATION COMPANY, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14019
FORXIGA;
02435470;
dapagliflozin (dapagliflozin propanediol monohydrate) 10 mg;
2015-01-16;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91978
FORXIGA;
02435462;
dapagliflozin (dapagliflozin propanediol monohydrate) 5 mg;
2015-01-16;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91977
DAPSONE;
02041510;
dapsone 100 mg;
1994-12-31;
Oral;
Tablet;
08:16.92 – MISCELLANEOUS ANTIMYCOBACTERIALS;
Prescription;
JACOBUS PHARMACEUTICAL COMPANY, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16584
MAR-DAPSONE;
02481227;
dapsone 100 mg;
2018-11-13;
Oral;
Tablet;
08:16.92 – MISCELLANEOUS ANTIMYCOBACTERIALS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97168
RIVA-DAPSONE;
02489058;
dapsone 100 mg;
2019-08-21;
Oral;
Tablet;
08:16.92 – MISCELLANEOUS ANTIMYCOBACTERIALS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97910
ACZONE;
02281074;
dapsone 5 % / w/w;
2011-10-21;
Topical;
Gel;
84:04.92 – MISCELLANEOUS LOCAL ANTI-INFECTIVES;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76674
CUBICIN RF;
02465493;
daptomycin 500 mg / vial;
2018-01-17;
Intravenous;
Powder For Solution;
08:12.28.12 – CYCLIC LIPOPEPTIDES;
Prescription;
CUBIST PHARMACEUTICALS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95367
DAPTOMYCIN FOR INJECTION;
02490463;
daptomycin 500 mg / vial;
2020-11-19;
Intravenous;
Powder For Solution;
08:12.28.12 – CYCLIC LIPOPEPTIDES;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98052
DAPTOMYCIN FOR INJECTION;
02490838;
daptomycin 500 mg / vial;
2020-10-27;
Intravenous;
Powder For Solution;
08:12.28.12 – CYCLIC LIPOPEPTIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98087
DAPTOMYCIN FOR INJECTION;
02494590;
daptomycin 500 mg / vial;
2020-10-29;
Intravenous;
Powder For Solution;
08:12.28.12 – CYCLIC LIPOPEPTIDES;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98459
DARZALEX;
02455951;
daratumumab 100 mg / 5 ml;
2016-07-12;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94282
DARZALEX SC;
02502712;
daratumumab 1800 mg / 15 ml;
2020-08-12;
Subcutaneous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99226
DARZALEX;
02455978;
daratumumab 400 mg / 20 ml;
2016-07-12;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94283
ARANESP;
02391740;
darbepoetin alfa 100 mcg / ml;
2013-12-11;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87706
ARANESP;
02391759;
darbepoetin alfa 100 mcg / ml;
2014-05-07;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87707
ARANESP;
02392348;
darbepoetin alfa 100 mcg / ml;
2014-03-03;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87762
ARANESP;
02391767;
darbepoetin alfa 200 mcg / ml;
2014-01-27;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87708
ARANESP;
02391775;
darbepoetin alfa 200 mcg / ml;
2014-03-26;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87709
ARANESP;
02391783;
darbepoetin alfa 200 mcg / ml;
2014-02-10;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87710
ARANESP;
02392356;
darbepoetin alfa 200 mcg / ml;
2014-04-03;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87763
ARANESP;
02392313;
darbepoetin alfa 25 mcg / ml;
2013-08-16;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87760
ARANESP;
02392321;
darbepoetin alfa 40 mcg / ml;
2014-03-12;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87761
ARANESP;
02391791;
darbepoetin alfa 500 mcg / ml;
2014-04-21;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87711
ARANESP;
02391805;
darbepoetin alfa 500 mcg / ml;
2014-05-05;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87712
ARANESP;
02391821;
darbepoetin alfa 500 mcg / ml;
2013-11-04;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87714
ARANESP;
02392364;
darbepoetin alfa 500 mcg / ml;
2014-02-24;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87764
ENABLEX;
02273225;
darifenacin (darifenacin hydrobromide) 15 mg;
2006-04-06;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75872
ENABLEX;
02273217;
darifenacin (darifenacin hydrobromide) 7.5 mg;
2006-04-06;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75871
NUBEQA;
02496348;
darolutamide 300 mg;
2020-03-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98622
PREZISTA;
02416530;
darunavir (darunavir ethanolate) 100 mg / ml;
2014-08-06;
Oral;
Suspension;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90113
PREZISTA;
02369753;
darunavir (darunavir ethanolate) 150 mg;
2012-04-16;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85467
PREZISTA;
02324024;
darunavir (darunavir ethanolate) 600 mg;
2009-03-17;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80950
PREZISTA;
02338432;
darunavir (darunavir ethanolate) 75 mg;
2009-12-16;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82408
PREZISTA;
02393050;
darunavir (darunavir ethanolate) 800 mg;
2012-11-09;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87830
AURO-DARUNAVIR;
02486121;
darunavir (darunavir propylene glycolate) 600 mg;
2020-03-18;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97636
AURO-DARUNAVIR;
02486148;
darunavir (darunavir propylene glycolate) 800 mg;
2020-03-18;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97637
APO-DARUNAVIR;
02487241;
darunavir 600 mg;
2020-02-14;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97741
APO-DARUNAVIR;
02487268;
darunavir 800 mg;
2020-02-14;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97742
SPRYCEL;
02320193;
dasatinib (dasatinib monohydrate) 100 mg;
2009-05-04;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80564
SPRYCEL;
02360829;
dasatinib (dasatinib monohydrate) 140 mg;
2011-03-29;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84582
SPRYCEL;
02293129;
dasatinib (dasatinib monohydrate) 20 mg;
2007-04-13;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77850
SPRYCEL;
02293137;
dasatinib (dasatinib monohydrate) 50 mg;
2007-04-13;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77851
SPRYCEL;
02293145;
dasatinib (dasatinib monohydrate) 70 mg;
2007-04-13;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77852
SPRYCEL;
02360810;
dasatinib (dasatinib monohydrate) 80 mg;
2011-09-02;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84581
APO-DASATINIB;
02470721;
dasatinib 100 mg;
2020-01-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95973
TARO-DASATINIB;
02499339;
dasatinib 100 mg;
2021-03-04;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98907
TARO-DASATINIB;
02499347;
dasatinib 140 mg;
2021-03-04;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98908
APO-DASATINIB;
02470705;
dasatinib 20 mg;
2020-01-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95971
TARO-DASATINIB;
02499282;
dasatinib 20 mg;
2021-03-04;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98902
APO-DASATINIB;
02470713;
dasatinib 50 mg;
2020-01-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95972
TARO-DASATINIB;
02499304;
dasatinib 50 mg;
2021-03-04;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98904
APO-DASATINIB;
02481499;
dasatinib 70 mg;
2020-01-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97193
TARO-DASATINIB;
02499312;
dasatinib 70 mg;
2021-03-04;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98905
APO-DASATINIB;
02481502;
dasatinib 80 mg;
2020-01-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97194
TARO-DASATINIB;
02499320;
dasatinib 80 mg;
2021-03-04;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98906
CERUBIDINE;
01926683;
daunorubicin (daunorubicin hydrochloride) 20 mg / vial;
1971-12-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13226
EXJADE;
02287420;
deferasirox 125 mg;
2006-11-10;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77283
APO-DEFERASIROX;
02461544;
deferasirox 125 mg;
2017-06-26;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94918
TARO-DEFERASIROX;
02463520;
deferasirox 125 mg;
2017-06-26;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95161
SANDOZ DEFERASIROX;
02464454;
deferasirox 125 mg;
2017-07-04;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95259
PMS-DEFERASIROX;
02474328;
deferasirox 125 mg;
2018-04-25;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96437
JADENU;
02452227;
deferasirox 180 mg;
2016-03-24;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93865
APO-DEFERASIROX (TYPE J);
02485273;
deferasirox 180 mg;
2019-05-29;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97554
TARO-DEFERASIROX (TYPE J);
02507323;
deferasirox 180 mg;
2021-03-04;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99673
EXJADE;
02287439;
deferasirox 250 mg;
2006-11-10;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77284
APO-DEFERASIROX;
02461552;
deferasirox 250 mg;
2017-06-29;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94919
TARO-DEFERASIROX;
02463539;
deferasirox 250 mg;
2017-06-26;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95162
SANDOZ DEFERASIROX;
02464462;
deferasirox 250 mg;
2017-07-04;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95260
PMS-DEFERASIROX;
02474336;
deferasirox 250 mg;
2018-04-25;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96438
JADENU;
02452235;
deferasirox 360 mg;
2016-03-24;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93866
APO-DEFERASIROX (TYPE J);
02485281;
deferasirox 360 mg;
2019-05-29;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97555
TARO-DEFERASIROX (TYPE J);
02507331;
deferasirox 360 mg;
2021-03-04;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99674
EXJADE;
02287447;
deferasirox 500 mg;
2006-11-10;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77285
APO-DEFERASIROX;
02461560;
deferasirox 500 mg;
2017-06-26;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94920
TARO-DEFERASIROX;
02463547;
deferasirox 500 mg;
2017-06-30;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95163
SANDOZ DEFERASIROX;
02464470;
deferasirox 500 mg;
2017-07-04;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95261
PMS-DEFERASIROX;
02474344;
deferasirox 500 mg;
2018-04-25;
Oral;
Tablet For Suspension;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96439
JADENU;
02452219;
deferasirox 90 mg;
2016-03-24;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93864
APO-DEFERASIROX (TYPE J);
02485265;
deferasirox 90 mg;
2019-05-29;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97553
TARO-DEFERASIROX (TYPE J);
02507315;
deferasirox 90 mg;
2021-03-04;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99672
FERRIPROX;
02436523;
deferiprone 100 mg / ml;
2016-07-28;
Oral;
Solution;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
CHIESI CANADA CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92086
FERRIPROX;
02436558;
deferiprone 1000 mg;
2015-04-28;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
CHIESI CANADA CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92088
FERRIPROX;
02436531;
deferiprone 500 mg;
2016-03-21;
Oral;
Tablet;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
CHIESI CANADA CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92087
DEFEROXAMINE MESYLATE FOR INJECTION;
02247022;
deferoxamine mesylate 2 g / vial;
2004-01-12;
Intramuscular , Intraperitoneal , Intravenous , Subcutaneous;
Powder For Solution;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71256
DESFERAL 500MG;
01981242;
deferoxamine mesylate 500 mg / vial;
1992-12-31;
Intramuscular , Intraperitoneal , Intravenous , Subcutaneous;
Powder For Solution;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13546
DEFEROXAMINE MESYLATE FOR INJECTION;
02241600;
deferoxamine mesylate 500 mg / vial;
2000-04-12;
Intramuscular , Intraperitoneal , Intravenous , Subcutaneous;
Powder For Solution;
64:00.00 – HEAVY METAL ANTAGONISTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65257
DEFITELIO;
02465981;
defibrotide 80 mg / ml;
2017-09-06;
Intravenous;
Solution;
20:12.20 – THROMBOLYTIC AGENTS;
Prescription , Schedule D;
JAZZ PHARMACEUTICALS IRELAND LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95424
FIRMAGON;
02337037;
degarelix (degarelix acetate) 120 mg / vial;
2009-11-24;
Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS , 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82264
FIRMAGON;
02337029;
degarelix (degarelix acetate) 80 mg / vial;
2009-11-24;
Subcutaneous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS , 92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82263
XGEVA;
02368153;
denosumab 120 mg / 1.7 ml;
2011-06-06;
Subcutaneous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85304
PROLIA;
02343541;
denosumab 60 mg / ml;
2010-08-12;
Subcutaneous;
Solution;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82897
BELKYRA;
02443910;
deoxycholic acid 10 mg / ml;
2016-01-27;
Subcutaneous;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
KYTHERA BIOPHARMACEUTICALS, INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92869
DEQUADIN;
02100207;
dequalinium chloride 0.25 mg;
1997-04-01;
Oral;
Lozenge;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
BOYD PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28979
DEQUADIN ORAL PAINT;
02091453;
dequalinium chloride 0.5 % / w/v;
1995-12-31;
Buccal;
Solution;
52:04.92 – MISCELLANEOUS ANTI-INFECTIVES;
Otc;
BOYD PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19449
ALLERGENIC EXTRACT, STANDARDARDIZED MITE, D. FARINAE;
02217082;
dermatophagoides farinae 10000 unit / ml;
1997-09-15;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43205
ALLERGENIC EXTRACT – STANDARDIZED MITE DERMATOPHAGOIDES FARINAE;
02231321;
dermatophagoides farinae 10000 unit / ml;
1999-03-15;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50628
ALLERGENIC EXTRACT, STANDARDIZED MITE, D.PTERONYSSINUS;
02217104;
dermatophagoides pteronyssinus 10000 unit / ml;
1997-09-15;
Intradermal , Subcutaneous , Percutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
ALK-ABELLO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43207
ALLERGENIC EXTRACT – STANDARDIZED MITE DERMATOPHAGOIDES PTERONYSSINUS;
02231324;
dermatophagoides pteronyssinus 10000 unit / ml;
1999-03-15;
Intracutaneous , Subcutaneous;
Liquid;
92:05.00* – ALLERGENIC EXTRACTS;
Schedule D;
GREER LABORATORIES INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50631
SUPRANE;
02227428;
desflurane 100 % / v/v;
1996-12-23;
Inhalation;
Liquid;
28:04.16 – INHALATION ANESTHETICS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43455
DESIPRAMINE;
02216248;
desipramine (desipramine hydrochloride) 10 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20014
DESIPRAMINE;
02216280;
desipramine (desipramine hydrochloride) 100 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20021
DESIPRAMINE;
02216256;
desipramine (desipramine hydrochloride) 25 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20015
DESIPRAMINE;
02216264;
desipramine (desipramine hydrochloride) 50 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20023
DESIPRAMINE;
02216272;
desipramine (desipramine hydrochloride) 75 mg;
1996-12-31;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20022
AERIUS KIDS;
02247193;
desloratadine 0.5 mg / ml;
2005-03-21;
Oral;
Syrup;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71435
AERIUS;
02243919;
desloratadine 5 mg;
2002-01-10;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67861
DESLORATADINE ALLERGY CONTROL;
02298155;
desloratadine 5 mg;
2009-12-24;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78346
DDAVP MELT;
02285002;
desmopressin (desmopressin acetate) 120 mcg;
2006-11-02;
Sublingual;
Tablet (Orally Disintegrating);
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77053
DDAVP MELT;
02285010;
desmopressin (desmopressin acetate) 240 mcg;
2009-05-05;
Sublingual;
Tablet (Orally Disintegrating);
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77054
NOCDURNA;
02397927;
desmopressin (desmopressin acetate) 25 mcg;
2013-07-31;
Sublingual;
Tablet (Orally Disintegrating);
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88288
NOCDURNA;
02431076;
desmopressin (desmopressin acetate) 50 mcg;
2014-11-17;
Sublingual;
Tablet (Orally Disintegrating);
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91551
DDAVP MELT;
02284995;
desmopressin (desmopressin acetate) 60 mcg;
2006-11-02;
Sublingual;
Tablet (Orally Disintegrating);
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77052
PMS-DESMOPRESSIN;
02304368;
desmopressin acetate (desmopressin acetate trihydrate) 0.1 mg;
2008-01-23;
Oral;
Tablet;
68:28.00 – PITUITARY;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78965
DDAVP TABLETS 0.1MG;
00824305;
desmopressin acetate 0.1 mg;
1995-12-31;
Oral;
Tablet;
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19436
DESMOPRESSIN;
02284030;
desmopressin acetate 0.1 mg;
2007-01-31;
Oral;
Tablet;
68:28.00 – PITUITARY;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76960
DDAVP TABLETS 0.2MG;
00824143;
desmopressin acetate 0.2 mg;
1995-12-31;
Oral;
Tablet;
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19441
DESMOPRESSIN;
02284049;
desmopressin acetate 0.2 mg;
2007-01-31;
Oral;
Tablet;
68:28.00 – PITUITARY;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76961
DESMOPRESSIN SPRAY;
02242465;
desmopressin acetate 10 mcg / act;
2000-08-18;
Nasal;
Spray, Metered Dose;
68:28.00 – PITUITARY;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66190
OCTOSTIM LIQ INJ. 15MCG/ML;
02024179;
desmopressin acetate 15 mcg / ml;
1995-12-31;
Intravenous , Subcutaneous;
Solution;
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18289
DDAVP INJ 4MCG/ML;
00873993;
desmopressin acetate 4 mcg / ml;
1993-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
68:28.00 – PITUITARY;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13867
TRIDESILON 0.05% DESONIDE CREAM;
02154862;
desonide .05 %;
1996-11-11;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33930
TRIDESILON 0.05% DESONIDE OINTMENT;
02154870;
desonide .05 %;
1998-01-27;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=33931
PDP-DESONIDE;
02229315;
desonide 0.05 % / w/w;
1997-01-14;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43536
PDP-DESONIDE;
02229323;
desonide 0.05 % / w/w;
1997-01-14;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43537
TOPICORT;
02221918;
desoximetasone 0.05 %;
1996-11-07;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43315
TOPICORT;
02221926;
desoximetasone 0.05 %;
1996-12-04;
Topical;
Gel;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43316
TOPICORT;
02221896;
desoximetasone 0.25 %;
1997-03-24;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43314
TOPICORT;
02221934;
desoximetasone 0.25 %;
1997-03-24;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43317
PRISTIQ;
02321106;
desvenlafaxine (desvenlafaxine succinate) 100 mg;
2009-03-06;
Oral;
Tablet (Extended-Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80651
PRISTIQ;
02321092;
desvenlafaxine (desvenlafaxine succinate) 50 mg;
2009-03-05;
Oral;
Tablet (Extended-Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80650
APO-DESVENLAFAXINE;
02466996;
desvenlafaxine 100 mg;
2017-10-20;
Oral;
Tablet (Extended-Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95540
APO-DESVENLAFAXINE;
02466988;
desvenlafaxine 50 mg;
2017-10-20;
Oral;
Tablet (Extended-Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95539
DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP;
00874582;
dexamethasone (dexamethasone sodium phosphate) 10 mg / 1 ml;
1990-12-31;
Intramuscular , Intrasynovial , Intravenous;
Liquid;
68:04.00 – ADRENALS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12208
MAXIDEX;
00042560;
dexamethasone 0.1 % / w/v;
1977-12-31;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2620
MAXIDEX;
00042579;
dexamethasone 0.1 % / w/w;
1966-12-31;
Ophthalmic;
Ointment;
52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4591
PMS DEXAMETHASONE TAB 0.5MG USP;
01964976;
dexamethasone 0.5 mg;
1996-08-26;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23261
APO-DEXAMETHASONE;
02261081;
dexamethasone 0.5 mg;
2004-11-17;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74650
PMS-DEXAMETHASONE ELIXIR;
01946897;
dexamethasone 0.5 mg / 5 ml;
1992-12-31;
Oral;
Elixir;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12967
OZURDEX;
02363445;
dexamethasone 0.7 mg;
2011-06-02;
Intravitreal;
Implant;
52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84844
PMS DEXAMETHASONE TAB 0.75MG USP;
01964968;
dexamethasone 0.75 mg;
1996-09-05;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23260
PMS-DEXAMETHASONE;
02279363;
dexamethasone 2 mg;
2006-06-08;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76497
PMS DEXAMETHASONE TAB 4MG;
01964070;
dexamethasone 4 mg;
1996-09-05;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=23194
APO-DEXAMETHASONE;
02250055;
dexamethasone 4 mg;
2004-03-08;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73487
PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML;
00783900;
dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg / ml;
1990-12-31;
Intramuscular , Intravenous;
Liquid;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11011
DEXAMETHASONE-OMEGA;
02204274;
dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg / ml;
1999-06-30;
Intramuscular , Intravenous;
Liquid;
68:04.00 – ADRENALS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36481
DEXAMETHASONE OMEGA UNIDOSE;
02387743;
dexamethasone phosphate (dexamethasone sodium phosphate) 10 mg / 1 ml;
2013-05-08;
Intramuscular , Intrasynovial , Intravenous;
Solution;
68:04.00 – ADRENALS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87333
DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML;
00664227;
dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg / ml;
1986-12-31;
Intramuscular , Intrasynovial , Intravenous;
Solution;
68:04.00 – ADRENALS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6593
DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP;
01977547;
dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg / ml;
1992-12-31;
Intra-Articular , Intramuscular , Intravenous;
Liquid;
68:04.00 – ADRENALS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13255
DEXAMETHASONE-OMEGA;
02204266;
dexamethasone phosphate (dexamethasone sodium phosphate) 4 mg / ml;
1999-04-01;
Intra-Articular , Intralesional , Intramuscular , Intravenous , Soft Tissue Injection;
Liquid;
68:04.00 – ADRENALS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=36480
DEXAMETHASONE;
02023865;
dexamethasone sodium phosphate 0.1 %;
1994-12-31;
Ophthalmic , Otic;
Solution;
52:08.08 – CORTICOSTEROIDS;
Prescription;
PHARMA STULLN INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16262
DEXILANT;
02354950;
dexlansoprazole 30 mg;
2010-08-05;
Nasogastric , Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84014
DEXILANT;
02354969;
dexlansoprazole 60 mg;
2010-08-05;
Nasogastric , Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84015
PRECEDEX;
02339366;
dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
2010-02-24;
Intravenous;
Solution;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82498
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION;
02464381;
dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
2019-10-10;
Intravenous;
Solution;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95254
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP;
02467976;
dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
2019-01-15;
Intravenous;
Solution;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95633
DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION;
02477327;
dexmedetomidine (dexmedetomidine hydrochloride) 100 mcg / ml;
2019-03-29;
Intravenous;
Solution;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96831
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION;
02487365;
dexmedetomidine (dexmedetomidine hydrochloride) 200 mcg / 50 ml;
2020-09-30;
Intravenous;
Solution;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97754
PRECEDEX;
02437147;
dexmedetomidine (dexmedetomidine hydrochloride) 4 mcg / ml;
2016-05-09;
Intravenous;
Solution;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92145
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION;
02487373;
dexmedetomidine (dexmedetomidine hydrochloride) 400 mcg / 100 ml;
2020-09-30;
Intravenous;
Solution;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97755
ZINECARD;
02153432;
dexrazoxane 250 mg / vial;
1995-12-31;
Intravenous;
Powder For Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18480
DEXEDRINE SPANSULE SRC 10MG;
01924559;
dextroamphetamine sulfate 10 mg;
1992-12-31;
Oral;
Capsule (Sustained-Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15211
ACT DEXTROAMPHETAMINE SR;
02448319;
dextroamphetamine sulfate 10 mg;
2017-10-06;
Oral;
Capsule (Sustained-Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93401
DEXEDRINE SPANSULE SRC 15MG;
01924567;
dextroamphetamine sulfate 15 mg;
1992-12-31;
Oral;
Capsule (Sustained-Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15210
ACT DEXTROAMPHETAMINE SR;
02448327;
dextroamphetamine sulfate 15 mg;
2017-10-06;
Oral;
Capsule (Sustained-Release);
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93402
DEXEDRINE TABLETS (5MG);
01924516;
dextroamphetamine sulfate 5 mg;
1992-12-31;
Oral;
Tablet;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15225
DEXTROAMPHETAMINE;
02443236;
dextroamphetamine sulfate 5 mg;
2015-08-28;
Oral;
Tablet;
28:20.04 – AMPHETAMINES;
Schedule G (Cdsa I);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92781
ROBITUSSIN DM COUGHGELS LIQUI-GELS TOUX;
02252554;
dextromethorphan hydrobromide 15 mg;
2005-08-01;
Oral;
Capsule;
48:08.00 – ANTITUSSIVES;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73742
BRONCHOPHAN FORTE DM SYR;
00522791;
dextromethorphan hydrobromide 15 mg / 5 ml;
1981-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4590
KOFFEX DM (SUCROSE FREE);
01928791;
dextromethorphan hydrobromide 15 mg / 5 ml;
1979-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11847
KOFFEX DM;
01928783;
dextromethorphan hydrobromide 15 mg / 5 ml;
1979-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11848
BALMINIL DM (3MG/ML SUCROSE FREE);
01928775;
dextromethorphan hydrobromide 15 mg / 5 ml;
1979-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12788
DM COUGH SYRUP;
02241495;
dextromethorphan hydrobromide 15 mg / 5 ml;
2000-02-29;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65135
BENYLIN EXTRA STRENGTH DRY COUGH;
01944738;
dextromethorphan hydrobromide 30 mg / 10 ml;
1992-12-31;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12411
DRY COUGH RELIEF EXTRA STRENGTH;
02405946;
dextromethorphan hydrobromide 30 mg / 10 ml;
2013-07-19;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89069
VICKS DAYQUIL COUGH;
02283913;
dextromethorphan hydrobromide 5 mg / 5 ml;
2010-08-19;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76949
ADULT HONEY WORKS;
02464896;
dextromethorphan hydrobromide 5 mg / 5 ml;
2018-10-09;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
LIFELAB HEALTH LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95309
KIDS HONEY WORKS;
02464918;
dextromethorphan hydrobromide 5 mg / 5 ml;
2018-10-09;
Oral;
Syrup;
48:08.00 – ANTITUSSIVES;
Otc;
LIFELAB HEALTH LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95310
BENYLIN FOR CHILDREN DRY COUGH;
02215268;
dextromethorphan hydrobromide 7.5 mg / 5 ml;
1996-09-18;
Oral;
Solution;
48:08.00 – ANTITUSSIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37038
DEXTROSE 5% INJECTION;
02403536;
dextrose (dextrose monohydrate) 50 mg / ml;
2014-01-29;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88832
10% DEXTROSE INJECTION, USP;
00060364;
dextrose 10 g / 100 ml;
1997-08-13;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59976
DEXTROSE INJECTION USP;
00037958;
dextrose 100 mg / ml;
1951-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1748
10% DEXTROSE INJECTION USP;
01924427;
dextrose 100 mg / ml;
1993-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14251
DEXTROSE INJECTION USP;
00037966;
dextrose 200 mg / ml;
1980-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3747
DEXTROSE-45 5.55-4.5;
02160978;
dextrose 222.7 g / bottle;
1995-12-31;
Dialysis;
Powder;
40:34.00* – HEMODIALYSIS SOLUTION;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18319
5% DEXTROSE INJECTION, USP;
00060348;
dextrose 5 g / 100 ml;
1990-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10511
DEXTROSE INJECTION USP;
00037915;
dextrose 50 mg / ml;
1978-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2902
5% DEXTROSE INJECTION USP;
01924281;
dextrose 50 mg / ml;
1993-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
B. BRAUN MEDICAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13714
DEXTROSE INJECTION USP;
00037974;
dextrose 500 mg / ml;
1951-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1746
DEXTROSE INJECTION USP;
02468514;
dextrose 500 mg / ml;
2020-08-18;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95694
70% DEXTROSE INJECTION USP;
02014874;
dextrose 70 g / 100 ml;
1995-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18686
DEXTROSE INJECTION USP;
00244988;
dextrose 700 mg / ml;
1979-12-31;
Intravenous;
Solution;
40:20.00 – CALORIC AGENTS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3585
DIAZEPAM;
00405337;
diazepam 10 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3291
DIAZEPAM INJECTION USP;
00399728;
diazepam 10 mg / 2 ml;
1980-12-31;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3721
DIAZEPAM;
00405329;
diazepam 2 mg;
1979-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3290
DIAZEPAM;
00362158;
diazepam 5 mg;
1977-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2657
VALIUM 5 TAB;
00013285;
diazepam 5 mg;
1978-12-31;
Oral;
Tablet;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3178
DIASTAT;
02238162;
diazepam 5 mg / ml;
2000-01-28;
Rectal;
Gel;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
VALEANT PHARMACEUTICALS NORTH AMERICA LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61553
DIAZEPAM INJECTION USP;
02385392;
diazepam 5 mg / ml;
2017-03-16;
Intramuscular , Intravenous;
Solution;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87102
PROGLYCEM;
00503347;
diazoxide 100 mg;
1985-12-31;
Oral;
Capsule;
24:08.20 – DIRECT VASODILATORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6269
VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH;
02338580;
diclofenac diethylamine 1.16 % / w/w;
2010-06-21;
Topical;
Gel;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82423
VOLTAREN EMULGEL BACK & MUSCLE PAIN;
02465035;
diclofenac diethylamine 1.16 % / w/w;
2018-03-15;
Topical;
Gel;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95324
VOLTAREN EMULGEL EXTRA STRENGTH;
02393190;
diclofenac diethylamine 2.32 %;
2014-10-06;
Topical;
Gel;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87843
VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH;
02465043;
diclofenac diethylamine 2.32 % / w/w;
2018-06-27;
Topical;
Gel;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95325
VOLTAREN RAPIDE TABLETS 50MG;
00881635;
diclofenac potassium 50 mg;
1993-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13805
TEVA-DICLOFENAC-K;
02239355;
diclofenac potassium 50 mg;
1999-01-13;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62824
PMS-DICLOFENAC K;
02239753;
diclofenac potassium 50 mg;
1999-03-04;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63235
SANDOZ DICLOFENAC RAPIDE;
02261774;
diclofenac potassium 50 mg;
2006-02-02;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74714
CAMBIA;
02381680;
diclofenac potassium 50 mg / sachet;
2012-06-02;
Oral;
Powder For Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS , 28:32.92 – ANTIMIGRAINE AGENTS, MISCELLANEOUS;
Prescription;
ARALEZ PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86754
VOLTAREN OPHTHA;
01940414;
diclofenac sodium 0.1 % / w/v;
1991-12-31;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11969
APO-DICLOFENAC OPHTHALMIC;
02441020;
diclofenac sodium 0.1 % / w/v;
2015-09-01;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92539
SANDOZ DICLOFENAC OPHTHA;
02454807;
diclofenac sodium 0.1 % / w/v;
2016-09-29;
Ophthalmic;
Solution;
52:08.20 – NONSTEROIDAL ANTI-INFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94156
DICLOFENAC;
02475065;
diclofenac sodium 0.1 % / w/v;
2019-03-29;
Ophthalmic;
Solution;
52:02.00 – ANTIALLERGIC AGENTS;
Prescription;
PHARMA STULLN INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96535
PENNSAID;
02247265;
diclofenac sodium 1.5 % / w/w;
2003-04-01;
Topical;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71508
PMS-DICLOFENAC;
02356783;
diclofenac sodium 1.5 % / w/w;
2014-12-02;
Topical;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84191
TARO-DICLOFENAC;
02420988;
diclofenac sodium 1.5 % / w/w;
2014-03-31;
Topical;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90557
DICLOFENAC TOPICAL SOLUTION;
02434571;
diclofenac sodium 1.5 % / w/w;
2015-11-23;
Topical;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91890
JAMP DICLOFENAC TOPICAL SOLUTION;
02472309;
diclofenac sodium 1.5 % / w/w;
2018-07-13;
Topical;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96140
DICLOFENAC SODIUM SOLUTION;
02476134;
diclofenac sodium 1.5 % / w/w;
2018-08-22;
Topical;
Solution;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TELIGENT PHARMA, INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96706
VOLTAREN SR;
00590827;
diclofenac sodium 100 mg;
1985-12-31;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6379
VOLTAREN;
00632732;
diclofenac sodium 100 mg;
1985-12-31;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6462
DICLOFENAC-SR;
02224127;
diclofenac sodium 100 mg;
1997-01-15;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43394
PMS-DICLOFENAC-SR;
02231505;
diclofenac sodium 100 mg;
1997-11-28;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50845
PMS-DICLOFENAC;
02231508;
diclofenac sodium 100 mg;
1998-08-07;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50848
SANDOZ-DICLOFENAC;
02261936;
diclofenac sodium 100 mg;
2008-10-01;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74728
SANDOZ-DICLOFENAC SR;
02261944;
diclofenac sodium 100 mg;
2006-02-02;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74729
APO-DICLO SR;
02091194;
diclofenac sodium 100 mg / srt;
1994-12-31;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16471
TEVA-DICLOFENAC EC;
00808539;
diclofenac sodium 25 mg;
1989-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9888
APO-DICLO;
00839175;
diclofenac sodium 25 mg;
1989-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10036
PMS-DICLOFENAC;
02302616;
diclofenac sodium 25 mg;
2008-05-12;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78791
VOLTAREN;
00514012;
diclofenac sodium 50 mg;
1980-12-31;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4043
VOLTAREN;
00632724;
diclofenac sodium 50 mg;
1985-12-31;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6461
TEVA-DICLOFENAC EC;
00808547;
diclofenac sodium 50 mg;
1989-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9889
APO-DICLO;
00839183;
diclofenac sodium 50 mg;
1989-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10037
DICLOFENAC-50;
00870978;
diclofenac sodium 50 mg;
1990-12-31;
Oral;
Tablet (Enteric-Coated);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10772
PMS-DICLOFENAC;
02231506;
diclofenac sodium 50 mg;
1998-08-07;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50847
SANDOZ-DICLOFENAC;
02261928;
diclofenac sodium 50 mg;
2008-10-01;
Rectal;
Suppository;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74727
SANDOZ-DICLOFENAC;
02261960;
diclofenac sodium 50 mg;
2006-02-02;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74731
PMS-DICLOFENAC;
02302624;
diclofenac sodium 50 mg;
2008-05-12;
Oral;
Tablet (Delayed-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78792
VOLTAREN SR;
00782459;
diclofenac sodium 75 mg;
1989-12-31;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9943
TEVA-DICLOFENAC SR;
02158582;
diclofenac sodium 75 mg;
1995-12-31;
Oral;
Tablet (Extended-Release);
28:08.04.08 – CYCLOOXYGENASE-2 (COX-2) INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18239
APO-DICLO SR;
02162814;
diclofenac sodium 75 mg;
1995-12-31;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19125
DICLOFENAC-SR;
02224119;
diclofenac sodium 75 mg;
1997-08-06;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43393
PMS-DICLOFENAC-SR;
02231504;
diclofenac sodium 75 mg;
1997-11-28;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50844
SANDOZ-DICLOFENAC SR;
02261901;
diclofenac sodium 75 mg;
2006-02-02;
Oral;
Tablet (Extended-Release);
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74726
JAMP-DICYCLOMINE HCL;
02391619;
dicyclomine hydrochloride 10 mg;
2012-10-23;
Oral;
Tablet;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87694
JAMP-DICYCLOMINE HCL;
02366088;
dicyclomine hydrochloride 20 mg;
2011-08-08;
Oral;
Tablet;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85095
VISANNE;
02374900;
dienogest 2 mg;
2011-10-25;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86025
ASPEN-DIENOGEST;
02493055;
dienogest 2 mg;
2020-04-14;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98304
JAMP DIENOGEST;
02498189;
dienogest 2 mg;
2020-12-10;
Oral;
Tablet;
68:32.00 – PROGESTINS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98796
DUREZOL;
02415534;
difluprednate 0.05 % / w/v;
2014-02-19;
Ophthalmic;
Emulsion;
52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90012
TOLOXIN;
02242320;
digoxin 0.05 mg / ml;
2001-06-01;
Oral;
Solution;
24:04.08 – CARDIOTONIC AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66031
TOLOXIN;
02335700;
digoxin 0.0625 mg;
2009-12-23;
Oral;
Tablet;
24:04.08 – CARDIOTONIC AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82129
TOLOXIN;
02335719;
digoxin 0.125 mg;
2009-12-23;
Oral;
Tablet;
24:04.08 – CARDIOTONIC AGENTS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82130
DIGOXIN INJECTION C.S.D.;
02048264;
digoxin 0.5 mg / 2 ml;
1994-12-31;
Intramuscular , Intravenous;
Liquid;
24:04.08 – CARDIOTONIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15757
DIGIFAB;
02361043;
digoxin immune fab (ovine) 40 mg / vial;
2011-11-04;
Intravenous;
Powder For Solution;
92:12.00 – ANTIDOTES;
Prescription , Schedule D;
BTG INTERNATIONAL INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84609
MIGRANAL NASAL SPRAY 4MG/ML;
02228947;
dihydroergotamine mesylate 0.5 mg / act;
1996-11-05;
Nasal;
Liquid;
12:16.00 – SYMPATHOLYTIC (ADRENERGIC BLOCKING) AGENTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43498
DIHYDROERGOTAMINE (DHE), 1MG/ML;
00027243;
dihydroergotamine mesylate 1 mg / ml;
1946-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:16.00 – SYMPATHOLYTIC (ADRENERGIC BLOCKING) AGENTS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=415
APO-DILTIAZ CD;
02230997;
diltiazem hydrochloride 120 mg;
1997-03-27;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50278
TIAZAC;
02231150;
diltiazem hydrochloride 120 mg;
1997-06-09;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50458
DILTIAZEM-CD;
02231472;
diltiazem hydrochloride 120 mg;
1998-06-01;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50796
TEVA-DILTIAZEM CD;
02242538;
diltiazem hydrochloride 120 mg;
2000-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66289
SANDOZ DILTIAZEM CD;
02243338;
diltiazem hydrochloride 120 mg;
2001-02-20;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67243
SANDOZ DILTIAZEM T;
02245918;
diltiazem hydrochloride 120 mg;
2006-01-26;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70038
TIAZAC XC;
02256738;
diltiazem hydrochloride 120 mg;
2004-08-13;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74195
TEVA-DILTIAZEM HCL ER CAPSULES;
02271605;
diltiazem hydrochloride 120 mg;
2006-01-30;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75715
ACT DILTIAZEM T;
02370441;
diltiazem hydrochloride 120 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85560
ACT DILTIAZEM CD;
02370611;
diltiazem hydrochloride 120 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85575
DILTIAZEM CD;
02445999;
diltiazem hydrochloride 120 mg;
2015-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93126
MAR-DILTIAZEM T;
02465353;
diltiazem hydrochloride 120 mg;
2018-05-28;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95355
MAR-DILTIAZEM CD;
02484064;
diltiazem hydrochloride 120 mg;
2020-03-30;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97439
APO-DILTIAZ CD;
02230998;
diltiazem hydrochloride 180 mg;
1997-03-27;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50279
TIAZAC;
02231151;
diltiazem hydrochloride 180 mg;
1997-06-09;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50459
DILTIAZEM-CD;
02231474;
diltiazem hydrochloride 180 mg;
1998-06-02;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50798
TEVA-DILTIAZEM CD;
02242539;
diltiazem hydrochloride 180 mg;
2000-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66290
SANDOZ DILTIAZEM CD;
02243339;
diltiazem hydrochloride 180 mg;
2001-02-20;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67244
SANDOZ DILTIAZEM T;
02245919;
diltiazem hydrochloride 180 mg;
2006-01-26;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70039
TIAZAC XC;
02256746;
diltiazem hydrochloride 180 mg;
2004-08-13;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74196
TEVA-DILTIAZEM HCL ER CAPSULES;
02271613;
diltiazem hydrochloride 180 mg;
2006-01-30;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75716
ACT DILTIAZEM T;
02370492;
diltiazem hydrochloride 180 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85564
ACT DILTIAZEM CD;
02370638;
diltiazem hydrochloride 180 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85576
DILTIAZEM CD;
02446006;
diltiazem hydrochloride 180 mg;
2015-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93127
MAR-DILTIAZEM T;
02465361;
diltiazem hydrochloride 180 mg;
2018-05-28;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95356
MAR-DILTIAZEM CD;
02484072;
diltiazem hydrochloride 180 mg;
2020-03-30;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97440
APO-DILTIAZ CD;
02230999;
diltiazem hydrochloride 240 mg;
1997-03-27;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50280
TIAZAC;
02231152;
diltiazem hydrochloride 240 mg;
1997-06-09;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50460
DILTIAZEM-CD;
02231475;
diltiazem hydrochloride 240 mg;
1998-06-02;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50799
TEVA-DILTIAZEM CD;
02242540;
diltiazem hydrochloride 240 mg;
2000-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66291
SANDOZ DILTIAZEM CD;
02243340;
diltiazem hydrochloride 240 mg;
2001-02-20;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67245
TIAZAC XC;
02256754;
diltiazem hydrochloride 240 mg;
2004-08-13;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74197
TEVA-DILTIAZEM HCL ER CAPSULES;
02271621;
diltiazem hydrochloride 240 mg;
2006-01-30;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75717
ACT DILTIAZEM T;
02370506;
diltiazem hydrochloride 240 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85565
DILTIAZEM CD;
02446014;
diltiazem hydrochloride 240 mg;
2015-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93128
MAR-DILTIAZEM T;
02465388;
diltiazem hydrochloride 240 mg;
2018-05-28;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95357
MAR-DILTIAZEM CD;
02484080;
diltiazem hydrochloride 240 mg;
2020-03-30;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97441
AA-DILTIAZ;
00771376;
diltiazem hydrochloride 30 mg;
1988-12-31;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9172
APO-DILTIAZ CD;
02229526;
diltiazem hydrochloride 300 mg;
1996-09-12;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47431
DILTIAZEM-CD;
02231057;
diltiazem hydrochloride 300 mg;
1998-10-09;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50338
TIAZAC;
02231154;
diltiazem hydrochloride 300 mg;
1997-06-09;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50461
TEVA-DILTIAZEM CD;
02242541;
diltiazem hydrochloride 300 mg;
2000-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66292
SANDOZ DILTIAZEM CD;
02243341;
diltiazem hydrochloride 300 mg;
2001-02-20;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67246
SANDOZ DILTIAZEM T;
02245921;
diltiazem hydrochloride 300 mg;
2006-01-26;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70041
TIAZAC XC;
02256762;
diltiazem hydrochloride 300 mg;
2004-08-13;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74198
TEVA-DILTIAZEM HCL ER CAPSULES;
02271648;
diltiazem hydrochloride 300 mg;
2006-01-30;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75718
ACT DILTIAZEM T;
02370514;
diltiazem hydrochloride 300 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85566
ACT DILTIAZEM CD;
02370654;
diltiazem hydrochloride 300 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85578
DILTIAZEM CD;
02446022;
diltiazem hydrochloride 300 mg;
2015-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93129
MAR-DILTIAZEM T;
02465396;
diltiazem hydrochloride 300 mg;
2018-05-22;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95358
MAR-DILTIAZEM CD;
02484099;
diltiazem hydrochloride 300 mg;
2020-03-30;
Oral;
Capsule (Controlled-Delivery);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97442
TIAZAC;
02231155;
diltiazem hydrochloride 360 mg;
1997-06-09;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50462
TIAZAC XC;
02256770;
diltiazem hydrochloride 360 mg;
2004-08-13;
Oral;
Tablet (Extended-Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74199
TEVA-DILTIAZEM HCL ER CAPSULES;
02271656;
diltiazem hydrochloride 360 mg;
2006-01-30;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75719
ACT DILTIAZEM T;
02370522;
diltiazem hydrochloride 360 mg;
2011-10-06;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85567
MAR-DILTIAZEM T;
02465418;
diltiazem hydrochloride 360 mg;
2018-05-22;
Oral;
Capsule (Extended Release);
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95359
DILTIAZEM HYDROCHLORIDE INJECTION;
02244728;
diltiazem hydrochloride 5 mg / ml;
2002-01-09;
Intravenous;
Solution;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68717
AA-DILTIAZ;
00771384;
diltiazem hydrochloride 60 mg;
1988-12-31;
Oral;
Tablet;
24:28.92 – MISCELLANEOUS CALCIUM-CHANNEL BLOCKING AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9173
DIMENHYDRINATE INJ 10MG;
00392731;
dimenhydrinate 10 mg / ml;
1973-12-31;
Intravenous;
Liquid;
56:22.08 – ANTIHISTAMINES;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3595
GRAVOL SUPPOSITORIES;
00013609;
dimenhydrinate 100 mg;
1951-12-31;
Rectal;
Suppository;
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=193
CONFAB DIMENHYDRINATE 100 MG;
00392545;
dimenhydrinate 100 mg;
1974-12-31;
Rectal;
Suppository;
56:22.08 – ANTIHISTAMINES;
Otc;
LABORATOIRES CONFAB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2890
GRAVOL IMMEDIATE RELEASE & LONG ACTING CAPLETS;
02254409;
dimenhydrinate 100 mg;
2005-02-10;
Oral;
Tablet (Combined Release);
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73930
KIDS GRAVOL CHEWABLES;
02384116;
dimenhydrinate 15 mg;
2012-11-14;
Oral;
Tablet (Chewable);
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86986
KIDS GRAVOL LIQUID;
00230197;
dimenhydrinate 15 mg / 5 ml;
1951-12-31;
Oral;
Syrup;
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1256
KIDS GRAVOL SUPPOSITORIES;
00783595;
dimenhydrinate 25 mg;
1989-12-31;
Rectal;
Suppository;
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9585
TEVA-DIMENATE;
00021423;
dimenhydrinate 50 mg;
1967-12-31;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=577
APO DIMENHYDRINATE TAB 50MG;
00363766;
dimenhydrinate 50 mg;
1977-12-31;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2701
CONFAB DIMENHYDRINATE 50 MG;
00392553;
dimenhydrinate 50 mg;
1974-12-31;
Rectal;
Suppository;
56:22.08 – ANTIHISTAMINES;
Otc;
LABORATOIRES CONFAB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2891
GRAVOL TABLETS;
00013803;
dimenhydrinate 50 mg;
1980-12-31;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3944
TRAVEL TABS 50 MG;
00605786;
dimenhydrinate 50 mg;
1984-12-31;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5572
DIMENHYDRINATE TABLETS;
02006669;
dimenhydrinate 50 mg;
2001-11-06;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=25821
ANTI-NAUSEANT;
02241532;
dimenhydrinate 50 mg;
2000-05-01;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65184
JAMP-DIMENHYDRINATE;
02245416;
dimenhydrinate 50 mg;
2003-07-31;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69468
GRAVOL LIQUID GELS;
02245867;
dimenhydrinate 50 mg;
2002-09-23;
Oral;
Capsule;
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69984
TRAVEL TABS;
02263432;
dimenhydrinate 50 mg;
2010-01-07;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74882
ANTI-NAUSEANT;
02377179;
dimenhydrinate 50 mg;
2013-07-02;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86277
GRAVOL CHEWABLES;
02384132;
dimenhydrinate 50 mg;
2012-11-14;
Oral;
Tablet (Chewable);
56:22.08 – ANTIHISTAMINES;
Otc;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86988
DIMENHYDRINATE CAPSULES;
02407396;
dimenhydrinate 50 mg;
2014-07-24;
Oral;
Capsule;
56:22.08 – ANTIHISTAMINES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89209
GAVISCON NAUSEA;
02490528;
dimenhydrinate 50 mg;
2020-02-24;
Oral;
Tablet;
56:22.08 – ANTIHISTAMINES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98056
ANTI-NAUSEANT LIQUID GELS;
02493004;
dimenhydrinate 50 mg;
2020-08-04;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98298
GRAVOL IM;
00013579;
dimenhydrinate 50 mg / ml;
1953-12-31;
Intramuscular;
Solution;
56:22.08 – ANTIHISTAMINES;
Ethical;
CHURCH & DWIGHT CANADA CORP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=197
DIMENHYDRINATE INJ 50MG USP;
00392537;
dimenhydrinate 50 mg / ml;
1973-12-31;
Intramuscular , Intravenous;
Liquid;
56:22.08 – ANTIHISTAMINES;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3397
DIMENHYDRINATE INJECTION USP;
02428954;
dimenhydrinate 50 mg / ml;
2016-01-28;
Intramuscular , Intravenous;
Solution;
56:22.08 – ANTIHISTAMINES;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91339
DIMENHYDRINATE INJECTION USP WITH PRESERVATIVE;
02435241;
dimenhydrinate 50 mg / ml;
2016-01-28;
Intramuscular , Intravenous;
Solution;
56:22.08 – ANTIHISTAMINES;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91952
PROSHIELD PLUS;
02256975;
dimethicone 1 % / w/w;
2005-02-11;
Topical;
Ointment;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
SMITH & NEPHEW INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74220
CAVILON DURABLE BARRIER CREAM;
02455838;
dimethicone 1.3 % / w/w;
2017-04-28;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
3M CANADA COMPANY
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94265
BAZA CLEANSE & PROTECT;
02243966;
dimethicone 2 % / w/w;
2002-06-01;
Topical;
Lotion;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
COLOPLAST A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67909
COMFORT SHIELD;
02245871;
dimethicone 3 %;
2004-12-10;
Topical;
Wipe;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
SAGE PRODUCTS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69988
DIMETHICONE PROTECTANT;
02301725;
dimethicone 5.0 % / w/w;
2008-05-30;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
SMITH & NEPHEW INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78703
NYDA;
02373785;
dimethicone 50 %;
2012-01-06;
Topical;
Solution;
84:04.12 – SCABICIDES AND PEDICULICIDES;
Otc;
G POHL-BOSKAMP GMBH & CO KG
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85900
SWEEN 24;
02250322;
dimethicone 6 % / w/w;
2004-11-29;
Topical;
Cream;
84:24.12 – BASIC OINTMENTS AND PROTECTANTS;
Otc;
COLOPLAST A/S
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73513
TECFIDERA;
02404508;
dimethyl fumarate 120 mg;
2013-04-12;
Oral;
Capsule (Delayed Release);
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
BIOGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88926
TECFIDERA;
02420201;
dimethyl fumarate 240 mg;
2014-02-04;
Oral;
Capsule (Delayed Release);
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
BIOGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90480
RIMSO-50;
00493392;
dimethyl sulfoxide 500 mg / g;
1980-12-31;
Intravesical;
Solution;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3769
PROSTIN E2 TABLETS;
00400688;
dinoprostone 0.5 mg;
1977-12-31;
Oral;
Tablet;
76:00.00 – OXYTOCICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2684
PREPIDIL GEL;
00860786;
dinoprostone 0.5 mg / 2.5 ml;
1990-12-31;
Intracervical;
Gel;
76:00.00 – OXYTOCICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10492
PROSTIN E2 VAGINAL GEL;
01919679;
dinoprostone 1 mg / 3 g;
1991-12-31;
Vaginal;
Gel;
76:00.00 – OXYTOCICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11830
CERVIDIL;
02231047;
dinoprostone 10 mg / insert;
1997-06-17;
Vaginal;
Insert;
76:00.00 – OXYTOCICS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50327
PROSTIN E2 VAGINAL GEL;
01919687;
dinoprostone 2 mg / 3 g;
1991-12-31;
Vaginal;
Gel;
76:00.00 – OXYTOCICS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11831
UNITUXIN;
02483076;
dinutuximab 3.5 mg / ml;
2019-05-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
UNITED THERAPEUTICS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97347
CHILDREN’S BENADRYL ALLERGY CHEWABLES;
02061287;
diphenhydramine hydrochloride 12.5 mg;
1998-03-06;
Oral;
Tablet (Chewable);
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27547
JUNIOR STRENGTH ALLERGY FORMULA;
02328895;
diphenhydramine hydrochloride 12.5 mg;
2010-12-10;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81456
ALLERNIX ELIXIR;
00804193;
diphenhydramine hydrochloride 12.5 mg / 5 ml;
1991-12-31;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11772
BENADRYL ALLERGY LIQUID;
02019736;
diphenhydramine hydrochloride 12.5 mg / 5 ml;
1994-12-31;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15516
ALLERGY FORMULA LIQUID;
02141736;
diphenhydramine hydrochloride 12.5 mg / 5 ml;
1997-09-29;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31478
BENYLIN SLEEP TIME;
02248859;
diphenhydramine hydrochloride 12.5 mg / 5 ml;
2012-08-31;
Oral;
Liquid;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73231
DIPHENHYDRAMINE HYDROCHLORIDE ELIXIR USP;
02298503;
diphenhydramine hydrochloride 12.5 mg / 5 ml;
2009-01-30;
Oral;
Elixir;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78380
ALLERGY FORMULA ELIXIR;
02446170;
diphenhydramine hydrochloride 12.5 mg / 5 ml;
2016-10-19;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93143
ALLERGY FORMULA;
02465108;
diphenhydramine hydrochloride 12.5 mg / 5 ml;
2018-09-10;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95330
BENADRYL CREAM 2%;
02019701;
diphenhydramine hydrochloride 2 %;
1993-12-31;
Topical;
Cream;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14257
ANTI-ITCH CREAM;
02247560;
diphenhydramine hydrochloride 2 %;
2007-12-20;
Topical;
Cream;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71812
PDP-DIPHENHYDRAMINE;
00757683;
diphenhydramine hydrochloride 25 mg;
1990-12-31;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10874
ALLERGY TABLETS 25MG;
01949454;
diphenhydramine hydrochloride 25 mg;
1992-12-31;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13447
BENADRYL ALLERGY;
02017849;
diphenhydramine hydrochloride 25 mg;
1993-12-31;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13782
ALLERNIX;
02097583;
diphenhydramine hydrochloride 25 mg;
1995-12-31;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17794
ALLERGY FORMULA CAPLETS;
02141728;
diphenhydramine hydrochloride 25 mg;
1997-09-29;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31477
ALLERGY FORMULA;
02229492;
diphenhydramine hydrochloride 25 mg;
1997-04-01;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=47391
SLEEP-EZE REGULAR STRENGTH CAPLETS;
02229960;
diphenhydramine hydrochloride 25 mg;
1997-11-12;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48414
NADRYL 25MG;
02239029;
diphenhydramine hydrochloride 25 mg;
2002-02-14;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62481
JAMP DIPHENHYDRAMINE 25 MG;
02257548;
diphenhydramine hydrochloride 25 mg;
2005-09-12;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74279
NIGHTTIME SLEEP AID;
02297701;
diphenhydramine hydrochloride 25 mg;
2014-01-24;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78305
BENADRYL ALLERGY LIQUIGELS;
02304252;
diphenhydramine hydrochloride 25 mg;
2008-05-05;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78954
ALLERGY FORMULA LIQUID CAPSULES;
02306352;
diphenhydramine hydrochloride 25 mg;
2008-07-11;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79190
ALLERGY FORMULA;
02323346;
diphenhydramine hydrochloride 25 mg;
2010-07-21;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80881
SLEEP-EZE;
02348608;
diphenhydramine hydrochloride 25 mg;
2010-08-03;
Oral;
Tablet;
04:04.00 – FIRST GENERATION ANTIHISTAMINES;
Otc;
PRESTIGE BRANDS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83395
REGULAR STRENGTH SLEEP AID;
02365685;
diphenhydramine hydrochloride 25 mg;
2011-03-31;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85056
ZZZQUIL;
02383268;
diphenhydramine hydrochloride 25 mg;
2013-02-12;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86902
ALLERGY LIQUID GEL CAPSULES;
02447835;
diphenhydramine hydrochloride 25 mg;
2016-10-13;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93343
ALLERGY FORMULA CAPLETS;
02479710;
diphenhydramine hydrochloride 25 mg;
2018-11-14;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97036
DORMIPHEN EXTRA-FORT CAPSULE;
00489867;
diphenhydramine hydrochloride 50 mg;
1980-12-31;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
LABORATOIRE LALCO INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3775
EXTRA STRENGTH NYTOL TAB 50MG;
00583332;
diphenhydramine hydrochloride 50 mg;
1983-12-31;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5187
PDP-DIPHENHYDRAMINE EXTRA STRENGTH/ EXTRA FORT;
00757691;
diphenhydramine hydrochloride 50 mg;
1990-12-31;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10875
NYTOL EXTRA STRENGTH SLEEP AID CAPLET 50MG;
01934414;
diphenhydramine hydrochloride 50 mg;
1991-12-31;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11762
UNISOM;
01946986;
diphenhydramine hydrochloride 50 mg;
1982-12-31;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12743
ALLERNIX EXTRA STRENGTH;
02097575;
diphenhydramine hydrochloride 50 mg;
1995-12-31;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17781
SLEEP AID EXTRA STRENGTH TAB 50MG;
01991086;
diphenhydramine hydrochloride 50 mg;
1997-03-04;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=24750
UNISOM SLEEPGELS EXTRA STRENGTH;
02061597;
diphenhydramine hydrochloride 50 mg;
1996-09-05;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=27528
SLEEP-EZE EXTRA STRENGTH CAPLETS;
02229959;
diphenhydramine hydrochloride 50 mg;
1997-11-12;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=48413
ALLERGY TABLETS EXTRA STRENGTH;
02230398;
diphenhydramine hydrochloride 50 mg;
1997-04-21;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TANTA PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49235
SLEEP AID;
02230485;
diphenhydramine hydrochloride 50 mg;
1997-06-10;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=49476
EXTRA STRENGTH NYTOL QUICKGELS;
02237169;
diphenhydramine hydrochloride 50 mg;
1999-01-08;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60487
DORMIPHEN EXTRA-FORT COMPRIME;
02237789;
diphenhydramine hydrochloride 50 mg;
1998-06-05;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
LABORATOIRE LALCO INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61146
SLEEP-EZE EXTRA STRENGTH GELCAPS;
02238644;
diphenhydramine hydrochloride 50 mg;
1999-12-14;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62073
EXTRA STRENGTH BENADRYL ALLERGY NIGHTTIME;
02239138;
diphenhydramine hydrochloride 50 mg;
1999-04-06;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62594
SLEEP AID LIQUID FASTGELS;
02244203;
diphenhydramine hydrochloride 50 mg;
2001-09-01;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68166
JAMP DIPHENHYDRAMINE 50 MG;
02257556;
diphenhydramine hydrochloride 50 mg;
2005-09-12;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74280
SLEEP AID EXTRA STRENGTH;
02297728;
diphenhydramine hydrochloride 50 mg;
2017-06-05;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78306
EXTRA STRENGTH ALLERGY FORMULA LIQUID CAPSULES;
02321270;
diphenhydramine hydrochloride 50 mg;
2009-11-05;
Oral;
Capsule;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80667
INSOMNAL;
02358689;
diphenhydramine hydrochloride 50 mg;
2011-02-14;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84371
EXTRA STRENGTH DORMEX CAPLETS;
02409259;
diphenhydramine hydrochloride 50 mg;
2013-11-06;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89397
EXTRA STRENGTH BENADRYL ALLERGY;
02470144;
diphenhydramine hydrochloride 50 mg;
2018-03-26;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95910
SLEEP-EZE EXTRA STRENGTH MINIS;
02478757;
diphenhydramine hydrochloride 50 mg;
2018-12-03;
Oral;
Tablet;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96950
DIPHENHYDRAMINE HYDROCHLORIDE INJECTION USP;
00596612;
diphenhydramine hydrochloride 50 mg / ml;
1983-12-31;
Intramuscular , Intravenous;
Liquid;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5430
DIPHENIST 50MG/ML;
02219336;
diphenhydramine hydrochloride 50 mg / ml;
1997-10-28;
Intramuscular , Intravenous;
Liquid;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37198
DIPHENHYDRAMINE HYDROCHLORIDE INJECTION;
02369567;
diphenhydramine hydrochloride 50 mg / ml;
2012-02-17;
Intramuscular , Intravenous;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85449
NIGHTTIME SLEEP-AID;
02404869;
diphenhydramine hydrochloride 50 mg / 30 ml;
2015-02-12;
Oral;
Liquid;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88969
ZZZQUIL LIQUID;
02419769;
diphenhydramine hydrochloride 50 mg / 30 ml;
2014-08-15;
Oral;
Liquid;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PROCTER & GAMBLE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90439
NIGHTTIME SLEEP AID LIQUID;
02427427;
diphenhydramine hydrochloride 50 mg / 30 ml;
2015-05-13;
Oral;
Solution;
04:04.00 – FIRST GENERATION ANTIHISTAMINES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91195
SLEEP-EZE EZE-LIQUID;
02432129;
diphenhydramine hydrochloride 50 mg / 30 ml;
2015-03-30;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91657
NIGHTTIME SLEEP AID;
02464683;
diphenhydramine hydrochloride 50 mg / 30 ml;
2018-06-14;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95281
SLEEP-EZE EZE-FREE;
02474867;
diphenhydramine hydrochloride 50 mg / 30 ml;
2018-12-03;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MEDTECH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96508
CHILDREN’S BENADRYL ALLERGY LIQUID;
02019698;
diphenhydramine hydrochloride 6.25 mg / 5 ml;
1991-12-31;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15880
CHILDREN’S ALLERGY FORMULA;
02246936;
diphenhydramine hydrochloride 6.25 mg / 5 ml;
2004-11-01;
Oral;
Syrup;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71163
BENYLIN FOR CHILDREN COUGH NIGHT;
02248858;
diphenhydramine hydrochloride 6.25 mg / 5 ml;
2013-01-28;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73230
CHILDREN’S CLEAR ALLERGY FORMULA;
02478242;
diphenhydramine hydrochloride 6.25 mg / 5 ml;
2020-04-24;
Oral;
Solution;
04:04.04 – ETHANOLAMINE DERIVATIVES;
Otc;
JUNO OTC INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96896
APO-DIPYRIDAMOLE-FC TAB 25MG;
00895644;
dipyridamole 25 mg;
1990-12-31;
Oral;
Tablet;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11034
PERSANTINE;
00637734;
dipyridamole 5 mg / ml;
1986-12-31;
Intravenous;
Solution;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
GLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6720
DIPYRIDAMOLE INJECTION, USP;
02244475;
dipyridamole 5 mg / ml;
2002-04-23;
Intravenous;
Liquid;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68448
APO-DIPYRIDAMOLE-FC TAB 50MG;
00895652;
dipyridamole 50 mg;
1990-12-31;
Oral;
Tablet;
24:12.92 – MISCELLANEOUS VASODILATATING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11035
RYTHMODAN;
02224801;
disopyramide 100 mg;
2003-09-12;
Oral;
Capsule;
24:04.04.04 – CLASS IA ANTIARRYTHMICS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37379
DOBUTAMINE INJECTION USP;
02242010;
dobutamine (dobutamine hydrochloride) 12.5 mg / ml;
2000-10-02;
Intravenous;
Liquid;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65680
DOBUTAMINE INJECTION USP;
02462729;
dobutamine (dobutamine hydrochloride) 12.5 mg / ml;
2017-12-14;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95055
DOBUTAMINE INJECTION USP;
02210401;
dobutamine (dobutamine hydrochloride) 250 mg / 20 ml;
1996-10-24;
Intravenous;
Solution;
12:12.08.08 – SELECTIVE BETA 1-ADRENERGIC AGONISTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43041
DOCETAXEL INJECTION USP;
02361957;
docetaxel 10 mg / ml;
2011-03-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84699
DOCETAXEL INJECTION;
02439336;
docetaxel 10 mg / ml;
2016-06-02;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92370
DOCETAXEL INJECTION;
02437031;
docetaxel 20 mg / ml;
2015-02-27;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92134
DOCETAXEL INJECTION;
02458020;
docetaxel 20 mg / ml;
2017-10-17;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BIOLYSE PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94508
ABREVA;
02245677;
docosanol 10 %;
2005-08-15;
Topical;
Cream;
84:04.06 – ANTIVIRALS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69777
DOCUSATE CALCIUM;
02246741;
docusate calcium 240 mg;
2003-03-13;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70938
JAMP-DOCUSATE CALCIUM;
02283255;
docusate calcium 240 mg;
2006-10-18;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76888
DOCUSATE SODIUM;
00870218;
docusate sodium 10 mg / ml;
1991-12-31;
Oral;
Drops;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11521
COLACE;
02090163;
docusate sodium 10 mg / ml;
1997-04-01;
Oral;
Drops;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
BOYD PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28453
SELAX CAP 100MG;
00514888;
docusate sodium 100 mg;
1985-12-31;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6258
PMS-DOCUSATE SODIUM;
00703494;
docusate sodium 100 mg;
1986-12-31;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7365
TARO-DOCUSATE;
00716731;
docusate sodium 100 mg;
1988-12-31;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8974
TEVA-DOCUSATE SODIUM;
00870196;
docusate sodium 100 mg;
1990-12-31;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10986
SOFLAX CAPSULES 100MG;
01994344;
docusate sodium 100 mg;
1993-12-31;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14487
NOVO-DOCUSATE;
02020084;
docusate sodium 100 mg;
1988-12-31;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16492
COLACE CAPSULES;
02106256;
docusate sodium 100 mg;
1997-07-02;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
BOYD PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=29540
STOOL SOFTENER;
02232969;
docusate sodium 100 mg;
1998-08-07;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PERRIGO INTERNATIONAL
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=52463
APO-DOCUSATE SODIUM;
02245079;
docusate sodium 100 mg;
2002-11-04;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69083
JAMP-DOCUSATE SODIUM;
02245946;
docusate sodium 100 mg;
2004-06-30;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70070
DOCUSATE SODIUM;
02246036;
docusate sodium 100 mg;
2003-04-08;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70167
SANDOZ DOCUSATE SODIUM;
02247385;
docusate sodium 100 mg;
2006-11-20;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71630
STOOL SOFTENER;
02281031;
docusate sodium 100 mg;
2007-10-01;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76671
DOCUSATE SODIUM;
02326086;
docusate sodium 100 mg;
2009-06-12;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81142
STOOL SOFTENER;
02357305;
docusate sodium 100 mg;
2011-01-10;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84243
JAMP DOCUSATE S OBLONG;
02376121;
docusate sodium 100 mg;
2016-04-12;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86158
DOCUSATE SODIUM;
02426838;
docusate sodium 100 mg;
2014-07-16;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91138
M-DOCUSATE SODIUM 100 MG;
02437317;
docusate sodium 100 mg;
2019-09-24;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92166
ALTA-DOCUSATE SODIUM;
02465329;
docusate sodium 100 mg;
2018-05-25;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95352
COLACE CLEAR;
02484226;
docusate sodium 100 mg;
2019-03-08;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
BOYD PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97454
PMS-DOCUSATE SODIUM;
00703508;
docusate sodium 20 mg / 5 ml;
1987-12-31;
Oral;
Syrup;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7366
RATIO-DOCUSATE SODIUM;
00870226;
docusate sodium 20 mg / 5 ml;
1991-12-31;
Oral;
Syrup;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11520
SOFLAX SYRUP 4MG/ML;
02006758;
docusate sodium 20 mg / 5 ml;
1995-12-31;
Oral;
Syrup;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18776
COLACE SYRUP;
02086018;
docusate sodium 20 mg / 5 ml;
1997-04-01;
Oral;
Syrup;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
BOYD PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=28280
SIROP DOCUSATE DE SODIUM U.S.P. 4MG/ML;
02238283;
docusate sodium 20 mg / 5 ml;
1998-09-02;
Oral;
Syrup;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61679
DOCUSATE SODIUM;
02246854;
docusate sodium 20 mg / 5 ml;
2003-04-08;
Oral;
Syrup;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71056
PMS-DOCUSATE SODIUM;
00765104;
docusate sodium 200 mg;
1990-12-31;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10975
SOFLAX;
02029529;
docusate sodium 200 mg;
1998-04-16;
Oral;
Capsule;
56:12.00 – CATHARTICS AND LAXATIVES;
Otc;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26561
TIVICAY;
02461218;
dolutegravir (dolutegravir sodium) 10 mg;
2017-06-20;
Oral;
Tablet;
08:18.08.92 – MISCELLANEOUS ANTIRETROVIRALS*;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94871
TIVICAY;
02461226;
dolutegravir (dolutegravir sodium) 25 mg;
2017-06-20;
Oral;
Tablet;
08:18.08.92 – MISCELLANEOUS ANTIRETROVIRALS*;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94872
TIVICAY;
02414945;
dolutegravir (dolutegravir sodium) 50 mg;
2013-11-08;
Oral;
Tablet;
08:18.08.92 – MISCELLANEOUS ANTIRETROVIRALS*;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89957
TEVA-DOMPERIDONE;
01912070;
domperidone (domperidone maleate) 10 mg;
1993-12-31;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13180
APO-DOMPERIDONE – TAB 10MG;
02103613;
domperidone (domperidone maleate) 10 mg;
1997-09-17;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43813
DOMPERIDONE-10;
02236857;
domperidone (domperidone maleate) 10 mg;
1998-07-13;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60147
DOMPERIDONE;
02238341;
domperidone (domperidone maleate) 10 mg;
1998-09-03;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61748
RAN-DOMPERIDONE;
02268078;
domperidone (domperidone maleate) 10 mg;
2005-07-05;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75346
DOMPERIDONE;
02350440;
domperidone (domperidone maleate) 10 mg;
2010-05-12;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83565
JAMP-DOMPERIDONE;
02369206;
domperidone (domperidone maleate) 10 mg;
2011-10-07;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85414
MAR-DOMPERIDONE;
02403870;
domperidone (domperidone maleate) 10 mg;
2014-01-02;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88864
BIO-DOMPERIDONE;
02445034;
domperidone (domperidone maleate) 10 mg;
2016-04-26;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93024
PRIVA-DOMPERIDONE;
02445328;
domperidone (domperidone maleate) 10 mg;
2017-02-16;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93055
PRZ-DOMPERIDONE;
02462834;
domperidone (domperidone maleate) 10 mg;
2018-04-02;
Oral;
Tablet;
56:32.00 – PROKINETIC AGENTS;
Prescription;
PHARMARIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95069
PMS-DONEPEZIL;
02322358;
donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80780
APO-DONEPEZIL;
02362279;
donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg;
2014-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84729
ACT DONEPEZIL ODT;
02397625;
donepezil hydrochloride (donepezil hydrochloride monohydrate) 10 mg;
2013-12-27;
Oral;
Tablet (Orally Disintegrating);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88256
PMS-DONEPEZIL;
02322331;
donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80779
APO-DONEPEZIL;
02362260;
donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84728
ACT DONEPEZIL ODT;
02397617;
donepezil hydrochloride (donepezil hydrochloride monohydrate) 5 mg;
2013-12-27;
Oral;
Tablet (Orally Disintegrating);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88255
ARICEPT;
02232044;
donepezil hydrochloride 10 mg;
1997-08-20;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51492
ARICEPT RDT;
02269465;
donepezil hydrochloride 10 mg;
2006-01-02;
Oral;
Tablet (Orally Disintegrating);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75484
SANDOZ DONEPEZIL;
02328682;
donepezil hydrochloride 10 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81419
TEVA-DONEPEZIL;
02340615;
donepezil hydrochloride 10 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82619
TARO-DONEPEZIL;
02381516;
donepezil hydrochloride 10 mg;
2013-12-24;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86736
AURO-DONEPEZIL;
02400588;
donepezil hydrochloride 10 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88537
MAR-DONEPEZIL;
02402106;
donepezil hydrochloride 10 mg;
2014-01-06;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88697
ACH-DONEPEZIL;
02402653;
donepezil hydrochloride 10 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88750
MINT-DONEPEZIL;
02408619;
donepezil hydrochloride 10 mg;
2019-06-11;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89335
BIO-DONEPEZIL;
02412861;
donepezil hydrochloride 10 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89757
DONEPEZIL;
02416425;
donepezil hydrochloride 10 mg;
2013-12-30;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90098
JAMP-DONEPEZIL TABLETS;
02416956;
donepezil hydrochloride 10 mg;
2014-09-26;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90158
DONEPEZIL;
02420600;
donepezil hydrochloride 10 mg;
2014-02-11;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90517
DONEPEZIL;
02426854;
donepezil hydrochloride 10 mg;
2018-03-21;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91140
NAT-DONEPEZIL;
02439565;
donepezil hydrochloride 10 mg;
2015-07-22;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92398
PRIVA-DONEPEZIL;
02446677;
donepezil hydrochloride 10 mg;
2020-12-11;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93211
M-DONEPEZIL;
02467461;
donepezil hydrochloride 10 mg;
2017-12-14;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95584
DONEPEZIL;
02475286;
donepezil hydrochloride 10 mg;
2018-05-16;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96564
ARICEPT;
02232043;
donepezil hydrochloride 5 mg;
1997-08-20;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=51491
ARICEPT RDT;
02269457;
donepezil hydrochloride 5 mg;
2006-01-02;
Oral;
Tablet (Orally Disintegrating);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75483
SANDOZ DONEPEZIL;
02328666;
donepezil hydrochloride 5 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81417
TEVA-DONEPEZIL;
02340607;
donepezil hydrochloride 5 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82618
TARO-DONEPEZIL;
02381508;
donepezil hydrochloride 5 mg;
2013-12-24;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86735
AURO-DONEPEZIL;
02400561;
donepezil hydrochloride 5 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88536
MAR-DONEPEZIL;
02402092;
donepezil hydrochloride 5 mg;
2014-01-06;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88696
ACH-DONEPEZIL;
02402645;
donepezil hydrochloride 5 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88749
MINT-DONEPEZIL;
02408600;
donepezil hydrochloride 5 mg;
2019-06-11;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89334
BIO-DONEPEZIL;
02412853;
donepezil hydrochloride 5 mg;
2013-12-27;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89756
DONEPEZIL;
02416417;
donepezil hydrochloride 5 mg;
2013-12-30;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90097
JAMP-DONEPEZIL TABLETS;
02416948;
donepezil hydrochloride 5 mg;
2014-09-26;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90157
DONEPEZIL;
02420597;
donepezil hydrochloride 5 mg;
2014-02-11;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90516
DONEPEZIL;
02426846;
donepezil hydrochloride 5 mg;
2018-03-21;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91139
NAT-DONEPEZIL;
02439557;
donepezil hydrochloride 5 mg;
2015-07-22;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92397
PRIVA-DONEPEZIL;
02446669;
donepezil hydrochloride 5 mg;
2020-12-11;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93210
M-DONEPEZIL;
02467453;
donepezil hydrochloride 5 mg;
2017-12-14;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95583
DONEPEZIL;
02475278;
donepezil hydrochloride 5 mg;
2018-05-16;
Oral;
Tablet;
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96563
PIFELTRO;
02481545;
doravirine 100 mg;
2018-11-14;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97199
PULMOZYME 1MG/ML;
02046733;
dornase alfa 1 mg / ml;
1994-12-31;
Inhalation;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15483
TRUSOPT;
02216205;
dorzolamide (dorzolamide hydrochloride) 2 %;
1996-12-31;
Ophthalmic;
Solution;
52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20083
TRUSOPT;
02269090;
dorzolamide (dorzolamide hydrochloride) 2 %;
2006-02-01;
Ophthalmic;
Solution;
52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
ELVIUM LIFE SCIENCES
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75449
SANDOZ DORZOLAMIDE;
02316307;
dorzolamide (dorzolamide hydrochloride) 2 %;
2010-10-25;
Ophthalmic;
Solution;
52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80181
JAMP-DORZOLAMIDE;
02453347;
dorzolamide (dorzolamide hydrochloride) 2 % / w/v;
2019-12-24;
Ophthalmic;
Solution;
52:40.12 – CARBONIC ANHYDRASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93987
TEVA-DOXAZOSIN;
02242728;
doxazosin (doxazosin mesylate) 1 mg;
2000-09-01;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66535
JAMP-DOXAZOSIN;
02489937;
doxazosin (doxazosin mesylate) 1 mg;
2020-05-06;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98001
APO-DOXAZOSIN;
02240588;
doxazosin (doxazosin mesylate) 1 mg / tab;
1999-07-22;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64159
TEVA-DOXAZOSIN;
02242729;
doxazosin (doxazosin mesylate) 2 mg;
2000-09-01;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66536
JAMP-DOXAZOSIN;
02489945;
doxazosin (doxazosin mesylate) 2 mg;
2020-05-06;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98002
APO-DOXAZOSIN;
02240589;
doxazosin (doxazosin mesylate) 2 mg / tab;
1999-07-22;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64160
TEVA-DOXAZOSIN;
02242730;
doxazosin (doxazosin mesylate) 4 mg;
2000-09-01;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66537
APO-DOXAZOSIN;
02240590;
doxazosin (doxazosin mesylate) 4 mg / tab;
1999-07-22;
Oral;
Tablet;
24:20.00 – ALPHA-ADRENERGIC BLOCKING AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64161
SINEQUAN;
00024325;
doxepin (doxepin hydrochloride) 10 mg;
1970-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=944
SINEQUAN;
00326925;
doxepin (doxepin hydrochloride) 100 mg;
1975-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2049
SINEQUAN;
00024333;
doxepin (doxepin hydrochloride) 25 mg;
1970-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=945
SILENOR;
02398257;
doxepin (doxepin hydrochloride) 3.00 mg;
2013-01-08;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88319
SINEQUAN;
00024341;
doxepin (doxepin hydrochloride) 50 mg;
1970-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=946
SILENOR;
02398265;
doxepin (doxepin hydrochloride) 6.00 mg;
2013-01-08;
Oral;
Tablet;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88320
SINEQUAN;
00400750;
doxepin (doxepin hydrochloride) 75 mg;
1977-12-31;
Oral;
Capsule;
28:16.04.28 – TRICYCLICS AND OTHER NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2780
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP;
02194457;
doxorubicin hydrochloride 10 mg / vial;
1998-03-12;
Intravenous , Intravesical;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42943
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP;
02194473;
doxorubicin hydrochloride 150 mg / vial;
1997-05-08;
Intravenous , Intravesical;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42945
CAELYX;
02238389;
doxorubicin hydrochloride 2 mg / ml;
1998-08-19;
Intravenous;
Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61804
DOXORUBICIN INJECTION, BP;
02381982;
doxorubicin hydrochloride 2 mg / ml;
2014-12-16;
Intravenous , Intravesical;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86785
DOXORUBICIN HYDROCHLORIDE INJECTION;
02409275;
doxorubicin hydrochloride 2 mg / ml;
2014-02-27;
Intravenous , Intravesical;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89399
DOXORUBICIN;
02410397;
doxorubicin hydrochloride 2 mg / ml;
2014-05-21;
Intravenous , Intravesical;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89506
DOXORUBICIN HYDROCHLORIDE INJECTION, USP;
02413973;
doxorubicin hydrochloride 2 mg / ml;
2015-01-08;
Intravenous , Intravesical;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89862
TARO-DOXORUBICIN LIPOSOMAL;
02493020;
doxorubicin hydrochloride 2 mg / ml;
2020-05-19;
Intravenous;
Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98300
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP;
02194465;
doxorubicin hydrochloride 50 mg / vial;
1997-07-30;
Intravenous , Intravesical;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42944
APO-DOXY CAP 100MG;
00740713;
doxycycline (doxycycline hyclate) 100 mg;
1987-12-31;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7627
DOXYCIN TAB 100MG;
00860751;
doxycycline (doxycycline hyclate) 100 mg;
1989-12-31;
Oral;
Tablet;
08:12.24 – TETRACYCLINES;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10024
TEVA-DOXYCYCLINE;
00725250;
doxycycline (doxycycline hyclate) 100 mg;
1989-12-31;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10117
APO-DOXY TABS 100MG;
00874256;
doxycycline (doxycycline hyclate) 100 mg;
1990-12-31;
Oral;
Tablet;
08:12.24 – TETRACYCLINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10383
DOXYTAB;
00887064;
doxycycline (doxycycline hyclate) 100 mg;
1990-12-31;
Oral;
Tablet;
08:12.24 – TETRACYCLINES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10897
TEVA-DOXYCYCLINE;
02158574;
doxycycline (doxycycline hyclate) 100 mg;
1995-12-31;
Oral;
Tablet;
08:12.24 – TETRACYCLINES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18421
DOXYCYCLINE CAPSULES;
02351234;
doxycycline (doxycycline hyclate) 100 mg;
2010-06-15;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83642
DOXYCYCLINE TABLETS;
02351242;
doxycycline (doxycycline hyclate) 100 mg;
2010-06-15;
Oral;
Tablet;
08:12.24 – TETRACYCLINES;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83643
PERIOSTAT;
02247104;
doxycycline (doxycycline hyclate) 20 mg;
2003-09-03;
Oral;
Capsule;
08:12.24 – TETRACYCLINES;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71343
ATRIDOX;
02242473;
doxycycline (doxycycline hyclate) 8.8 % / w/w;
2001-01-31;
Subgingival;
Gel (Controlled-Release);
52:04.04 – ANTIBACTERIALS;
Prescription;
DEN-MAT HOLDINGS, LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66197
APPRILON;
02375885;
doxycycline (doxycycline monohydrate) 40 mg;
2012-11-29;
Oral;
Capsule (Immediate And Delayed Release);
08:12.24 – TETRACYCLINES;
Prescription;
GALDERMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86128
MULTAQ;
02330989;
dronedarone (dronedarone hydrochloride) 400 mg;
2009-09-28;
Oral;
Tablet;
24:04.04.20 – CLASS III ANTIARRYTHMICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81672
TRULICITY;
02448599;
dulaglutide 0.75 mg / 0.5 ml;
2016-01-08;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93430
TRULICITY;
02448602;
dulaglutide 1.5 mg / 0.5 ml;
2015-11-24;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93431
CYMBALTA;
02301482;
duloxetine (duloxetine hydrochloride) 30 mg;
2008-01-18;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78681
PMS-DULOXETINE;
02429446;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91389
AURO-DULOXETINE;
02436647;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92097
DULOXETINE DR;
02437082;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92139
RAN-DULOXETINE;
02438259;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92262
MINT-DULOXETINE;
02438984;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92335
SANDOZ DULOXETINE;
02439948;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92433
APO-DULOXETINE;
02440423;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-03;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92479
MAR-DULOXETINE;
02446081;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-10;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93136
RIVA-DULOXETINE;
02451077;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93732
JAMP-DULOXETINE;
02451913;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-03;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93831
DULOXETINE;
02452650;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-03;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93902
DULOXETINE;
02453630;
duloxetine (duloxetine hydrochloride) 30 mg;
2016-05-05;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94019
TEVA-DULOXETINE;
02456753;
duloxetine (duloxetine hydrochloride) 30 mg;
2020-04-24;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94374
M-DULOXETINE;
02473208;
duloxetine (duloxetine hydrochloride) 30 mg;
2018-06-26;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96254
AG-DULOXETINE;
02475308;
duloxetine (duloxetine hydrochloride) 30 mg;
2018-07-19;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96567
NRA-DULOXETINE;
02482126;
duloxetine (duloxetine hydrochloride) 30 mg;
2019-03-06;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97243
PRIVA-DULOXETINE;
02490412;
duloxetine (duloxetine hydrochloride) 30 mg;
2020-05-07;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98047
DULOXETINE;
02490889;
duloxetine (duloxetine hydrochloride) 30 mg;
2019-09-10;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98092
DULOXETINE;
02495082;
duloxetine (duloxetine hydrochloride) 30 mg;
2020-04-06;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98503
CYMBALTA;
02301490;
duloxetine (duloxetine hydrochloride) 60 mg;
2008-01-18;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78682
PMS-DULOXETINE;
02429454;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91391
AURO-DULOXETINE;
02436655;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92098
DULOXETINE DR;
02437090;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92140
RAN-DULOXETINE;
02438267;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92263
MINT-DULOXETINE;
02438992;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92336
SANDOZ DULOXETINE;
02439956;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-02;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92434
APO-DULOXETINE;
02440431;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-03;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92480
MAR-DULOXETINE;
02446103;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-10;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93137
RIVA-DULOXETINE;
02451085;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-12;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93733
JAMP-DULOXETINE;
02451921;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-03;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93832
DULOXETINE;
02452669;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-03;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93903
DULOXETINE;
02453649;
duloxetine (duloxetine hydrochloride) 60 mg;
2016-05-05;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94020
TEVA-DULOXETINE;
02456761;
duloxetine (duloxetine hydrochloride) 60 mg;
2020-04-24;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94375
M-DULOXETINE;
02473216;
duloxetine (duloxetine hydrochloride) 60 mg;
2018-09-26;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96255
AG-DULOXETINE;
02475316;
duloxetine (duloxetine hydrochloride) 60 mg;
2018-07-19;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96568
NRA-DULOXETINE;
02482134;
duloxetine (duloxetine hydrochloride) 60 mg;
2019-03-06;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97244
PRIVA-DULOXETINE;
02490420;
duloxetine (duloxetine hydrochloride) 60 mg;
2020-05-07;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98046
DULOXETINE;
02490897;
duloxetine (duloxetine hydrochloride) 60 mg;
2019-09-10;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98093
DULOXETINE;
02495090;
duloxetine (duloxetine hydrochloride) 60 mg;
2020-04-06;
Oral;
Capsule (Delayed Release);
28:16.04.16 – SELECTIVE SEROTONIN AND NOREPINEPHRINE-REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98504
DUPIXENT;
02470365;
dupilumab 150 mg / ml;
2018-02-06;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95935
DUPIXENT;
02492504;
dupilumab 200 mg / 1.14 ml;
2019-11-29;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98251
IMFINZI;
02468816;
durvalumab 50 mg / ml;
2017-11-20;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95736
AVODART;
02247813;
dutasteride 0.5 mg;
2003-11-14;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72107
APO-DUTASTERIDE;
02404206;
dutasteride 0.5 mg;
2014-07-18;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88899
TEVA-DUTASTERIDE;
02408287;
dutasteride 0.5 mg;
2014-07-16;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89301
ACT DUTASTERIDE;
02412691;
dutasteride 0.5 mg;
2014-09-05;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89736
MED-DUTASTERIDE;
02416298;
dutasteride 0.5 mg;
2014-10-10;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90086
DUTASTERIDE;
02421712;
dutasteride 0.5 mg;
2014-07-22;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90637
SANDOZ DUTASTERIDE CAPSULE;
02424444;
dutasteride 0.5 mg;
2014-07-22;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90912
RIVA-DUTASTERIDE;
02427753;
dutasteride 0.5 mg;
2014-09-18;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91226
MINT-DUTASTERIDE;
02428873;
dutasteride 0.5 mg;
2014-09-19;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91334
DUTASTERIDE;
02429012;
dutasteride 0.5 mg;
2014-10-08;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91345
DUTASTERIDE;
02443058;
dutasteride 0.5 mg;
2015-07-21;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92760
AURO-DUTASTERIDE;
02469308;
dutasteride 0.5 mg;
2018-06-04;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95804
JAMP DUTASTERIDE;
02484870;
dutasteride 0.5 mg;
2019-11-07;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97515
PRIVA-DUTASTERIDE;
02490587;
dutasteride 0.5 mg;
2020-06-16;
Oral;
Capsule;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98062
SOLIRIS;
02322285;
eculizumab 10 mg / ml;
2009-05-25;
Intravenous;
Solution;
92:32.00 – COMPLEMENT INHIBITORS;
Prescription , Schedule D;
ALEXION PHARMA GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80774
RADICAVA;
02475472;
edaravone 30 mg / 100 ml;
2019-10-29;
Intravenous;
Solution;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
MITSUBISHI TANABE PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96585
LIXIANA;
02458640;
edoxaban (edoxaban tosylate monohydrate) 15 mg;
2017-04-25;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94579
LIXIANA;
02458659;
edoxaban (edoxaban tosylate monohydrate) 30 mg;
2017-04-25;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94580
LIXIANA;
02458667;
edoxaban (edoxaban tosylate monohydrate) 60 mg;
2017-04-25;
Oral;
Tablet;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94581
SUSTIVA 200MG;
02239888;
efavirenz 200 mg;
1999-03-25;
Oral;
Capsule;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63376
SUSTIVA 50MG;
02239886;
efavirenz 50 mg;
1999-03-25;
Oral;
Capsule;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63374
SUSTIVA TABLETS;
02246045;
efavirenz 600 mg;
2002-11-05;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70176
MYLAN-EFAVIRENZ;
02381524;
efavirenz 600 mg;
2013-07-30;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86737
TEVA-EFAVIRENZ;
02389762;
efavirenz 600 mg;
2013-07-30;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87524
AURO-EFAVIRENZ;
02418428;
efavirenz 600 mg;
2014-03-03;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90299
JAMP-EFAVIRENZ;
02458233;
efavirenz 600 mg;
2019-06-14;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94530
JUBLIA;
02413388;
efinaconazole 10 % / w/w;
2014-07-21;
Topical;
Solution;
84:04.08.08 – AZOLES;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89805
VANIQA;
02243837;
eflornithine hydrochloride 13.9 % / w/w;
2005-11-01;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
CIPHER PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67778
ORILISSA;
02481332;
elagolix (elagolix sodium) 150 mg;
2018-10-30;
Oral;
Tablet;
92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97182
ORILISSA;
02481340;
elagolix (elagolix sodium) 200 mg;
2019-05-24;
Oral;
Tablet;
92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
Prescription;
ABBVIE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97183
RELPAX;
02256290;
eletriptan (eletriptan hydrobromide) 20 mg;
2004-10-13;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74152
GD-ELETRIPTAN;
02342235;
eletriptan (eletriptan hydrobromide) 20 mg;
2012-10-11;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82774
TEVA-ELETRIPTAN;
02382091;
eletriptan (eletriptan hydrobromide) 20 mg;
2013-12-20;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86796
APO-ELETRIPTAN;
02386054;
eletriptan (eletriptan hydrobromide) 20 mg;
2013-09-12;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87164
AURO-ELETRIPTAN;
02479451;
eletriptan (eletriptan hydrobromide) 20 mg;
2019-02-01;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97013
ELETRIPTAN;
02489961;
eletriptan (eletriptan hydrobromide) 20 mg;
2019-07-31;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98004
RELPAX;
02256304;
eletriptan (eletriptan hydrobromide) 40 mg;
2004-10-13;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74153
GD-ELETRIPTAN;
02342243;
eletriptan (eletriptan hydrobromide) 40 mg;
2012-10-11;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82775
TEVA-ELETRIPTAN;
02382105;
eletriptan (eletriptan hydrobromide) 40 mg;
2013-12-20;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86797
APO-ELETRIPTAN;
02386062;
eletriptan (eletriptan hydrobromide) 40 mg;
2013-09-12;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87165
AURO-ELETRIPTAN;
02479478;
eletriptan (eletriptan hydrobromide) 40 mg;
2019-02-01;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97014
ELETRIPTAN;
02489988;
eletriptan (eletriptan hydrobromide) 40 mg;
2019-07-31;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98005
CERDELGA;
02463261;
eliglustat (eliglustat tartrate) 84 mg;
2017-07-26;
Oral;
Capsule;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95117
VIMIZIM;
02427184;
elosulfase alfa 1 mg / ml;
2014-08-27;
Intravenous;
Solution;
44:00.00 – ENZYMES;
Prescription , Schedule D;
BIOMARIN INTERNATIONAL LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91171
REVOLADE;
02361825;
eltrombopag (eltrombopag olamine) 25 mg;
2011-04-04;
Oral;
Tablet;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84687
REVOLADE;
02361833;
eltrombopag (eltrombopag olamine) 50 mg;
2011-04-01;
Oral;
Tablet;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84688
VIBERZI;
02460904;
eluxadoline 100 mg;
2017-04-24;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94841
VIBERZI;
02460890;
eluxadoline 75 mg;
2017-04-24;
Oral;
Tablet;
56:92.00 – MISCELLANEOUS GI DRUGS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94840
HEMLIBRA;
02479656;
emicizumab 105 mg / 0.7 ml;
2019-02-21;
Subcutaneous;
Solution;
20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97032
HEMLIBRA;
02479664;
emicizumab 150 mg / ml;
2018-11-27;
Subcutaneous;
Solution;
20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97033
HEMLIBRA;
02479621;
emicizumab 30 mg / 1 ml;
2018-10-19;
Subcutaneous;
Solution;
20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97030
HEMLIBRA;
02479648;
emicizumab 60 mg / 0.4 ml;
2018-10-19;
Subcutaneous;
Solution;
20:28.92 – ANTIHEMORRHAGIC AGENTS, MISCELLANEOUS;
Prescription , Schedule D;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97031
JARDIANCE;
02443937;
empagliflozin 10 mg;
2015-08-11;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92871
JARDIANCE;
02443945;
empagliflozin 25 mg;
2015-08-11;
Oral;
Tablet;
68:20.18 – Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors;
Prescription;
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92872
APO-ENALAPRIL TAB 10MG;
02019892;
enalapril maleate 10 mg;
1993-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14387
PRO-ENALAPRIL – 10;
02311429;
enalapril maleate 10 mg;
2008-07-04;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79700
MAR-ENALAPRIL;
02444771;
enalapril maleate 10 mg;
2019-03-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92998
JAMP ENALAPRIL;
02474808;
enalapril maleate 10 mg;
2019-02-25;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96499
APO-ENALAPRIL TAB 2.5MG;
02020025;
enalapril maleate 2.5 mg;
1993-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14385
PRO-ENALAPRIL – 2.5;
02311402;
enalapril maleate 2.5 mg;
2008-07-04;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79698
MAR-ENALAPRIL;
02459450;
enalapril maleate 2.5 mg;
2019-03-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94669
JAMP ENALAPRIL;
02474786;
enalapril maleate 2.5 mg;
2019-02-25;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96497
APO-ENALAPRIL TAB 20MG;
02019906;
enalapril maleate 20 mg;
1993-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14388
PRO-ENALAPRIL – 20;
02311437;
enalapril maleate 20 mg;
2008-07-04;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79701
MAR-ENALAPRIL;
02444798;
enalapril maleate 20 mg;
2019-03-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92999
JAMP ENALAPRIL;
02474816;
enalapril maleate 20 mg;
2019-02-25;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96500
APO-ENALAPRIL TAB 5MG;
02019884;
enalapril maleate 5 mg;
1993-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14386
PRO-ENALAPRIL – 5;
02311410;
enalapril maleate 5 mg;
2008-07-04;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79699
MAR-ENALAPRIL;
02459469;
enalapril maleate 5 mg;
2019-03-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94670
JAMP ENALAPRIL;
02474794;
enalapril maleate 5 mg;
2019-02-25;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96498
VASOTEC;
00670928;
enalapril sodium (enalapril maleate) 16 mg;
1987-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8103
ACT ENALAPRIL;
02291908;
enalapril sodium (enalapril maleate) 16 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77727
ENALAPRIL;
02442981;
enalapril sodium (enalapril maleate) 16 mg;
2015-08-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92751
ACT ENALAPRIL;
02291878;
enalapril sodium (enalapril maleate) 2 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77724
ENALAPRIL;
02442957;
enalapril sodium (enalapril maleate) 2 mg;
2015-08-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92748
VASOTEC;
00708879;
enalapril sodium (enalapril maleate) 4 mg;
1987-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8111
ACT ENALAPRIL;
02291886;
enalapril sodium (enalapril maleate) 4 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77725
ENALAPRIL;
02442965;
enalapril sodium (enalapril maleate) 4 mg;
2015-08-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92749
VASOTEC;
00670901;
enalapril sodium (enalapril maleate) 8 mg;
1987-12-31;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8102
ACT ENALAPRIL;
02291894;
enalapril sodium (enalapril maleate) 8 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77726
ENALAPRIL;
02442973;
enalapril sodium (enalapril maleate) 8 mg;
2015-08-10;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92750
SANDOZ ENALAPRIL;
02299976;
enalapril sodium 16 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78531
RIVA-ENALAPRIL;
02300834;
enalapril sodium 16 mg;
2007-10-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78617
RAN-ENALAPRIL;
02352265;
enalapril sodium 16 mg;
2010-08-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83750
ENALAPRIL;
02400685;
enalapril sodium 16 mg;
2013-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88546
SANDOZ ENALAPRIL;
02299933;
enalapril sodium 2 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78528
RIVA-ENALAPRIL;
02300796;
enalapril sodium 2 mg;
2007-10-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78614
RAN-ENALAPRIL;
02352230;
enalapril sodium 2 mg;
2010-08-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83747
SANDOZ ENALAPRIL;
02299941;
enalapril sodium 4 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78529
RIVA-ENALAPRIL;
02300818;
enalapril sodium 4 mg;
2007-10-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78615
RAN-ENALAPRIL;
02352249;
enalapril sodium 4 mg;
2010-08-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83748
SANDOZ ENALAPRIL;
02299968;
enalapril sodium 8 mg;
2007-10-17;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78530
RIVA-ENALAPRIL;
02300826;
enalapril sodium 8 mg;
2007-10-20;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78616
RAN-ENALAPRIL;
02352257;
enalapril sodium 8 mg;
2010-08-01;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83749
ENALAPRIL;
02400677;
enalapril sodium 8 mg;
2013-02-13;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88545
VASOTEC IV;
01923846;
enalaprilat 1.25 mg / ml;
1992-12-31;
Intravenous;
Solution;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12650
ENALAPRILAT INJECTION USP;
02388499;
enalaprilat 1.25 mg / ml;
2012-09-10;
Intravenous;
Solution;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87402
IDHIFA;
02485435;
enasidenib (enasidenib mesylate) 100 mg;
2019-02-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97568
IDHIFA;
02485427;
enasidenib (enasidenib mesylate) 50 mg;
2019-02-27;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CELGENE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97567
FUZEON;
02247725;
enfuvirtide 108 mg / vial;
2003-08-18;
Subcutaneous;
Powder For Solution;
08:18.08.04 – HIV FUSION INHIBITORS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72003
LOVENOX WITH PRESERVATIVE 300MG/3ML;
02236564;
enoxaparin sodium 100 mg / ml;
1998-01-21;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=59932
LOVENOX;
02378442;
enoxaparin sodium 100 mg / ml;
2012-09-21;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86424
REDESCA;
02509113;
enoxaparin sodium 100 mg / ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99843
LOVENOX HP;
02242692;
enoxaparin sodium 120 mg / 0.8 ml;
2002-05-21;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66484
REDESCA HP;
02509148;
enoxaparin sodium 120 mg / 0.8 ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99845
LOVENOX HP;
02378469;
enoxaparin sodium 150 mg / ml;
2012-12-07;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86426
REDESCA HP;
02509156;
enoxaparin sodium 150 mg / ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99846
LOVENOX;
02012472;
enoxaparin sodium 30 mg / 0.3 ml;
1993-12-31;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14049
REDESCA;
02509075;
enoxaparin sodium 30 mg / 0.3 ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99839
REDESCA;
02509121;
enoxaparin sodium 300 mg / 3 ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99844
LOVENOX;
02236883;
enoxaparin sodium 40 mg / 0.4 ml;
1998-06-02;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60174
REDESCA;
02509083;
enoxaparin sodium 40 mg / 0.4 ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99840
LOVENOX;
02378426;
enoxaparin sodium 60 mg / 0.6 ml;
2012-11-13;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86422
REDESCA;
02509091;
enoxaparin sodium 60 mg / 0.6 ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99841
LOVENOX;
02378434;
enoxaparin sodium 80 mg / 0.8 ml;
2012-09-11;
Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86423
REDESCA;
02509105;
enoxaparin sodium 80 mg / 0.8 ml;
2021-04-09;
Intravenous , Subcutaneous;
Solution;
20:12.04.16 – HEPARINS;
Prescription;
SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99842
COVERGIRL TRUBLEND BASE BUSINESS SKIN PRIMER BASE POUR LA PEAU;
02480131;
ensulizole 3 %;
2018-12-11;
Topical;
Emulsion;
84:80.00 – SUNSCREEN AGENTS;
Otc;
HFC PRESTIGE INTERNATIONAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97065
COMTAN;
02243763;
entacapone 200 mg;
2001-06-21;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67698
TEVA-ENTACAPONE;
02375559;
entacapone 200 mg;
2012-03-29;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86097
SANDOZ ENTACAPONE;
02380005;
entacapone 200 mg;
2012-03-30;
Oral;
Tablet;
28:36.12 – CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86585
AURO-ENTECAVIR;
02448777;
entecavir (entecavir monohydrate) 0.5 mg;
2015-12-01;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93451
ENTECAVIR TABLETS;
02453797;
entecavir (entecavir monohydrate) 0.5 mg;
2020-12-01;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
STRIDES PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94033
JAMP ENTECAVIR;
02467232;
entecavir (entecavir monohydrate) 0.5 mg;
2018-06-11;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95562
ACCEL-ENTECAVIR;
02479907;
entecavir (entecavir monohydrate) 0.5 mg;
2020-03-11;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
ACCEL PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97047
MINT-ENTECAVIR;
02485907;
entecavir (entecavir monohydrate) 0.5 mg;
2020-01-06;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97614
BARACLUDE;
02282224;
entecavir 0.5 mg;
2006-09-12;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
BRISTOL-MYERS SQUIBB CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76788
APO-ENTECAVIR;
02396955;
entecavir 0.5 mg;
2013-01-18;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88196
PMS-ENTECAVIR;
02430576;
entecavir 0.5 mg;
2014-09-09;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91502
PMS-ENTECAVIR;
02430584;
entecavir 1 mg;
2014-09-10;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91503
ROZLYTREK;
02495007;
entrectinib 100 mg;
2020-03-10;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98496
ROZLYTREK;
02495015;
entrectinib 200 mg;
2020-03-04;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98497
XTANDI;
02407329;
enzalutamide 40 mg;
2013-06-07;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89203
EPHEDRINE SULFATE INJECTION USP;
00876534;
ephedrine sulfate 50 mg / ml;
1990-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11096
EMERADE;
02458446;
epinephrine (epinephrine bitartrate) 0.3 mg / 0.3 ml;
2020-10-08;
Intramuscular;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94557
EMERADE;
02458454;
epinephrine (epinephrine bitartrate) 0.5 mg / 0.5 ml;
2020-10-08;
Intramuscular;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94558
ADRENALIN CHLORIDE SOL 1:1000 AMP;
00155357;
epinephrine (epinephrine hydrochloride) 1 mg / ml;
1951-12-31;
Intramuscular , Intravenous , Subcutaneous;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=940
ADRENALIN CHLORIDE SOL 1:1000;
00155365;
epinephrine (epinephrine hydrochloride) 1 mg / ml;
1951-12-31;
Nasal;
Solution;
52:32.00 – VASOCONSTRICTORS;
Ethical;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1508
ALLERJECT;
02382059;
epinephrine 0.15 mg / 0.15 ml;
2012-12-11;
Intramuscular;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
KALEO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86792
EPIPEN JR;
00578657;
epinephrine 0.15 mg / 0.3 ml;
1984-12-31;
Intramuscular;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
MYLAN SPECIALTY LP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5970
EPIPEN;
00509558;
epinephrine 0.3 mg / 0.3 ml;
1980-12-31;
Intramuscular;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
MYLAN SPECIALTY LP
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3883
ALLERJECT;
02382067;
epinephrine 0.3 mg / 0.3 ml;
2012-12-11;
Intramuscular;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
KALEO INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86793
EPINEPHRINE INJECTION USP;
00721891;
epinephrine 1 mg / 1 ml;
1988-12-31;
Intracardiac , Intramuscular , Intratracheal , Intravenous , Subcutaneous;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9164
EPINEPHRINE INJECTION USP;
02435810;
epinephrine 1 mg / 1 ml;
2015-07-20;
Intramuscular , Intratracheal , Intravenous , Subcutaneous;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92016
EPINEPHRINE INJECTION USP;
00710814;
epinephrine 1 mg / 10 ml;
1987-12-31;
Intracardiac , Intravenous;
Solution;
12:12.12 – ALPHA-AND BETA-ADRENERGIC AGONISTS;
Ethical;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8352
EPIRUBICIN FOR INJECTION;
02324091;
epirubicin hydrochloride 2 mg / ml;
2009-09-14;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80958
PMS-EPIRUBICIN;
02410400;
epirubicin hydrochloride 2 mg / ml;
2014-06-05;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89507
INSPRA;
02323052;
eplerenone 25 mg;
2009-05-08;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80855
MINT-EPLERENONE;
02471442;
eplerenone 25 mg;
2018-04-09;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96055
INSPRA;
02323060;
eplerenone 50 mg;
2009-05-05;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80856
MINT-EPLERENONE;
02471450;
eplerenone 50 mg;
2018-04-09;
Oral;
Tablet;
24:32.20 – MINERALOCORTICOID (ALDOSTERONE) RECEPTOR ANTAGONISTS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96056
EPREX STERILE SOLUTION 1000IU/0.5ML;
02231583;
epoetin alfa 1000 unit / 0.5 ml;
1997-09-19;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50949
EPREX STERILE SOLUTION 10000IU/1.0ML;
02231587;
epoetin alfa 10000 unit / ml;
1997-09-19;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50953
EPREX STERILE SOLUTION 2000IU/0.5ML;
02231584;
epoetin alfa 2000 unit / 0.5 ml;
1997-09-19;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50950
EPREX STERILE SOLUTION;
02243239;
epoetin alfa 20000 unit / 0.5 ml;
2005-08-24;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67133
EPREX STERILE SOLUTION 3000IU/0.3ML;
02231585;
epoetin alfa 3000 unit / 0.3 ml;
1997-09-19;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50951
EPREX STERILE SOLUTION;
02288680;
epoetin alfa 30000 unit / 0.75 ml;
2007-11-19;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77409
EPREX STERILE SOLUTION 4000IU/0.4ML;
02231586;
epoetin alfa 4000 unit / 0.4 ml;
1997-09-19;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50952
EPREX STERILE SOLUTION 40000IU/ML;
02240722;
epoetin alfa 40000 unit / ml;
1999-12-21;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64311
EPREX STERILE SOLUTION 5000IU/0.5ML;
02243400;
epoetin alfa 5000 unit / 0.5 ml;
2002-07-01;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67308
EPREX STERILE SOLUTION 6000 IU/0.6 ML;
02243401;
epoetin alfa 6000 unit / 0.6 ml;
2001-02-20;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67309
EPREX STERILE SOLUTION 8000 IU/0.8 ML;
02243403;
epoetin alfa 8000 unit / 0.8 ml;
2001-02-20;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67311
FLOLAN;
02230845;
epoprostenol (epoprostenol sodium) 0.5 mg / vial;
1997-07-28;
Intravenous;
Powder For Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50121
CARIPUL;
02397447;
epoprostenol (epoprostenol sodium) 0.5 mg / vial;
2013-04-24;
Intravenous;
Powder For Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88240
FLOLAN;
02230848;
epoprostenol (epoprostenol sodium) 1.5 mg / vial;
1997-07-28;
Intravenous;
Powder For Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50122
CARIPUL;
02397455;
epoprostenol (epoprostenol sodium) 1.5 mg / vial;
2013-04-24;
Intravenous;
Powder For Solution;
48:48.00 – VASODILATING AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88241
TEVETEN;
02240432;
eprosartan (eprosartan mesylate) 400 mg;
2000-09-08;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63981
TEVETEN;
02243942;
eprosartan (eprosartan mesylate) 600 mg;
2001-05-25;
Oral;
Tablet;
24:32.08 – ANGIOTENSIN II RECEPTOR ANTAGONISTS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67885
NIASTASE RT;
02417103;
eptacog alfa (activated) 1 mg / vial;
2015-05-05;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90174
NIASTASE RT;
02417111;
eptacog alfa (activated) 2 mg / vial;
2015-05-05;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90175
NIASTASE RT;
02417138;
eptacog alfa (activated) 5 mg / vial;
2015-05-05;
Intravenous;
Kit , Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90176
INTEGRILIN;
02240351;
eptifibatide 0.75 mg / ml;
1999-06-23;
Intravenous;
Solution;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63892
INTEGRILIN;
02240352;
eptifibatide 2 mg / ml;
1999-06-23;
Intravenous;
Solution;
20:12.18 – PLATELET AGGREGATION INHIBITORS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63894
BALVERSA;
02493217;
erdafitinib 3 mg;
2019-12-09;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98320
BALVERSA;
02493225;
erdafitinib 4 mg;
2019-12-09;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98321
BALVERSA;
02493233;
erdafitinib 5 mg;
2019-12-09;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98322
AIMOVIG;
02487306;
erenumab 140 mg / ml;
2019-05-22;
Subcutaneous;
Solution;
28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97746
AIMOVIG;
02479613;
erenumab 70 mg / ml;
2018-12-04;
Subcutaneous;
Solution;
28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
Prescription , Schedule D;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97029
ERGONOVINE MALEATE INJECTION USP;
02441241;
ergonovine maleate 0.25 mg / ml;
2016-02-19;
Intramuscular , Intravenous;
Solution;
76:00.00 – OXYTOCICS;
Prescription;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92564
HALAVEN;
02377438;
eribulin mesylate 0.5 mg / ml;
2012-03-19;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
EISAI LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86314
TARCEVA;
02269015;
erlotinib (erlotinib hydrochloride) 100 mg;
2005-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75442
TEVA-ERLOTINIB;
02377705;
erlotinib (erlotinib hydrochloride) 100 mg;
2014-12-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86352
PMS-ERLOTINIB;
02454386;
erlotinib (erlotinib hydrochloride) 100 mg;
2016-07-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94096
APO-ERLOTINIB;
02461870;
erlotinib (erlotinib hydrochloride) 100 mg;
2017-08-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94961
NAT-ERLOTINIB;
02483920;
erlotinib (erlotinib hydrochloride) 100 mg;
2019-05-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97428
TARCEVA;
02269023;
erlotinib (erlotinib hydrochloride) 150 mg;
2005-07-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75443
TEVA-ERLOTINIB;
02377713;
erlotinib (erlotinib hydrochloride) 150 mg;
2014-12-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86353
PMS-ERLOTINIB;
02454394;
erlotinib (erlotinib hydrochloride) 150 mg;
2016-07-28;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94097
APO-ERLOTINIB;
02461889;
erlotinib (erlotinib hydrochloride) 150 mg;
2017-08-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94962
NAT-ERLOTINIB;
02483939;
erlotinib (erlotinib hydrochloride) 150 mg;
2019-05-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97429
TARCEVA;
02269007;
erlotinib (erlotinib hydrochloride) 25 mg;
2007-01-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
HOFFMANN-LA ROCHE LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75441
TEVA-ERLOTINIB;
02377691;
erlotinib (erlotinib hydrochloride) 25 mg;
2014-12-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86351
APO-ERLOTINIB;
02461862;
erlotinib (erlotinib hydrochloride) 25 mg;
2017-08-22;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94960
NAT-ERLOTINIB;
02483912;
erlotinib (erlotinib hydrochloride) 25 mg;
2019-05-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97427
INVANZ;
02247437;
ertapenem (ertapenem sodium) 1 g / vial;
2003-08-27;
Intramuscular , Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71683
ERTAPENEM FOR INJECTION;
02490773;
ertapenem (ertapenem sodium) 1 g / vial;
2020-02-10;
Intramuscular , Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
JUNO PHARMACEUTICALS CORP.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98083
ERTAPENEM FOR INJECTION;
02511150;
ertapenem (ertapenem sodium) 1 g / vial;
2021-01-27;
Intramuscular , Intravenous;
Powder For Solution;
08:12.07.08 – CARBAPENEMS;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100038
ERYTHROCIN I.V.;
00682276;
erythromycin (erythromycin lactobionate) 1 g / vial;
1988-12-31;
Intravenous;
Powder For Solution;
08:12.12.04 – ERYTHROMYCINS;
Prescription;
AMDIPHARM LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9397
ERYTHROCIN I.V.;
00682268;
erythromycin (erythromycin lactobionate) 500 mg / vial;
1988-12-31;
Intravenous;
Powder For Solution;
08:12.12.04 – ERYTHROMYCINS;
Prescription;
AMDIPHARM LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9396
ERYTHRO-BASE;
00682020;
erythromycin 250 mg;
1986-12-31;
Oral;
Tablet;
08:12.12.04 – ERYTHROMYCINS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6687
ERYC DELAYED-RELEASE CAPSULES;
00873454;
erythromycin 333 mg;
1990-12-31;
Oral;
Capsule (Enteric-Coated);
08:12.12.04 – ERYTHROMYCINS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10707
PDP-ERYTHROMYCIN;
01912755;
erythromycin 5 mg / g;
1991-12-31;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS;
Prescription;
PENDOPHARM DIVISION OF PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11423
ERYTHROMYCIN OPHTHALMIC OINTMENT USP;
02326663;
erythromycin 5 mg / g;
2010-02-12;
Ophthalmic;
Ointment;
52:04.04 – ANTIBACTERIALS;
Prescription;
LABORATOIRES STERIGEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81202
CHROM-O-RED DISCLOSING SOLUTION CONCENTRATE;
02021137;
erythrosine 2 %;
1998-01-26;
Dental;
Solution;
34:00.00 – DENTAL AGENTS;
Otc;
GERMIPHENE CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=26307
CIPRALEX -10MG;
02263238;
escitalopram (escitalopram oxalate) 10 mg;
2005-02-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74862
APO-ESCITALOPRAM;
02295016;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78034
ESCITALOPRAM;
02303949;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78926
MYLAN-ESCITALOPRAM;
02309467;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79506
TEVA-ESCITALOPRAM;
02318180;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80368
SANDOZ ESCITALOPRAM;
02364077;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84901
RAN-ESCITALOPRAM;
02385481;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87111
AURO-ESCITALOPRAM;
02397358;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88231
MINT-ESCITALOPRAM;
02407418;
escitalopram (escitalopram oxalate) 10 mg;
2015-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89210
MAR-ESCITALOPRAM;
02423480;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90820
ESCITALOPRAM;
02424401;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-15;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90910
PRIVA-ESCITALOPRAM;
02426331;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91093
RIVA-ESCITALOPRAM;
02428830;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-25;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91329
ESCITALOPRAM;
02429039;
escitalopram (escitalopram oxalate) 10 mg;
2015-01-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91347
JAMP-ESCITALOPRAM;
02429780;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-11;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91422
ESCITALOPRAM;
02430118;
escitalopram (escitalopram oxalate) 10 mg;
2014-09-18;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91451
ACH-ESCITALOPRAM;
02434652;
escitalopram (escitalopram oxalate) 10 mg;
2016-06-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91896
NAT-ESCITALOPRAM;
02440296;
escitalopram (escitalopram oxalate) 10 mg;
2015-07-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92466
PMS-ESCITALOPRAM;
02469243;
escitalopram (escitalopram oxalate) 10 mg;
2018-05-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95793
M-ESCITALOPRAM;
02471418;
escitalopram (escitalopram oxalate) 10 mg;
2018-04-11;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96051
NRA-ESCITALOPRAM;
02476851;
escitalopram (escitalopram oxalate) 10 mg;
2018-10-04;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96678
AG-ESCITALOPRAM;
02477742;
escitalopram (escitalopram oxalate) 10 mg;
2018-09-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96819
BIO-ESCITALOPRAM;
02481154;
escitalopram (escitalopram oxalate) 10 mg;
2019-06-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97143
ESCITALOPRAM;
02489171;
escitalopram (escitalopram oxalate) 10 mg;
2020-03-27;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97927
CIPRALEX -20MG;
02263254;
escitalopram (escitalopram oxalate) 20 mg;
2005-02-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74864
APO-ESCITALOPRAM;
02295024;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78035
MYLAN-ESCITALOPRAM;
02309475;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79507
TEVA-ESCITALOPRAM;
02318202;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80371
SANDOZ ESCITALOPRAM;
02364085;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84902
RAN-ESCITALOPRAM;
02385503;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87112
AURO-ESCITALOPRAM;
02397374;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88233
MINT-ESCITALOPRAM;
02407434;
escitalopram (escitalopram oxalate) 20 mg;
2015-03-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89212
MAR-ESCITALOPRAM;
02423502;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90822
ESCITALOPRAM;
02424428;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-15;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90911
PRIVA-ESCITALOPRAM;
02426358;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91094
RIVA-ESCITALOPRAM;
02428857;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-25;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91332
ESCITALOPRAM;
02429047;
escitalopram (escitalopram oxalate) 20 mg;
2015-01-14;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91348
JAMP-ESCITALOPRAM;
02429799;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-11;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91423
ESCITALOPRAM;
02430126;
escitalopram (escitalopram oxalate) 20 mg;
2014-09-18;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91453
ACH-ESCITALOPRAM;
02434660;
escitalopram (escitalopram oxalate) 20 mg;
2016-06-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91897
NAT-ESCITALOPRAM;
02440318;
escitalopram (escitalopram oxalate) 20 mg;
2015-07-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92467
PMS-ESCITALOPRAM;
02469251;
escitalopram (escitalopram oxalate) 20 mg;
2018-05-22;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95794
M-ESCITALOPRAM;
02471426;
escitalopram (escitalopram oxalate) 20 mg;
2018-04-11;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96052
NRA-ESCITALOPRAM;
02476878;
escitalopram (escitalopram oxalate) 20 mg;
2018-11-28;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96679
AG-ESCITALOPRAM;
02477769;
escitalopram (escitalopram oxalate) 20 mg;
2018-09-06;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96821
BIO-ESCITALOPRAM;
02481170;
escitalopram (escitalopram oxalate) 20 mg;
2019-06-19;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97145
ESCITALOPRAM;
02489201;
escitalopram (escitalopram oxalate) 20 mg;
2020-03-27;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97929
ACT ESCITALOPRAM ODT;
02454297;
escitalopram 10 mg;
2016-08-17;
Oral;
Tablet (Orally Disintegrating);
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94081
ACT ESCITALOPRAM ODT;
02454300;
escitalopram 20 mg;
2016-08-17;
Oral;
Tablet (Orally Disintegrating);
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94082
SPRAVATO;
02499290;
esketamine (esketamine hydrochloride) 28 mg / 2 act;
2020-06-11;
Nasal;
Solution;
28:16.04.92 – MISCELLANEOUS ANTIDEPRESSANTS;
Narcotic;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98903
APTIOM;
02426862;
eslicarbazepine acetate 200 mg;
2014-08-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91141
APTIOM;
02426870;
eslicarbazepine acetate 400 mg;
2014-08-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91142
APTIOM;
02426889;
eslicarbazepine acetate 600 mg;
2014-08-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91143
APTIOM;
02426897;
eslicarbazepine acetate 800 mg;
2014-08-07;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91145
BREVIBLOC INJECTION 10MG/ML;
02188880;
esmolol hydrochloride 10 mg / ml;
1996-08-16;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42910
BREVIBLOC PREMIXED INJECTION;
02309238;
esmolol hydrochloride 10 mg / ml;
2008-09-12;
Intravenous;
Solution;
24:24.00 – BETA-ADRENERGIC BLOCKING AGENTS;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79483
TEVA-ESOMEPRAZOLE;
02423855;
esomeprazole (esomeprazole magnesium dihydrate) 20 mg;
2015-11-09;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90860
SANDOZ ESOMEPRAZOLE;
02460920;
esomeprazole (esomeprazole magnesium dihydrate) 20 mg;
2018-09-25;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94844
TEVA-ESOMEPRAZOLE;
02423863;
esomeprazole (esomeprazole magnesium dihydrate) 40 mg;
2015-11-09;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90861
ESOMEPRAZOLE;
02431173;
esomeprazole (esomeprazole magnesium dihydrate) 40 mg;
2014-09-22;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91561
SANDOZ ESOMEPRAZOLE;
02460939;
esomeprazole (esomeprazole magnesium dihydrate) 40 mg;
2018-09-25;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94845
NEXIUM;
02300524;
esomeprazole (esomeprazole magnesium trihydrate) 10 mg / sachet;
2008-01-02;
Oral;
Granules For Suspension, Delayed Release;
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78581
NEXIUM – 20MG;
02244521;
esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
2001-08-20;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68498
NEXIUM 24HR;
02444712;
esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
2016-08-10;
Oral;
Capsule (Delayed Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92986
MYL-ESOMEPRAZOLE;
02479419;
esomeprazole (esomeprazole magnesium trihydrate) 20 mg;
2020-04-20;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97006
NEXIUM – 40MG;
02244522;
esomeprazole (esomeprazole magnesium trihydrate) 40 mg;
2001-08-20;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68499
MYL-ESOMEPRAZOLE;
02479427;
esomeprazole (esomeprazole magnesium trihydrate) 40 mg;
2020-04-20;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97007
APO-ESOMEPRAZOLE;
02339099;
esomeprazole (esomeprazole magnesium) 20 mg;
2012-03-02;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82472
ESOMEPRAZOLE;
02394839;
esomeprazole (esomeprazole magnesium) 20 mg;
2013-06-06;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87999
RAN-ESOMEPRAZOLE;
02423979;
esomeprazole (esomeprazole magnesium) 20 mg;
2014-10-09;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90870
ESOMEPRAZOLE;
02442493;
esomeprazole (esomeprazole magnesium) 20 mg;
2015-07-22;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92684
APO-ESOMEPRAZOLE;
02339102;
esomeprazole (esomeprazole magnesium) 40 mg;
2011-03-07;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82473
ESOMEPRAZOLE;
02394847;
esomeprazole (esomeprazole magnesium) 40 mg;
2012-11-22;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88000
RAN-ESOMEPRAZOLE;
02423987;
esomeprazole (esomeprazole magnesium) 40 mg;
2014-10-09;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90871
ESOMEPRAZOLE;
02442507;
esomeprazole (esomeprazole magnesium) 40 mg;
2015-07-22;
Oral;
Tablet (Delayed-Release);
56:28.36 – PROTON-PUMP INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92685
ESTROGEL;
02238704;
estradiol (estradiol hemihydrate) 0.06 % / w/w;
1998-11-16;
Transdermal;
Gel;
68:16.04 – ESTROGENS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=62136
LUPIN-ESTRADIOL;
02449048;
estradiol (estradiol hemihydrate) 0.5 mg;
2016-02-29;
Oral;
Tablet;
68:16.04 – ESTROGENS;
Prescription;
LUPIN PHARMA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93486
LUPIN-ESTRADIOL;
02449056;
estradiol (estradiol hemihydrate) 1 mg;
2016-02-29;
Oral;
Tablet;
68:16.04 – ESTROGENS;
Prescription;
LUPIN PHARMA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93487
VAGIFEM 10;
02325462;
estradiol (estradiol hemihydrate) 10 mcg;
2010-04-28;
Vaginal;
Vaginal Tablet;
68:16.04 – ESTROGENS;
Prescription;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81084
SANDOZ ESTRADIOL DERM 100;
02246969;
estradiol (estradiol hemihydrate) 100 mcg / 24 hour;
2003-04-24;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71198
LUPIN-ESTRADIOL;
02449064;
estradiol (estradiol hemihydrate) 2 mg;
2016-02-29;
Oral;
Tablet;
68:16.04 – ESTROGENS;
Prescription;
LUPIN PHARMA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93488
CLIMARA 25;
02247499;
estradiol (estradiol hemihydrate) 25 mcg / 24 hour;
2004-03-12;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71749
CLIMARA 50;
02231509;
estradiol (estradiol hemihydrate) 50 mcg / 24 hour;
1997-12-01;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50849
SANDOZ ESTRADIOL DERM 50;
02246967;
estradiol (estradiol hemihydrate) 50 mcg / 24 hour;
2003-04-24;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71196
SANDOZ ESTRADIOL DERM 75;
02246968;
estradiol (estradiol hemihydrate) 75 mcg / 24 hour;
2003-04-24;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71197
CLIMARA 75;
02247500;
estradiol (estradiol hemihydrate) 75 mcg / 24 hour;
2004-03-12;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71750
DIVIGEL;
02424835;
estradiol 0.1 %;
2015-04-13;
Transdermal;
Gel;
68:16.04 – ESTROGENS;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90950
DIVIGEL;
02424843;
estradiol 0.1 %;
2015-04-13;
Transdermal;
Gel;
68:16.04 – ESTROGENS;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90951
DIVIGEL;
02424924;
estradiol 0.1 %;
2015-04-13;
Transdermal;
Gel;
68:16.04 – ESTROGENS;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90959
ESTRACE;
02225190;
estradiol 0.5 mg;
1997-07-10;
Oral;
Tablet;
68:16.04 – ESTROGENS;
Prescription;
ACERUS PHARMACEUTICALS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43420
ESTRACE;
02148587;
estradiol 1 mg;
1995-12-31;
Oral;
Tablet;
68:16.04 – ESTROGENS;
Prescription;
ACERUS PHARMACEUTICALS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19406
ESTRADOT 100;
02244002;
estradiol 100 mcg / 24 hour;
2001-09-05;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67945
ESTRING;
02168898;
estradiol 2 mg;
1995-12-31;
Vaginal;
Ring (Slow-Release);
68:16.04 – ESTROGENS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18640
ESTRACE;
02148595;
estradiol 2 mg;
1995-12-31;
Oral;
Tablet;
68:16.04 – ESTROGENS;
Prescription;
ACERUS PHARMACEUTICALS CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19405
OESCLIM;
02243722;
estradiol 25 mcg / 24 hour;
2002-03-22;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67654
ESTRADOT 25;
02245676;
estradiol 25 mcg / 24 hour;
2002-10-03;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69776
ESTRADOT 37.5;
02243999;
estradiol 37.5 mcg / 24 hour;
2001-09-05;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67942
OESCLIM;
02243724;
estradiol 50 mcg / 24 hour;
2002-03-21;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67656
ESTRADOT 50;
02244000;
estradiol 50 mcg / 24 hour;
2001-09-05;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67943
ESTRADOT 75;
02244001;
estradiol 75 mcg / 24 hour;
2001-09-05;
Transdermal;
Patch;
68:16.04 – ESTROGENS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67944
ESTRAGYN VAGINAL CREAM;
00727369;
estrone 0.1 % / w/w;
1987-12-31;
Vaginal;
Cream;
68:16.04 – ESTROGENS;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=7645
LUNESTA;
02453207;
eszopiclone 1 mg;
2020-10-20;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93974
LUNESTA;
02453215;
eszopiclone 2 mg;
2020-10-20;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93975
LUNESTA;
02453223;
eszopiclone 3 mg;
2020-10-20;
Oral;
Tablet;
28:24.92 – MISCELLANEOUS ANXIOLYTICS SEDATIVES AND HYPNOTICS;
Prescription;
SUNOVION PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93976
ERELZI;
02462877;
etanercept 25 mg / 0.5 ml;
2017-12-08;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95074
ENBREL;
02274728;
etanercept 50 mg / ml;
2005-12-21;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
IMMUNEX CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76019
BRENZYS;
02455323;
etanercept 50 mg / ml;
2016-09-23;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SAMSUNG BIOEPIS CO., LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94214
BRENZYS;
02455331;
etanercept 50 mg / ml;
2016-09-13;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SAMSUNG BIOEPIS CO., LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94215
ERELZI;
02462850;
etanercept 50 mg / ml;
2017-08-04;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95072
ERELZI;
02462869;
etanercept 50 mg / ml;
2017-08-04;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95073
VPI-ETHACRYNATE SODIUM;
02462362;
ethacrynic acid (ethacrynate sodium) 50 mg / vial;
2018-05-22;
Intravenous;
Powder For Solution;
40:28.08 – LOOP DIURETICS;
Prescription;
VPI PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95012
ETHACRYNATE SODIUM FOR INJECTION USP;
02469456;
ethacrynic acid (ethacrynate sodium) 50 mg / vial;
2018-03-29;
Intravenous;
Powder For Solution;
40:28.08 – LOOP DIURETICS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95825
EDECRIN;
02258528;
ethacrynic acid 25 mg;
2004-10-15;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74372
ETIBI;
00247960;
ethambutol hydrochloride 100 mg;
1972-12-31;
Oral;
Tablet;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1471
ETIBI;
00247979;
ethambutol hydrochloride 400 mg;
1972-12-31;
Oral;
Tablet;
08:16.04 – ANTITUBERCULOSIS AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1472
PARSITAN 50MG;
01927744;
ethopropazine (ethopropazine hydrochloride) 50 mg;
1952-12-31;
Oral;
Tablet;
12:08.04 – ANTIPARKINSONIAN AGENTS , 28:36.08 – ANTICHOLINERGIC AGENTS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12549
ZARONTIN CAP 250MG;
00022799;
ethosuximide 250 mg;
1960-12-31;
Oral;
Capsule;
28:12.20 – SUCCINIMIDES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=771
ZARONTIN SYR 250MG/5ML;
00023485;
ethosuximide 250 mg / 5 ml;
1964-12-31;
Oral;
Syrup;
28:12.20 – SUCCINIMIDES;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=731
ACT ETIDRONATE;
02248686;
etidronate disodium 200 mg;
2004-11-10;
Oral;
Tablet;
92:24.00 – BONE RESORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73050
TOMVI;
02498650;
etomidate 2 mg / ml;
2020-09-14;
Intravenous;
Solution;
28:04.92 – MISCELLANEOUS GENERAL ANESTHETICS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98840
NEXPLANON;
02499509;
etonogestrel 68 mg;
2020-08-17;
Subcutaneous;
Implant;
68:12.00 – CONTRACEPTIVES;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98924
ETOPOSIDE INJECTION;
02080036;
etoposide 20 mg / ml;
1994-12-31;
Intravenous;
Liquid;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16507
VEPESID;
00616192;
etoposide 50 mg;
1984-12-31;
Oral;
Capsule;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5963
INTELENCE;
02306778;
etravirine 100 mg;
2008-03-27;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79246
INTELENCE;
02375931;
etravirine 200 mg;
2011-12-12;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86137
INTELENCE;
02396750;
etravirine 25 mg;
2013-06-14;
Oral;
Tablet;
08:18.08.16 – NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88177
AFINITOR;
02339528;
everolimus 10 mg;
2010-01-19;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82512
TEVA-EVEROLIMUS;
02463253;
everolimus 10 mg;
2019-12-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95116
SANDOZ EVEROLIMUS;
02492946;
everolimus 10 mg;
2020-09-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98292
AFINITOR DISPERZ;
02425645;
everolimus 2 mg;
2014-11-28;
Oral;
Tablet For Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91028
AFINITOR;
02369257;
everolimus 2.5 mg;
2011-08-05;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85419
TEVA-EVEROLIMUS;
02463229;
everolimus 2.5 mg;
2019-12-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95113
SANDOZ EVEROLIMUS;
02492911;
everolimus 2.5 mg;
2020-09-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98290
AFINITOR DISPERZ;
02425653;
everolimus 3 mg;
2014-11-28;
Oral;
Tablet For Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91029
AFINITOR;
02339501;
everolimus 5 mg;
2010-03-15;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82511
AFINITOR DISPERZ;
02425661;
everolimus 5 mg;
2014-11-28;
Oral;
Tablet For Suspension;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91030
TEVA-EVEROLIMUS;
02463237;
everolimus 5 mg;
2019-12-06;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95114
SANDOZ EVEROLIMUS;
02492938;
everolimus 5 mg;
2020-09-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98291
REPATHA;
02459779;
evolocumab 120 mg / ml;
2017-04-04;
Subcutaneous;
Solution;
24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94710
REPATHA;
02446057;
evolocumab 140 mg / ml;
2015-09-28;
Subcutaneous;
Solution;
24:06.24 – PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9) INHIBITORS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93132
AROMASIN;
02242705;
exemestane 25 mg;
2000-08-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66502
ACT EXEMESTANE;
02390183;
exemestane 25 mg;
2012-07-26;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87564
MED-EXEMESTANE;
02407841;
exemestane 25 mg;
2013-12-02;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
GENERIC MEDICAL PARTNERS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89256
TEVA-EXEMESTANE;
02408473;
exemestane 25 mg;
2013-10-01;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89323
BYETTA;
02361817;
exenatide 10 mcg / act;
2011-05-31;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84686
BYDUREON;
02448610;
exenatide 2 mg / dose;
2016-02-16;
Subcutaneous;
Powder For Suspension, Sustained-Release , Kit;
68:20.06 – INCRETIN MIMETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93433
BYETTA;
02361809;
exenatide 5 mcg / act;
2011-06-01;
Subcutaneous;
Solution;
68:20.06 – INCRETIN MIMETICS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84685
EZETROL;
02247521;
ezetimibe 10 mg;
2003-06-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71771
TEVA-EZETIMIBE;
02354101;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83931
PMS-EZETIMIBE;
02416409;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90096
SANDOZ EZETIMIBE;
02416778;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90134
RAN-EZETIMIBE;
02419548;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90416
EZETIMIBE;
02422549;
ezetimibe 10 mg;
2014-09-17;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90723
MAR-EZETIMIBE;
02422662;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90733
JAMP-EZETIMIBE;
02423235;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90797
MINT-EZETIMIBE;
02423243;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90798
BIO-EZETIMIBE;
02425211;
ezetimibe 10 mg;
2014-10-08;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90986
PRIVA-EZETIMIBE;
02425238;
ezetimibe 10 mg;
2014-09-15;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90987
ACH-EZETIMIBE;
02425610;
ezetimibe 10 mg;
2014-09-17;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91025
APO-EZETIMIBE;
02427826;
ezetimibe 10 mg;
2014-09-23;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91232
EZETIMIBE;
02429659;
ezetimibe 10 mg;
2014-09-16;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91410
EZETIMIBE;
02431300;
ezetimibe 10 mg;
2014-10-08;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91572
GLN-EZETIMIBE;
02460750;
ezetimibe 10 mg;
2019-07-23;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94824
M-EZETIMIBE;
02467437;
ezetimibe 10 mg;
2017-12-14;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
MANTRA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95581
AURO-EZETIMIBE;
02469286;
ezetimibe 10 mg;
2018-04-25;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95800
AG-EZETIMIBE;
02475898;
ezetimibe 10 mg;
2018-07-20;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96664
EZETIMIBE;
02478544;
ezetimibe 10 mg;
2018-08-14;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96932
NRA-EZETIMIBE;
02481669;
ezetimibe 10 mg;
2018-12-10;
Oral;
Tablet;
24:06.05 – CHOLESTEROL ABSORPTION INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97215
CORIFACT 1250;
02418746;
factor xiii 1250 unit / vial;
2014-04-03;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90330
CORIFACT 250;
02418738;
factor xiii 250 unit / vial;
2014-04-03;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90329
FAMVIR;
02229110;
famciclovir 125 mg;
1996-09-11;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
ATNAHS PHARMA UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43513
SANDOZ FAMCICLOVIR;
02278634;
famciclovir 125 mg;
2006-08-15;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76420
APO-FAMCICLOVIR;
02292025;
famciclovir 125 mg;
2007-02-22;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77739
ACT FAMCICLOVIR;
02305682;
famciclovir 125 mg;
2008-10-29;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79124
FAMVIR;
02229129;
famciclovir 250 mg;
1996-09-11;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
ATNAHS PHARMA UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43514
PMS-FAMCICLOVIR;
02278103;
famciclovir 250 mg;
2006-11-17;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76368
SANDOZ FAMCICLOVIR;
02278642;
famciclovir 250 mg;
2006-08-15;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76421
APO-FAMCICLOVIR;
02292041;
famciclovir 250 mg;
2007-02-22;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77741
ACT FAMCICLOVIR;
02305690;
famciclovir 250 mg;
2008-10-29;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79125
FAMVIR;
02177102;
famciclovir 500 mg;
1995-12-31;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
ATNAHS PHARMA UK LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18768
SANDOZ FAMCICLOVIR;
02278650;
famciclovir 500 mg;
2006-08-15;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76422
APO-FAMCICLOVIR;
02292068;
famciclovir 500 mg;
2007-02-22;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77742
ACT FAMCICLOVIR;
02305704;
famciclovir 500 mg;
2008-10-29;
Oral;
Tablet;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79126
PEPCID AC;
02185938;
famotidine 10 mg;
1996-07-23;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42879
ACID CONTROL;
02237223;
famotidine 10 mg;
1998-10-27;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
VITA HEALTH PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60544
FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE);
02247735;
famotidine 10 mg / ml;
2003-10-30;
Intravenous;
Solution;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72016
FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL);
02247745;
famotidine 10 mg / ml;
2003-10-31;
Intravenous;
Solution;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72026
TEVA-FAMOTIDINE;
02022133;
famotidine 20 mg;
1993-12-31;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13654
MAXIMUM STRENGTH PEPCID AC;
02273357;
famotidine 20 mg;
2007-04-16;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Otc;
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75884
FAMOTIDINE TABLETS;
02351102;
famotidine 20 mg;
2010-06-15;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83631
TEVA-FAMOTIDINE;
02022141;
famotidine 40 mg;
1993-12-31;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13655
FAMOTIDINE TABLETS;
02351110;
famotidine 40 mg;
2010-06-15;
Oral;
Tablet;
56:28.12 – HISTAMINE H2-ANTAGONISTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83632
FAMPYRA;
02379910;
fampridine 10 mg;
2012-02-24;
Oral;
Tablet (Extended-Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
BIOGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86577
TARO-FAMPRIDINE;
02482398;
fampridine 10 mg;
2020-11-24;
Oral;
Tablet (Extended-Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97285
PMS-FAMPRIDINE;
02496216;
fampridine 10 mg;
2021-04-12;
Oral;
Tablet (Extended-Release);
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98608
TEVA-FEBUXOSTAT;
02466198;
febuxostat (febuxostat hemihydrate) 80 mg;
2019-11-28;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95449
MAR-FEBUXOSTAT;
02473607;
febuxostat (febuxostat hemihydrate) 80 mg;
2019-05-16;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96300
ULORIC;
02357380;
febuxostat 80 mg;
2010-09-30;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84250
JAMP FEBUXOSTAT;
02490870;
febuxostat 80 mg;
2020-02-25;
Oral;
Tablet;
92:16.00 – ANTIGOUT AGENTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98091
PLENDIL 10 MG;
00851787;
felodipine 10 mg;
1992-12-31;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12459
SANDOZ FELODIPINE;
02280272;
felodipine 10 mg;
2006-08-15;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76594
APO-FELODIPINE;
02452383;
felodipine 10 mg;
2016-04-22;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93877
PLENDIL 2.5 MG;
02057778;
felodipine 2.5 mg;
1994-12-31;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15574
APO-FELODIPINE;
02452367;
felodipine 2.5 mg;
2016-04-22;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93875
PLENDIL 5 MG;
00851779;
felodipine 5 mg;
1992-12-31;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12458
SANDOZ FELODIPINE;
02280264;
felodipine 5 mg;
2006-08-15;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76593
APO-FELODIPINE;
02452375;
felodipine 5 mg;
2016-04-22;
Oral;
Tablet (Extended-Release);
24:28.08 – DIHYDROPYRIDINES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93876
APO-FENO-SUPER;
02246859;
fenofibrate 100 mg;
2006-04-21;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71082
SANDOZ FENOFIBRATE S;
02288044;
fenofibrate 100 mg;
2007-01-11;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77343
LIPIDIL EZ;
02269082;
fenofibrate 145 mg;
2005-07-26;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75448
TARO-FENOFIBRATE E;
02454696;
fenofibrate 145 mg;
2020-12-14;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94139
SANDOZ FENOFIBRATE E;
02390701;
fenofibrate 145.0 mg;
2012-08-24;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87611
LIPIDIL SUPRA;
02241602;
fenofibrate 160 mg;
2000-03-16;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65259
APO-FENO-SUPER;
02246860;
fenofibrate 160 mg;
2006-04-21;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71083
SANDOZ FENOFIBRATE S;
02288052;
fenofibrate 160 mg;
2007-01-11;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77344
AA-FENO-MICRO;
02239864;
fenofibrate 200 mg;
1999-03-29;
Oral;
Capsule;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63352
LIPIDIL EZ;
02269074;
fenofibrate 48 mg;
2005-07-26;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75447
SANDOZ FENOFIBRATE E;
02390698;
fenofibrate 48.0 mg;
2012-12-12;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87610
AA-FENO-MICRO;
02243180;
fenofibrate 67 mg;
2001-02-21;
Oral;
Capsule;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67060
FENTORA;
02408007;
fentanyl (fentanyl citrate) 100 mcg;
2014-05-14;
Buccal , Sublingual;
Tablet (Effervescent);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89270
FENTANYL INJECTION BP;
02496143;
fentanyl (fentanyl citrate) 100 mcg / 2 ml;
2020-09-09;
Intramuscular , Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98602
FENTANYL INJECTION BP;
02496178;
fentanyl (fentanyl citrate) 1000 mcg / 20 ml;
2020-04-23;
Intramuscular , Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98604
FENTORA;
02408015;
fentanyl (fentanyl citrate) 200 mcg;
2014-05-14;
Buccal , Sublingual;
Tablet (Effervescent);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89271
FENTANYL INJECTION BP;
02496151;
fentanyl (fentanyl citrate) 250 mcg / 5 ml;
2020-04-23;
Intramuscular , Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98603
FENTANYL INJECTION BP;
02496186;
fentanyl (fentanyl citrate) 2500 mcg / 50 ml;
2020-04-23;
Intramuscular , Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98605
FENTORA;
02408023;
fentanyl (fentanyl citrate) 400 mcg;
2014-05-14;
Buccal , Sublingual;
Tablet (Effervescent);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89272
FENTANYL CITRATE INJECTION USP;
02240434;
fentanyl (fentanyl citrate) 50 mcg / ml;
2000-02-10;
Intramuscular , Intravenous , Epidural;
Liquid;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63983
FENTANYL CITRATE INJECTION SDZ;
02384124;
fentanyl (fentanyl citrate) 50 mcg / ml;
2013-02-21;
Intramuscular , Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86987
FENTANYL CITRATE INJECTION USP;
02385406;
fentanyl (fentanyl citrate) 50 mcg / ml;
2016-04-18;
Intramuscular , Intravenous , Epidural;
Solution;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87103
FENTORA;
02408031;
fentanyl (fentanyl citrate) 600 mcg;
2014-05-14;
Buccal , Sublingual;
Tablet (Effervescent);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89273
FENTORA;
02408058;
fentanyl (fentanyl citrate) 800 mcg;
2014-05-14;
Buccal , Sublingual;
Tablet (Effervescent);
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89274
TEVA-FENTANYL;
02282984;
fentanyl 100 mcg / hour;
2006-07-04;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76860
SANDOZ FENTANYL PATCH;
02327163;
fentanyl 100 mcg / hour;
2010-11-01;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81248
PMS-FENTANYL MTX;
02341417;
fentanyl 100 mcg / hour;
2010-03-18;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82693
TEVA-FENTANYL;
02311925;
fentanyl 12 mcg / hour;
2008-06-27;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79746
SANDOZ FENTANYL PATCH;
02327112;
fentanyl 12 mcg / hour;
2010-11-01;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81243
PMS-FENTANYL MTX;
02341379;
fentanyl 12 mcg / hour;
2010-03-18;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82689
TEVA-FENTANYL;
02282941;
fentanyl 25 mcg / hour;
2006-07-04;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76857
SANDOZ FENTANYL PATCH;
02327120;
fentanyl 25 mcg / hour;
2010-11-01;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81244
PMS-FENTANYL MTX;
02341387;
fentanyl 25 mcg / hour;
2010-03-18;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82690
SANDOZ FENTANYL PATCH;
02327139;
fentanyl 37 mcg / hour;
2010-11-01;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81245
TEVA-FENTANYL;
02282968;
fentanyl 50 mcg / hour;
2006-07-04;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76858
SANDOZ FENTANYL PATCH;
02327147;
fentanyl 50 mcg / hour;
2010-11-01;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81246
PMS-FENTANYL MTX;
02341395;
fentanyl 50 mcg / hour;
2010-03-18;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82691
TEVA-FENTANYL;
02282976;
fentanyl 75 mcg / hour;
2006-07-04;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76859
SANDOZ FENTANYL PATCH;
02327155;
fentanyl 75 mcg / hour;
2010-11-01;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81247
PMS-FENTANYL MTX;
02341409;
fentanyl 75 mcg / hour;
2010-03-18;
Transdermal;
Patch;
28:08.08 – OPIATE AGONISTS;
Narcotic (Cdsa I);
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82692
TOVIAZ;
02380021;
fesoterodine fumarate 4 mg;
2012-04-19;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86587
TOVIAZ;
02380048;
fesoterodine fumarate 8 mg;
2012-04-19;
Oral;
Tablet (Extended-Release);
86:12.04 – Antimuscarinics;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86588
ALLEGRA 24 HOUR;
02242819;
fexofenadine hydrochloride 120 mg;
2001-01-09;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66647
ALLEGRA 12 HOUR;
02231462;
fexofenadine hydrochloride 60 mg;
1997-07-10;
Oral;
Tablet;
04:08.00 – SECOND GENERATION ANTIHISTAMINES;
Otc;
SANOFI CONSUMER HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50779
FIBRYGA;
02464616;
fibrinogen (human) 1 g / vial;
2018-08-08;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
OCTAPHARMA PHARMAZEUTIKA PRODUKTIONSGES M B H
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95274
RIASTAP;
02393352;
fibrinogen (human) 1000 mg / vial;
2013-01-31;
Intravenous;
Powder For Solution;
20:28.16 – HEMOSTATICS;
Schedule D;
CSL BEHRING CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87858
DIFICID;
02387174;
fidaxomicin 200 mg;
2012-06-21;
Oral;
Tablet;
08:12.12.92 – OTHER MACROLIDES;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87275
NEUPOGEN;
01968017;
filgrastim 300 mcg / ml;
1992-12-31;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12474
NIVESTYM;
02485591;
filgrastim 300 mcg / ml;
2020-06-10;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97583
GRASTOFIL;
02441489;
filgrastim 300 mcg / 0.5 ml;
2016-03-17;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92587
NIVESTYM;
02485575;
filgrastim 300 mcg / 0.5 ml;
2020-05-11;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97581
GRASTOFIL;
02454548;
filgrastim 480 mcg / 0.8 ml;
2016-11-28;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94117
NIVESTYM;
02485583;
filgrastim 480 mcg / 0.8 ml;
2020-05-11;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97582
NIVESTYM;
02485656;
filgrastim 480 mcg / 1.6 ml;
2020-06-10;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97588
NEUPOGEN;
02420104;
filgrastim 600 mcg / ml;
2016-01-28;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90471
NEUPOGEN;
02420112;
filgrastim 600 mcg / ml;
2016-02-02;
Intravenous , Subcutaneous;
Solution;
20:16.00 – HEMATOPOIETIC AGENTS;
Prescription , Schedule D;
AMGEN CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90472
PROPECIA;
02238213;
finasteride 1 mg;
1998-07-09;
Oral;
Tablet;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61606
PMS-FINASTERIDE;
02320169;
finasteride 1 mg;
2010-05-13;
Oral;
Tablet;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80561
SANDOZ FINASTERIDE A;
02339471;
finasteride 1 mg;
2010-05-12;
Oral;
Tablet;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82509
AURO-FINASTERIDE 1MG;
02428148;
finasteride 1 mg;
2014-11-12;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91262
FINASTERIDE;
02445085;
finasteride 1 mg;
2015-10-14;
Oral;
Tablet;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93029
FINASTERIDE;
02447568;
finasteride 1 mg;
2015-11-25;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93314
PROSCAR;
02010909;
finasteride 5 mg;
1992-12-31;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13370
PMS-FINASTERIDE;
02310112;
finasteride 5 mg;
2010-03-17;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79578
SANDOZ FINASTERIDE;
02322579;
finasteride 5 mg;
2010-02-01;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80802
TEVA-FINASTERIDE;
02348500;
finasteride 5 mg;
2010-04-07;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83386
FINASTERIDE;
02350270;
finasteride 5 mg;
2010-04-29;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83549
ACH-FINASTERIDE;
02355043;
finasteride 5 mg;
2010-10-04;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84031
JAMP-FINASTERIDE;
02357224;
finasteride 5 mg;
2010-10-21;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84235
APO-FINASTERIDE;
02365383;
finasteride 5 mg;
2011-11-17;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85029
AG-FINASTERIDE;
02374404;
finasteride 5 mg;
2020-01-20;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85961
MINT-FINASTERIDE;
02389878;
finasteride 5 mg;
2012-07-25;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87534
AURO-FINASTERIDE;
02405814;
finasteride 5 mg;
2013-05-30;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89058
FINASTERIDE;
02445077;
finasteride 5 mg;
2015-10-14;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93028
FINASTERIDE;
02447541;
finasteride 5 mg;
2015-11-25;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93313
RIVA-FINASTERIDE;
02455013;
finasteride 5 mg;
2016-06-16;
Oral;
Tablet;
92:08.00 – 5 ALFA REDUCTASE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94182
GILENYA;
02482533;
fingolimod (fingolimod hydrochloride) 0.25 mg;
2019-01-03;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97297
GILENYA;
02365480;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2011-03-28;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85038
TEVA-FINGOLIMOD;
02469561;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-11-01;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95837
TARO-FINGOLIMOD;
02469618;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-10-24;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
TARO PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95841
MYLAN-FINGOLIMOD;
02469715;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-09-25;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95854
PMS-FINGOLIMOD;
02469782;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-08-30;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95865
APO-FINGOLIMOD;
02469936;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-11-01;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95885
MAR-FINGOLIMOD;
02474743;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-10-31;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96493
ACH-FINGOLIMOD;
02475669;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-12-11;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96603
SANDOZ FINGOLIMOD;
02482606;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-10-31;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97303
JAMP FINGOLIMOD;
02487772;
fingolimod (fingolimod hydrochloride) 0.5 mg;
2019-10-31;
Oral;
Capsule;
92:20.00 – Immunomodulatory Agents;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97793
APO-FLECAINIDE;
02275546;
flecainide acetate 100 mg;
2006-05-08;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76118
AURO-FLECAINIDE;
02459965;
flecainide acetate 100 mg;
2017-02-27;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94727
MAR-FLECAINIDE;
02476185;
flecainide acetate 100 mg;
2021-01-19;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96720
JAMP FLECAINIDE;
02493713;
flecainide acetate 100 mg;
2020-11-13;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98371
APO-FLECAINIDE;
02275538;
flecainide acetate 50 mg;
2006-05-08;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76117
AURO-FLECAINIDE;
02459957;
flecainide acetate 50 mg;
2017-02-27;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94726
MAR-FLECAINIDE;
02476177;
flecainide acetate 50 mg;
2021-01-19;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96719
JAMP FLECAINIDE;
02493705;
flecainide acetate 50 mg;
2020-10-27;
Oral;
Tablet;
24:04.04.12 – CLASS IC ANTIARRYTHMICS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98370
ADDYI;
02473550;
flibanserin 100 mg;
2018-11-13;
Oral;
Tablet;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Prescription;
SEARCHLIGHT PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96294
TEVA-FLUCONAZOLE;
02236979;
fluconazole 100 mg;
2002-07-15;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60274
APO-FLUCONAZOLE;
02237371;
fluconazole 100 mg;
1998-10-13;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60694
MYLAN-FLUCONAZOLE;
02245293;
fluconazole 100 mg;
2002-06-05;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69317
PMS-FLUCONAZOLE;
02245644;
fluconazole 100 mg;
2002-06-05;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69744
ACT FLUCONAZOLE;
02281279;
fluconazole 100 mg;
2007-12-03;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76692
PRO-FLUCONAZOLE;
02310686;
fluconazole 100 mg;
2008-07-08;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79630
DIFLUCAN ONE;
02141442;
fluconazole 150 mg;
1995-12-31;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17789
APO-FLUCONAZOLE-150;
02241895;
fluconazole 150 mg;
2000-03-20;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65565
RIVA-FLUCONAZOLE;
02255510;
fluconazole 150 mg;
2004-07-26;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74071
CANESORAL;
02311690;
fluconazole 150 mg;
2010-03-10;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79724
FLUCONAZOLE 150;
02352133;
fluconazole 150 mg;
2011-03-25;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83738
MAR-FLUCONAZOLE-150;
02428792;
fluconazole 150 mg;
2016-12-14;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91325
JAMP-FLUCONAZOLE;
02432471;
fluconazole 150 mg;
2015-01-08;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91671
BIO-FLUCONAZOLE;
02462168;
fluconazole 150 mg;
2019-09-20;
Oral;
Capsule;
08:14.08 – AZOLES;
Otc;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94989
DIFLUCAN;
00891835;
fluconazole 2 mg / ml;
1990-12-31;
Intravenous;
Solution;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10954
FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP;
02261472;
fluconazole 2 mg / ml;
2005-09-01;
Intravenous;
Solution;
08:14.08 – AZOLES;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74685
FLUCONAZOLE INJECTION SDZ;
02388448;
fluconazole 2 mg / ml;
2012-10-18;
Intravenous;
Solution;
08:14.08 – AZOLES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87397
TEVA-FLUCONAZOLE;
02236978;
fluconazole 50 mg;
2002-07-15;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60273
APO-FLUCONAZOLE;
02237370;
fluconazole 50 mg;
1998-10-13;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60693
MYLAN-FLUCONAZOLE;
02245292;
fluconazole 50 mg;
2002-06-05;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69316
PMS-FLUCONAZOLE;
02245643;
fluconazole 50 mg;
2002-06-05;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69743
ACT FLUCONAZOLE;
02281260;
fluconazole 50 mg;
2007-12-03;
Oral;
Tablet;
08:14.08 – AZOLES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76691
DIFLUCAN;
02024152;
fluconazole 50 mg / 5 ml;
1995-12-31;
Oral;
Powder For Solution;
08:14.08 – AZOLES;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18010
FLUDARA;
02246226;
fludarabine phosphate 10 mg;
2002-09-24;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70384
FLUDARABINE PHOSPHATE FOR INJECTION;
02283859;
fludarabine phosphate 25 mg / ml;
2006-12-04;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=76943
FLORINEF;
02086026;
fludrocortisone 21-acetate 0.1 mg;
1995-12-31;
Oral;
Tablet;
68:04.00 – ADRENALS;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19460
FLUMAZENIL INJECTION;
02249561;
flumazenil 0.1 mg / ml;
2004-04-21;
Intravenous;
Solution;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73439
FLUMAZENIL INJECTION;
02266342;
flumazenil 0.1 mg / ml;
2007-11-05;
Intravenous;
Solution;
28:92.00 – MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75176
FLUNARIZINE;
02246082;
flunarizine (flunarizine hydrochloride) 5 mg;
2002-08-08;
Oral;
Capsule;
04:04.16 – PIPERAZINE DERIVATIVES , 28:32.92 – ANTIMIGRAINE AGENTS, MISCELLANEOUS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70217
DERMA SMOOTHE/FS LIQ 0.01%;
00873292;
fluocinolone acetonide 0.01 %;
1991-12-31;
Topical;
Emulsion;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
HILL DERMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13875
DERMOTIC OIL EAR DROPS;
02300559;
fluocinolone acetonide 0.01 % / w/v;
2008-01-09;
Otic;
Solution;
52:08.08 – CORTICOSTEROIDS;
Prescription;
HILL DERMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78584
SYNALAR;
02162512;
fluocinolone acetonide 0.025 %;
1996-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20258
RETISERT;
02306980;
fluocinolone acetonide 0.59 mg;
2012-09-13;
Intravitreal;
Implant;
52:08.08 – CORTICOSTEROIDS;
Prescription;
BAUSCH & LOMB INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79266
TIAMOL CREAM 0.05%;
00598933;
fluocinonide 0.05 %;
1983-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5439
LYDERM CREAM 0.05%;
00716863;
fluocinonide 0.05 %;
1988-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9276
LYDERM OINTMENT 0.05%;
02236996;
fluocinonide 0.05 %;
1999-10-15;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60294
LYDERM GEL 0.05%;
02236997;
fluocinonide 0.05 %;
1998-04-27;
Topical;
Gel;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60295
LIDEX;
02161966;
fluocinonide 0.05 % / w/w;
1995-12-31;
Topical;
Ointment;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19203
LIDEMOL;
02163152;
fluocinonide 0.05 % / w/w;
1995-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19312
LIDEX;
02161974;
fluocinonide 0.05 % / w/w;
1995-12-31;
Topical;
Gel;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19317
LIDEX;
02161923;
fluocinonide 0.05 % / w/w;
1996-12-31;
Topical;
Cream;
84:06.00 – ANTI-INFLAMMATORY AGENTS;
Prescription;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=20008
FLUORESCITE;
00505005;
fluorescein (fluorescein sodium) 10 % / w/v;
1980-12-31;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
ALCON CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3781
DIOFLUOR STRIPS;
02160773;
fluorescein sodium 1 mg;
1995-12-31;
Ophthalmic;
Strip;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
DIOPTIC PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19197
MINIMS FLUORESCEIN SODIUM;
02148390;
fluorescein sodium 2 % / w/v;
1995-12-31;
Ophthalmic;
Drops;
36:58.00 – OCULAR DISORDERS;
Ethical;
BAUSCH HEALTH, CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18747
FML 0.1%;
00247855;
fluorometholone 0.1 %;
1972-12-31;
Ophthalmic;
Drops;
52:08.08 – CORTICOSTEROIDS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=1470
SANDOZ FLUOROMETHOLONE;
00432814;
fluorometholone 0.1 %;
2012-07-24;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=42778
FLAREX;
00756784;
fluorometholone acetate 0.1 % / w/v;
1987-12-31;
Ophthalmic;
Suspension;
52:08.08 – CORTICOSTEROIDS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=8229
TOLAK;
02485346;
fluorouracil (fluorouracil sodium) 4 % / w/w;
2019-06-25;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
HILL DERMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97559
EFUDEX;
00330582;
fluorouracil 5 %;
1975-12-31;
Topical;
Cream;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription;
VALEANT CANADA LP/VALEANT CANADA S.E.C.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2138
FLUOROURACIL INJECTION;
02473771;
fluorouracil 5 g / 100 ml;
2019-06-06;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
BIOLYSE PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96320
FLUOROURACIL INJECTION;
00012882;
fluorouracil 50 mg / ml;
1989-12-31;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10015
FLUOROURACIL INJECTION USP;
02413450;
fluorouracil 50 mg / ml;
2014-10-01;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89810
PROZAC CAPSULES 10MG;
02018985;
fluoxetine (fluoxetine hydrochloride) 10 mg;
1993-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13723
PMS-FLUOXETINE – CAP 10MG;
02177579;
fluoxetine (fluoxetine hydrochloride) 10 mg;
1995-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19074
TEVA-FLUOXETINE;
02216582;
fluoxetine (fluoxetine hydrochloride) 10 mg;
1996-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19916
APO-FLUOXETINE;
02216353;
fluoxetine (fluoxetine hydrochloride) 10 mg;
1996-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19962
FLUOXETINE;
02286068;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2009-10-22;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77154
RIVA-FLUOXETINE;
02305461;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2010-10-22;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79103
PRO-FLUOXETINE;
02314991;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2008-10-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80053
FLUOXETINE;
02374447;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2011-10-14;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85969
MINT-FLUOXETINE;
02380560;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2012-03-20;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86635
AURO-FLUOXETINE;
02385627;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2012-07-24;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87125
ACH-FLUOXETINE;
02393441;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2012-10-10;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87867
JAMP-FLUOXETINE;
02401894;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2013-04-30;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88677
PRIVA-FLUOXETINE;
02448416;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2018-12-03;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93410
BIO-FLUOXETINE;
02448424;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2016-10-25;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93411
SANDOZ FLUOXETINE;
02479486;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2018-12-19;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97015
AG-FLUOXETINE;
02485052;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2019-03-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97531
FLUOXETINE;
02490595;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2020-05-12;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98066
NRA-FLUOXETINE;
02503875;
fluoxetine (fluoxetine hydrochloride) 10 mg;
2020-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99331
PROZAC CAPSULES 20MG;
00636622;
fluoxetine (fluoxetine hydrochloride) 20 mg;
1989-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9703
PMS-FLUOXETINE – CAP 20MG;
02177587;
fluoxetine (fluoxetine hydrochloride) 20 mg;
1995-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19064
TEVA-FLUOXETINE;
02216590;
fluoxetine (fluoxetine hydrochloride) 20 mg;
1996-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19895
APO-FLUOXETINE;
02216361;
fluoxetine (fluoxetine hydrochloride) 20 mg;
1996-12-31;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19961
FLUOXETINE;
02286076;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2009-10-22;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77155
RIVA-FLUOXETINE;
02305488;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2009-09-21;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79104
PRO-FLUOXETINE;
02315009;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2008-10-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80054
FLUOXETINE;
02374455;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2011-10-14;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85980
MINT-FLUOXETINE;
02380579;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2012-03-20;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86636
ACH-FLUOXETINE;
02383241;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2012-05-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86901
AURO-FLUOXETINE;
02385635;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2012-07-24;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87126
JAMP-FLUOXETINE;
02386402;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2012-06-07;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87199
PRIVA-FLUOXETINE;
02448408;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2018-05-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93409
BIO-FLUOXETINE;
02448432;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2016-10-25;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93412
SANDOZ FLUOXETINE;
02479494;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2018-12-19;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97016
AG-FLUOXETINE;
02485060;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2019-03-15;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97532
FLUOXETINE;
02490609;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2020-03-05;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ALTAMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98067
NRA-FLUOXETINE;
02503883;
fluoxetine (fluoxetine hydrochloride) 20 mg;
2020-11-23;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
NORA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99332
APO-FLUOXETINE;
02231328;
fluoxetine (fluoxetine hydrochloride) 20 mg / 5 ml;
1997-06-16;
Oral;
Solution;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50635
ODAN-FLUOXETINE;
02459361;
fluoxetine (fluoxetine hydrochloride) 20 mg / 5 ml;
2017-01-24;
Oral;
Solution;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
ODAN LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94657
PMS-FLUOXETINE;
02464640;
fluoxetine (fluoxetine hydrochloride) 40 mg;
2018-02-21;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95277
PMS-FLUOXETINE;
02464659;
fluoxetine (fluoxetine hydrochloride) 60 mg;
2018-08-01;
Oral;
Capsule;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95278
FLUANXOL 0.5MG – TAB;
02156008;
flupentixol (flupentixol dihydrochloride) 0.5 mg;
1995-12-31;
Oral;
Tablet;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18739
FLUANXOL 3MG – TAB;
02156016;
flupentixol (flupentixol dihydrochloride) 3 mg;
1995-12-31;
Oral;
Tablet;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18740
FLUANXOL DEPOT 10%- LIQ IM 100MG/ML;
02156040;
flupentixol decanoate 100 mg / ml;
1995-12-31;
Intramuscular;
Solution;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18737
FLUANXOL DEPOT 2% -LIQ IM 20MG/ML;
02156032;
flupentixol decanoate 20 mg / ml;
1995-12-31;
Intramuscular;
Solution;
28:16.08.32 – THIOXANTHENES;
Prescription;
LUNDBECK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18800
FLUPHENAZINE;
00405345;
fluphenazine hydrochloride 1 mg;
1977-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2858
FLUPHENAZINE;
00410632;
fluphenazine hydrochloride 2 mg;
1977-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2861
FLUPHENAZINE;
00405361;
fluphenazine hydrochloride 5 mg;
1977-12-31;
Oral;
Tablet;
28:16.08.24 – PHENOTHIAZINES;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2860
FLURAZEPAM;
00521698;
flurazepam hydrochloride 15 mg;
1982-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4728
FLURAZEPAM;
00521701;
flurazepam hydrochloride 30 mg;
1982-12-31;
Oral;
Capsule;
28:24.08 – BENZODIAZEPINES;
Targeted (Cdsa Iv);
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4729
FLURBIPROFEN;
01912038;
flurbiprofen 100 mg;
1991-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11465
TEVA-FLURBIPROFEN;
02100517;
flurbiprofen 100 mg;
1994-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16515
FLURBIPROFEN;
01912046;
flurbiprofen 50 mg;
1991-12-31;
Oral;
Tablet;
28:08.04.92 – OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11466
FLUTAMIDE;
02238560;
flutamide 250 mg;
1998-10-08;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61987
ARNUITY ELLIPTA;
02446561;
fluticasone furoate 100 mcg / act;
2016-01-26;
Inhalation , Oral;
Powder;
52:08.08 – CORTICOSTEROIDS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93200
ARNUITY ELLIPTA;
02446588;
fluticasone furoate 200 mcg / act;
2015-12-14;
Inhalation , Oral;
Powder;
52:08.08 – CORTICOSTEROIDS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93201
AVAMYS;
02298589;
fluticasone furoate 27.5 mcg / act;
2007-10-22;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78388
FLOVENT DISKUS;
02237245;
fluticasone propionate 100 mcg / act;
1998-04-02;
Inhalation;
Powder;
68:04.00 – ADRENALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60565
AERMONY RESPICLICK;
02467909;
fluticasone propionate 113 mcg / act;
2020-09-30;
Inhalation;
Powder (Metered Dose);
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95625
FLOVENT HFA;
02244292;
fluticasone propionate 125 mcg / act;
2001-12-20;
Inhalation , Oral;
Metered-Dose Aerosol;
68:04.00 – ADRENALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68259
AERMONY RESPICLICK;
02467917;
fluticasone propionate 232 mcg / act;
2020-09-30;
Inhalation;
Powder (Metered Dose);
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95626
FLOVENT DISKUS;
02237246;
fluticasone propionate 250 mcg / act;
1998-04-02;
Inhalation;
Powder;
68:04.00 – ADRENALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60566
FLOVENT HFA;
02244293;
fluticasone propionate 250 mcg / act;
2001-12-20;
Inhalation , Oral;
Metered-Dose Aerosol;
68:04.00 – ADRENALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68260
PMS-FLUTICASONE HFA;
02503131;
fluticasone propionate 250 mcg / act;
2021-01-21;
Inhalation , Oral;
Metered-Dose Aerosol;
68:04.00 – ADRENALS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99264
APO-FLUTICASONE HFA;
02510987;
fluticasone propionate 250 mcg / act;
2021-04-26;
Inhalation , Oral;
Metered-Dose Aerosol;
68:04.00 – ADRENALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=100023
FLOVENT HFA;
02244291;
fluticasone propionate 50 mcg / act;
2001-12-20;
Inhalation , Oral;
Metered-Dose Aerosol;
68:04.00 – ADRENALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68258
FLONASE ALLERGY RELIEF;
02248307;
fluticasone propionate 50 mcg / act;
2017-02-01;
Nasal;
Spray, Metered Dose;
52:08.00 – ANTI-INFLAMMATORY AGENTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72648
APO-FLUTICASONE;
02294745;
fluticasone propionate 50 mcg / act;
2007-07-05;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78009
RATIO-FLUTICASONE;
02296071;
fluticasone propionate 50 mcg / act;
2007-06-07;
Nasal;
Metered-Dose Pump;
52:08.08 – CORTICOSTEROIDS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78143
TEVA-FLUTICASONE;
02453738;
fluticasone propionate 50 mcg / act;
2017-09-28;
Nasal;
Metered-Dose Pump;
52:08.08 – CORTICOSTEROIDS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94027
24HR NASAL ALLERGY RELIEF;
02460513;
fluticasone propionate 50 mcg / act;
2017-07-19;
Nasal;
Spray, Metered Dose;
52:08.08 – CORTICOSTEROIDS;
Otc;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94795
FLOVENT DISKUS;
02237247;
fluticasone propionate 500 mcg / act;
1998-04-02;
Inhalation;
Powder;
68:04.00 – ADRENALS;
Prescription;
GLAXOSMITHKLINE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60567
AERMONY RESPICLICK;
02467895;
fluticasone propionate 55 mcg / act;
2020-09-30;
Inhalation;
Powder (Metered Dose);
68:04.00 – ADRENALS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95621
TEVA-FLUVASTATIN;
02299224;
fluvastatin (fluvastatin sodium) 20 mg;
2012-12-11;
Oral;
Capsule;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78461
TEVA-FLUVASTATIN;
02299232;
fluvastatin (fluvastatin sodium) 40 mg;
2012-12-11;
Oral;
Capsule;
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78462
LESCOL XL;
02250527;
fluvastatin (fluvastatin sodium) 80 mg;
2004-04-05;
Oral;
Tablet (Extended-Release);
24:06.08 – HMG-COA REDUCTASE INHIBITORS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73534
LUVOX;
01919369;
fluvoxamine maleate 100 mg;
1991-12-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11751
APO-FLUVOXAMINE TABLETS;
02231330;
fluvoxamine maleate 100 mg;
1998-05-20;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50638
FLUVOXAMINE-100;
02236754;
fluvoxamine maleate 100 mg;
1998-04-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60041
ACT FLUVOXAMINE;
02255537;
fluvoxamine maleate 100 mg;
2004-08-13;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74073
RIVA-FLUVOX;
02303361;
fluvoxamine maleate 100 mg;
2008-06-11;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78869
LUVOX;
01919342;
fluvoxamine maleate 50 mg;
1991-12-31;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
BGP PHARMA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11752
APO-FLUVOXAMINE TABLETS;
02231329;
fluvoxamine maleate 50 mg;
1997-05-20;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50637
FLUVOXAMINE-50;
02236753;
fluvoxamine maleate 50 mg;
1998-04-10;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60040
ACT FLUVOXAMINE;
02255529;
fluvoxamine maleate 50 mg;
2004-08-13;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74072
RIVA-FLUVOX;
02303345;
fluvoxamine maleate 50 mg;
2008-06-11;
Oral;
Tablet;
28:16.04.20 – SELECTIVE-SEROTONIN REUPTAKE INHIBITORS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78867
FOLIC ACID INJECTION USP;
00816086;
folic acid (sodium folate) 5 mg / ml;
1990-12-31;
Intramuscular , Intravenous , Subcutaneous;
Liquid;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10312
FOLIC ACID INJECTION, USP;
02139480;
folic acid (sodium folate) 5 mg / ml;
1996-08-14;
Intramuscular , Intravenous , Subcutaneous;
Solution;
88:08.00 – VITAMIN B COMPLEX;
Ethical;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=31358
FOLIC ACID;
00426849;
folic acid 5 mg;
1978-12-31;
Oral;
Tablet;
88:08.00 – VITAMIN B COMPLEX;
Prescription;
AA PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3002
SANDOZ FOLIC ACID;
02285673;
folic acid 5 mg;
2006-11-27;
Oral;
Tablet;
88:08.00 – VITAMIN B COMPLEX;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77118
JAMP-FOLIC ACID;
02366061;
folic acid 5 mg;
2011-06-10;
Oral;
Tablet;
88:08.00 – VITAMIN B COMPLEX;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85094
GONAL-F PEN;
02270404;
follitropin alfa 300 unit / 0.5 ml;
2005-09-06;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75578
GONAL-F PEN;
02270390;
follitropin alfa 450 unit / 0.75 ml;
2005-09-06;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75577
GONAL-F;
02248154;
follitropin alfa 5.5 mcg / vial;
2003-12-29;
Intramuscular , Subcutaneous;
Powder For Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72486
GONAL-F PEN;
02270382;
follitropin alfa 900 unit / 1.5 ml;
2005-09-06;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
EMD SERONO, A DIVISION OF EMD INC., CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75576
PUREGON;
02243948;
follitropin beta 833 unit / ml;
2001-10-18;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67891
REKOVELLE;
02474093;
follitropin delta 12 mcg / 0.36 ml;
2018-05-23;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96414
REKOVELLE;
02487462;
follitropin delta 12 mcg / 0.36 ml;
2019-11-01;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97762
REKOVELLE;
02474085;
follitropin delta 36 mcg / 1.08 ml;
2018-05-23;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96413
REKOVELLE;
02487470;
follitropin delta 36 mcg / 1.08 ml;
2019-11-01;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97763
REKOVELLE;
02474077;
follitropin delta 72 mcg / 2.16 ml;
2018-05-23;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96412
REKOVELLE;
02487489;
follitropin delta 72 mcg / 2.16 ml;
2019-11-01;
Subcutaneous;
Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription , Schedule D;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97764
ANTIZOL;
02242980;
fomepizole 1 g / ml;
2001-03-30;
Intravenous;
Liquid;
92:12.00 – ANTIDOTES;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66820
FOMEPIZOLE FOR INJECTION;
02435667;
fomepizole 1 g / ml;
2015-09-22;
Intravenous;
Solution;
92:12.00 – ANTIDOTES;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92000
ARIXTRA;
02245531;
fondaparinux sodium 2.5 mg / 0.5 ml;
2002-07-19;
Intravenous , Subcutaneous;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69618
FONDAPARINUX SODIUM INJECTION;
02406853;
fondaparinux sodium 2.5 mg / 0.5 ml;
2014-03-21;
Intravenous , Subcutaneous;
Solution;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89154
ARIXTRA;
02258056;
fondaparinux sodium 7.5 mg / 0.6 ml;
2008-04-17;
Subcutaneous;
Solution;
20:12.04.92 – MISCELLANEOUS ANTICOAGULANTS;
Prescription;
ASPEN PHARMACARE CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74328
FONDAPARINUX SODIUM INJECTION;
02406896;
fondaparinux sodium 7.5 mg / 0.6 ml;
2014-03-21;
Subcutaneous;
Solution;
20:12.04.14 – Direct Factor Xa Inhibitors;
Prescription;
DR REDDY’S LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89156
FORADIL DRY POWDER CAPSULES FOR INHALATION;
02230898;
formoterol fumarate 12 mcg;
1997-07-08;
Inhalation;
Capsule;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50160
OXEZE TURBUHALER;
02237224;
formoterol fumarate dihydrate 12 mcg / act;
1998-03-12;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60542
OXEZE TURBUHALER;
02237225;
formoterol fumarate dihydrate 6 mcg / act;
1998-03-12;
Inhalation;
Powder;
12:12.08.12 – SELECTIVE BETA 2-ADRENERGIC AGONISTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=60543
TELZIR;
02261553;
fosamprenavir (fosamprenavir calcium) 50 mg / ml;
2005-02-23;
Oral;
Suspension;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74693
TELZIR;
02261545;
fosamprenavir (fosamprenavir calcium) 700 mg;
2004-12-22;
Oral;
Tablet;
08:18.08.08 – HIV PROTEASE INHIBITORS;
Prescription;
VIIV HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74692
EMEND IV;
02363356;
fosaprepitant (fosaprepitant dimeglumine) 150 mg / vial;
2011-04-04;
Intravenous;
Powder For Solution;
56:22.32 – NEUROKININ-1 RECEPTOR ANTAGONISTS;
Prescription;
MERCK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84835
VOCARVI;
02505924;
foscarnet sodium 24 mg / ml;
2021-03-30;
Intravenous;
Solution;
08:18.92 – MISCELLANEOUS ANTIVIRALS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99528
IVOZFO;
02488086;
fosfomycin (fosfomycin sodium) 4 g / vial;
2020-02-12;
Intravenous;
Powder For Solution;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
VERITY PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97819
MONUROL;
02240335;
fosfomycin (fosfomycin tromethamine) 3 g / sachet;
1999-09-15;
Oral;
Powder For Solution;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
PALADIN LABS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63874
JAMP-FOSFOMYCIN;
02473801;
fosfomycin (fosfomycin tromethamine) 3 g / sachet;
2018-08-02;
Oral;
Powder For Solution;
08:36.00 – URINARY ANTI-INFECTIVES;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96331
TEVA-FOSINOPRIL;
02247802;
fosinopril sodium 10 mg;
2003-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72096
APO-FOSINOPRIL;
02266008;
fosinopril sodium 10 mg;
2005-04-27;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75144
FOSINOPRIL-10;
02303000;
fosinopril sodium 10 mg;
2008-10-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78832
FOSINOPRIL;
02459388;
fosinopril sodium 10 mg;
2017-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94662
TEVA-FOSINOPRIL;
02247803;
fosinopril sodium 20 mg;
2003-12-05;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72097
APO-FOSINOPRIL;
02266016;
fosinopril sodium 20 mg;
2005-04-27;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75145
FOSINOPRIL-20;
02303019;
fosinopril sodium 20 mg;
2008-10-23;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78833
FOSINOPRIL;
02459396;
fosinopril sodium 20 mg;
2017-04-11;
Oral;
Tablet;
24:32.04 – ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94663
CEREBYX;
02230988;
fosphenytoin sodium 75 mg / ml;
2000-03-01;
Intramuscular , Intravenous;
Liquid;
28:12.12 – HYDANTOINS;
Prescription;
ERFA CANADA 2012 INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=50269
TAVALISSE;
02508052;
fostamatinib (fostamatinib disodium) 100 mg;
2020-12-10;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
RIGEL PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99741
TAVALISSE;
02508060;
fostamatinib (fostamatinib disodium) 150 mg;
2020-12-10;
Oral;
Tablet;
20:28.16 – HEMOSTATICS;
Prescription;
RIGEL PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99742
AJOVY;
02497859;
fremanezumab 225 mg / 1.5 ml;
2020-08-04;
Subcutaneous;
Solution;
28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
Prescription , Schedule D;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98765
AJOVY;
02509474;
fremanezumab 225 mg / 1.5 ml;
2021-04-01;
Subcutaneous;
Solution;
28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
Prescription , Schedule D;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99876
APO-FROVATRIPTAN;
02426471;
frovatriptan (frovatriptan succinate monohydrate) 2.5 mg;
2014-08-11;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91106
JAMP FROVATRIPTAN;
02497131;
frovatriptan (frovatriptan succinate monohydrate) 2.5 mg;
2021-01-19;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98700
FROVA;
02257084;
frovatriptan (frovatriptan succinate) 2.5 mg;
2008-01-04;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ENDO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74230
TEVA-FROVATRIPTAN;
02415844;
frovatriptan (frovatriptan succinate) 2.5 mg;
2015-01-16;
Oral;
Tablet;
28:32.28 – SELECTIVE SEROTONIN AGONISTS;
Prescription;
ENDO PHARMACEUTICALS INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90043
FASLODEX;
02248624;
fulvestrant 50 mg / ml;
2004-06-14;
Intramuscular;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72981
TEVA-FULVESTRANT INJECTION;
02460130;
fulvestrant 50 mg / ml;
2019-01-15;
Intramuscular;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94743
FULVESTRANT INJECTION;
02468549;
fulvestrant 50 mg / ml;
2020-04-27;
Intramuscular;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95697
FULVESTRANT INJECTION;
02483610;
fulvestrant 50 mg / ml;
2019-02-01;
Intramuscular;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97398
FUROSEMIDE INJ USP;
00527033;
furosemide 10 mg / ml;
1981-12-31;
Intramuscular , Intravenous;
Liquid;
40:28.08 – LOOP DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=4431
LASIX ORAL SOLUTION 10MG/ML;
02224720;
furosemide 10 mg / ml;
1996-12-04;
Oral;
Solution;
40:28.08 – LOOP DIURETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37372
FUROSEMIDE INJECTION SDZ;
02382539;
furosemide 10 mg / ml;
2012-07-26;
Intramuscular , Intravenous;
Solution;
40:28.08 – LOOP DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86837
FUROSEMIDE INJECTION USP;
02461404;
furosemide 10 mg / ml;
2017-07-31;
Intramuscular , Intravenous;
Solution;
40:28.08 – LOOP DIURETICS;
Prescription;
STERIMAX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94899
TEVA-FUROSEMIDE;
00337730;
furosemide 20 mg;
1976-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2333
APO FUROSEMIDE TAB 20MG;
00396788;
furosemide 20 mg;
1977-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2798
FUROSEMIDE 20 TAB;
00496723;
furosemide 20 mg;
1980-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3809
FUROSEMIDE;
02351420;
furosemide 20 mg;
2010-06-15;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83669
MINT-FUROSEMIDE;
02466759;
furosemide 20 mg;
2018-07-30;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95511
FUROSEMIDE INJECTION USP;
02384094;
furosemide 20 mg / 2 ml;
2013-08-22;
Intramuscular , Intravenous;
Solution;
40:28.08 – LOOP DIURETICS;
Prescription;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86984
FUROSEMIDE SPECIAL;
00401633;
furosemide 250 mg / 25 ml;
1991-12-31;
Intravenous;
Solution;
40:28.08 – LOOP DIURETICS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12218
TEVA-FUROSEMIDE;
00337749;
furosemide 40 mg;
1976-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2447
APO FUROSEMIDE TAB 40MG;
00362166;
furosemide 40 mg;
1976-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2472
FUROSEMIDE 40MG;
00397792;
furosemide 40 mg;
1977-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=2851
FUROSEMIDE;
02351439;
furosemide 40 mg;
2010-06-15;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83670
MINT-FUROSEMIDE;
02466767;
furosemide 40 mg;
2018-07-30;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95512
LASIX SPECIAL;
02224755;
furosemide 500 mg;
1997-08-20;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
SANOFI-AVENTIS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=37375
APO FUROSEMIDE TAB 80MG;
00707570;
furosemide 80 mg;
1986-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=6827
TEVA-FUROSEMIDE;
00765953;
furosemide 80 mg;
1988-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9240
FUROSEMIDE-80 TAB 80MG;
00667080;
furosemide 80 mg;
1995-12-31;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19189
FUROSEMIDE;
02351447;
furosemide 80 mg;
2010-06-15;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83671
MINT-FUROSEMIDE;
02466775;
furosemide 80 mg;
2018-07-30;
Oral;
Tablet;
40:28.08 – LOOP DIURETICS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95513
FUCIDIN OINTMENT 2%;
00586676;
fusidate sodium 2 %;
1984-12-31;
Topical;
Ointment;
84:04.04 – ANTIBIOTICS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5638
FUCITHALMIC;
02243862;
fusidic acid 1 % / w/w;
2001-08-29;
Ophthalmic;
Drops;
52:04.04 – ANTIBACTERIALS;
Prescription;
AMDIPHARM LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67803
FUCIDIN CREAM 2%;
00586668;
fusidic acid 2 %;
1984-12-31;
Topical;
Cream;
84:04.04 – ANTIBIOTICS;
Prescription;
LEO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=5637
NEURONTIN;
02084260;
gabapentin 100 mg;
1994-12-31;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15944
PMS-GABAPENTIN;
02243446;
gabapentin 100 mg;
2001-02-23;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67356
APO-GABAPENTIN;
02244304;
gabapentin 100 mg;
2001-08-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68271
TEVA-GABAPENTIN;
02244513;
gabapentin 100 mg;
2002-06-21;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68490
GABAPENTIN;
02246314;
gabapentin 100 mg;
2003-01-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70477
RIVA-GABAPENTIN;
02251167;
gabapentin 100 mg;
2004-03-25;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73612
PRO-GABAPENTIN;
02310449;
gabapentin 100 mg;
2008-10-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79608
AURO-GABAPENTIN;
02321203;
gabapentin 100 mg;
2011-06-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80660
GABAPENTIN;
02353245;
gabapentin 100 mg;
2010-07-30;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83846
JAMP-GABAPENTIN;
02361469;
gabapentin 100 mg;
2011-09-26;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84654
MAR-GABAPENTIN;
02391473;
gabapentin 100 mg;
2014-01-08;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87682
GABAPENTIN CAPSULES USP;
02416840;
gabapentin 100 mg;
2014-06-04;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90145
PRIVA-GABAPENTIN;
02450097;
gabapentin 100 mg;
2017-06-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93612
BIO-GABAPENTIN;
02450143;
gabapentin 100 mg;
2017-06-21;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93617
AG-GABAPENTIN;
02477912;
gabapentin 100 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96813
NEURONTIN;
02084279;
gabapentin 300 mg;
1994-12-31;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=15945
PMS-GABAPENTIN;
02243447;
gabapentin 300 mg;
2001-02-23;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67357
APO-GABAPENTIN;
02244305;
gabapentin 300 mg;
2001-08-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68273
TEVA-GABAPENTIN;
02244514;
gabapentin 300 mg;
2002-06-21;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68491
GABAPENTIN;
02246315;
gabapentin 300 mg;
2003-01-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70478
RIVA-GABAPENTIN;
02251175;
gabapentin 300 mg;
2004-03-25;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73613
PRO-GABAPENTIN;
02310457;
gabapentin 300 mg;
2008-10-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79609
RAN-GABAPENTIN;
02319063;
gabapentin 300 mg;
2009-01-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
RANBAXY PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80455
AURO-GABAPENTIN;
02321211;
gabapentin 300 mg;
2011-06-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80661
GABAPENTIN;
02353253;
gabapentin 300 mg;
2010-07-30;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83847
JAMP-GABAPENTIN;
02361485;
gabapentin 300 mg;
2011-09-26;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84656
MAR-GABAPENTIN;
02391481;
gabapentin 300 mg;
2014-01-08;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87683
GABAPENTIN CAPSULES USP;
02416859;
gabapentin 300 mg;
2014-06-04;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90146
PRIVA-GABAPENTIN;
02450100;
gabapentin 300 mg;
2017-06-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93613
BIO-GABAPENTIN;
02450151;
gabapentin 300 mg;
2017-06-21;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93618
AG-GABAPENTIN;
02477920;
gabapentin 300 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96814
NEURONTIN;
02084287;
gabapentin 400 mg;
1994-12-31;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16210
PMS-GABAPENTIN;
02243448;
gabapentin 400 mg;
2001-02-23;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67358
APO-GABAPENTIN;
02244306;
gabapentin 400 mg;
2001-08-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68274
TEVA-GABAPENTIN;
02244515;
gabapentin 400 mg;
2002-06-21;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=68492
GABAPENTIN;
02246316;
gabapentin 400 mg;
2003-01-07;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=70479
RIVA-GABAPENTIN;
02251183;
gabapentin 400 mg;
2004-03-25;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
LABORATOIRE RIVA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73614
PRO-GABAPENTIN;
02310465;
gabapentin 400 mg;
2008-10-27;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79610
AURO-GABAPENTIN;
02321238;
gabapentin 400 mg;
2011-06-15;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80662
GABAPENTIN;
02353261;
gabapentin 400 mg;
2010-07-30;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83848
JAMP-GABAPENTIN;
02361493;
gabapentin 400 mg;
2011-09-26;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84657
MAR-GABAPENTIN;
02391503;
gabapentin 400 mg;
2014-01-08;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
MARCAN PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87684
GABAPENTIN CAPSULES USP;
02416867;
gabapentin 400 mg;
2014-06-04;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90147
PRIVA-GABAPENTIN;
02450119;
gabapentin 400 mg;
2017-06-22;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PHARMAPAR INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93614
BIO-GABAPENTIN;
02450178;
gabapentin 400 mg;
2017-06-21;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93619
AG-GABAPENTIN;
02477939;
gabapentin 400 mg;
2018-09-28;
Oral;
Capsule;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ANGITA PHARMA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96815
NEURONTIN;
02239717;
gabapentin 600 mg;
2000-05-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63199
TEVA-GABAPENTIN;
02248457;
gabapentin 600 mg;
2003-11-19;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72809
APO-GABAPENTIN;
02293358;
gabapentin 600 mg;
2008-06-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77872
PRO-GABAPENTIN;
02310473;
gabapentin 600 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79611
GABAPENTIN;
02388200;
gabapentin 600 mg;
2012-06-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87375
GABAPENTIN TABLETS USP;
02392526;
gabapentin 600 mg;
2012-10-12;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87778
JAMP-GABAPENTIN TABLETS;
02402289;
gabapentin 600 mg;
2013-05-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88713
GLN-GABAPENTIN;
02410990;
gabapentin 600 mg;
2016-04-04;
Oral;
Tablet (Immediate Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89563
AURO-GABAPENTIN TABLETS;
02428334;
gabapentin 600 mg;
2019-01-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91281
GABAPENTIN;
02431289;
gabapentin 600 mg;
2014-09-23;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91570
BIO-GABAPENTIN;
02450186;
gabapentin 600 mg;
2017-06-21;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93620
NEURONTIN;
02239718;
gabapentin 800 mg;
2000-05-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
UPJOHN CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63200
TEVA-GABAPENTIN;
02247346;
gabapentin 800 mg;
2003-06-30;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=71589
APO-GABAPENTIN;
02293366;
gabapentin 800 mg;
2008-06-04;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77873
PRO-GABAPENTIN;
02310481;
gabapentin 800 mg;
2008-10-27;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79612
GABAPENTIN;
02388219;
gabapentin 800 mg;
2012-06-26;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SIVEM PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87376
GABAPENTIN TABLETS USP;
02392534;
gabapentin 800 mg;
2012-10-12;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=87779
JAMP-GABAPENTIN TABLETS;
02402297;
gabapentin 800 mg;
2013-05-01;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88714
GLN-GABAPENTIN;
02411008;
gabapentin 800 mg;
2016-04-04;
Oral;
Tablet (Immediate Release);
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
GLENMARK PHARMACEUTICALS CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89564
AURO-GABAPENTIN TABLETS;
02428342;
gabapentin 800 mg;
2019-01-29;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91282
GABAPENTIN;
02431297;
gabapentin 800 mg;
2014-09-23;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91571
BIO-GABAPENTIN;
02450194;
gabapentin 800 mg;
2019-07-17;
Oral;
Tablet;
28:12.92 – MISCELLANEOUS ANTICONVULSANTS;
Prescription;
BIOMED PHARMA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93621
MULTIHANCE;
02248302;
gadobenate dimeglumine 529 mg / ml;
2004-10-28;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
BRACCO IMAGING CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=72643
GADOVIST 1.0;
02241089;
gadobutrol 604.72 mg / ml;
2004-01-30;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=64684
OMNISCAN;
02172771;
gadodiamide 287 mg / ml;
1997-03-25;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
GE HEALTHCARE CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=44188
MAGNEVIST;
01989987;
gadopentetate dimeglumine 469 mg / ml;
1992-12-31;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=13384
DOTAREM;
02459329;
gadoterate meglumine 376.9 mg / ml;
2017-09-22;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
GUERBET
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94652
PROHANCE – LIQ IV 279.3MG/ML;
02229056;
gadoteridol 279.3 mg / ml;
1998-09-08;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
BRACCO IMAGING CANADA
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43507
PRIMOVIST;
02340666;
gadoxetate disodium 181.43 mg / ml;
2010-02-04;
Intravenous;
Solution;
36:89.00* – OTHER DIAGNOSTIC AGENTS;
Ethical;
BAYER INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82625
PAT-GALANTAMINE ER;
02316951;
galantamine (galantamine hydrobromide) 16 mg;
2011-01-05;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80245
MYLAN-GALANTAMINE ER;
02339447;
galantamine (galantamine hydrobromide) 16 mg;
2010-11-12;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82506
PMS-GALANTAMINE ER;
02398389;
galantamine (galantamine hydrobromide) 16 mg;
2013-06-13;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88333
GALANTAMINE ER;
02416581;
galantamine (galantamine hydrobromide) 16 mg;
2013-12-03;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90118
AURO-GALANTAMINE ER;
02425165;
galantamine (galantamine hydrobromide) 16 mg;
2014-06-12;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90982
GALANTAMINE ER;
02443023;
galantamine (galantamine hydrobromide) 16 mg;
2016-01-11;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92758
PAT-GALANTAMINE ER;
02316978;
galantamine (galantamine hydrobromide) 24 mg;
2011-01-05;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80246
MYLAN-GALANTAMINE ER;
02339455;
galantamine (galantamine hydrobromide) 24 mg;
2010-11-12;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82507
PMS-GALANTAMINE ER;
02398397;
galantamine (galantamine hydrobromide) 24 mg;
2013-06-13;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88334
AURO-GALANTAMINE ER;
02425173;
galantamine (galantamine hydrobromide) 24 mg;
2014-06-12;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90983
GALANTAMINE ER;
02443031;
galantamine (galantamine hydrobromide) 24 mg;
2016-01-11;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92759
PAT-GALANTAMINE ER;
02316943;
galantamine (galantamine hydrobromide) 8 mg;
2011-01-05;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80244
MYLAN-GALANTAMINE ER;
02339439;
galantamine (galantamine hydrobromide) 8 mg;
2010-11-12;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=82505
PMS-GALANTAMINE ER;
02398370;
galantamine (galantamine hydrobromide) 8 mg;
2013-06-13;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88332
AURO-GALANTAMINE ER;
02425157;
galantamine (galantamine hydrobromide) 8 mg;
2014-06-12;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
AURO PHARMA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90981
GALANTAMINE ER;
02443015;
galantamine (galantamine hydrobromide) 8 mg;
2016-01-11;
Oral;
Capsule (Extended Release);
12:04.00 – PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92757
EMGALITY;
02505134;
galcanezumab 100 mg / ml;
2021-01-11;
Subcutaneous;
Solution;
28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99448
EMGALITY;
02491060;
galcanezumab 120 mg / ml;
2019-10-07;
Subcutaneous;
Solution;
28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98107
EMGALITY;
02491087;
galcanezumab 120 mg / ml;
2019-10-02;
Subcutaneous;
Solution;
28:32.12 – CALCITONIN-GENE-RELATED PEPTIDE (CGRP) ANTAGONISTS;
Prescription , Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98110
NAGLAZYME;
02412683;
galsulfase 1 mg / ml;
2014-01-01;
Intravenous;
Solution;
44:00.00 – ENZYMES;
Schedule D;
BIOMARIN PHARMACEUTICAL INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89735
CYTOVENE;
02162695;
ganciclovir (ganciclovir sodium) 500 mg / vial;
1995-12-31;
Intravenous;
Powder For Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
CHEPLAPHARM ARZNEIMITTEL GMBH
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19553
GANCICLOVIR FOR INJECTION;
02404761;
ganciclovir (ganciclovir sodium) 500 mg / vial;
2014-04-08;
Intravenous;
Powder For Solution;
08:18.32 – NUCLEOSIDES AND NUCLEOTIDES;
Prescription;
FRESENIUS KABI CANADA LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88956
ORGALUTRAN;
02245641;
ganirelix (ganirelix acetate) 250 mcg / 0.5 ml;
2002-08-23;
Subcutaneous;
Solution;
92:40.00 – GONADOTROPIN-RELEASING HORMONE ANTAGONISTS;
Prescription;
ORGANON CANADA INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69741
APO-GATIFLOXACIN;
02327260;
gatifloxacin (gatifloxacin hemihydrate) 0.3 %;
2019-11-15;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81256
ZYMAR;
02257270;
gatifloxacin 0.3 %;
2004-09-27;
Ophthalmic;
Solution;
52:04.04 – ANTIBACTERIALS;
Prescription;
ALLERGAN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=74247
IRESSA;
02248676;
gefitinib 250 mg;
2003-12-17;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTRAZENECA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=73040
APO-GEFITINIB;
02468050;
gefitinib 250 mg;
2017-10-18;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95642
SANDOZ GEFITINIB;
02487748;
gefitinib 250 mg;
2019-06-26;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97788
NAT-GEFITINIB;
02491796;
gefitinib 250 mg;
2019-11-13;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98180
GEMCITABINE FOR INJECTION;
02324210;
gemcitabine (gemcitabine hydrochloride) 1 g / vial;
2009-07-16;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80969
GEMCITABINE FOR INJECTION;
02370034;
gemcitabine (gemcitabine hydrochloride) 2 g / vial;
2011-08-31;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ACCORD HEALTHCARE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=85506
GEMCITABINE INJECTION;
02402831;
gemcitabine (gemcitabine hydrochloride) 38 mg / ml;
2013-03-20;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88767
GEMCITABINE INJECTION;
02412292;
gemcitabine (gemcitabine hydrochloride) 40 mg / ml;
2013-09-24;
Intravenous;
Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89685
TEVA-GEMFIBROZIL;
02241704;
gemfibrozil 300 mg;
2000-02-29;
Oral;
Capsule;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=65364
TEVA-GEMFIBROZIL;
02142074;
gemfibrozil 600 mg;
1995-12-31;
Oral;
Tablet;
24:06.06 – FRIBIC ACID DERIVATIVES;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=17230
MYLOTARG;
02494388;
gemtuzumab ozogamicin 4.5 mg / vial;
2020-03-11;
Intravenous;
Powder For Solution;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription , Schedule D;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98440
GENTAMICIN(E);
02082136;
gentamicin (gentamicin sulfate) 1 mg / ml;
1995-12-31;
Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18242
GENTAMICIN(E);
02082152;
gentamicin (gentamicin sulfate) 1.6 mg / ml;
1995-12-31;
Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=18243
GENTAMICIN INJECTION USP;
02268531;
gentamicin (gentamicin sulfate) 10 mg / ml;
2005-08-29;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75394
GENTAMICIN INJECTION USP;
02470462;
gentamicin (gentamicin sulfate) 10 mg / ml;
2019-05-14;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95943
GENTAMICIN INJECTION USP;
02242652;
gentamicin (gentamicin sulfate) 40 mg / ml;
2000-12-20;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66434
GENTAMICIN INJECTION USP;
02457008;
gentamicin (gentamicin sulfate) 40 mg / ml;
2017-01-05;
Intramuscular , Intravenous;
Solution;
08:12.02 – AMINOGLYCOSIDES;
Prescription;
TELIGENT OU
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94412
XOSPATA;
02495058;
gilteritinib (gilteritinib fumarate) 40 mg;
2020-02-03;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
ASTELLAS PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98500
GIVLAARI;
02506343;
givosiran (givosiran sodium) 189 mg / ml;
2020-12-01;
Subcutaneous;
Solution;
92:92.00 – OTHER MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
ALNYLAM NETHERLANDS B.V.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=99566
DAURISMO;
02498480;
glasdegib (glasdegib maleate) 100 mg;
2020-08-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98825
DAURISMO;
02498472;
glasdegib (glasdegib maleate) 25 mg;
2020-08-10;
Oral;
Tablet;
10:00.00 – ANTINEOPLASTIC AGENTS;
Prescription;
PFIZER CANADA ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98824
COPAXONE;
02245619;
glatiramer acetate 20 mg / ml;
2002-05-01;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69719
GLATECT;
02460661;
glatiramer acetate 20 mg / ml;
2017-08-21;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription;
PHARMASCIENCE INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94809
COPAXONE;
02456915;
glatiramer acetate 40 mg / ml;
2016-08-26;
Subcutaneous;
Solution;
92:20.00 – Immunomodulatory Agents;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94398
DIAMICRON MR;
02242987;
gliclazide 30 mg;
2001-04-04;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66827
APO-GLICLAZIDE MR;
02297795;
gliclazide 30 mg;
2008-06-04;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=78313
MINT-GLICLAZIDE MR;
02423286;
gliclazide 30 mg;
2014-06-02;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
MINT PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90799
MYLAN-GLICLAZIDE MR;
02438658;
gliclazide 30 mg;
2015-08-07;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
MYLAN PHARMACEUTICALS ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92302
SANDOZ GLICLAZIDE MR;
02461323;
gliclazide 30 mg;
2017-06-02;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94883
TARO-GLICLAZIDE MR;
02463571;
gliclazide 30 mg;
2018-04-03;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95168
DIAMICRON MR;
02356422;
gliclazide 60 mg;
2010-12-09;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=84157
APO-GLICLAZIDE MR;
02407124;
gliclazide 60 mg;
2015-04-14;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89182
TARO-GLICLAZIDE MR;
02439328;
gliclazide 60 mg;
2016-06-01;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
SUN PHARMA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=92369
SANDOZ GLICLAZIDE MR;
02461331;
gliclazide 60 mg;
2017-06-02;
Oral;
Tablet (Extended-Release);
68:20.20 – SULFONYLUREAS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=94884
DIAMICRON;
00765996;
gliclazide 80 mg;
1990-12-31;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
SERVIER CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=10918
TEVA-GLICLAZIDE;
02238103;
gliclazide 80 mg;
1998-06-08;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=61497
APO-GLICLAZIDE;
02245247;
gliclazide 80 mg;
2002-07-02;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=69269
GLICLAZIDE;
02287072;
gliclazide 80 mg;
2010-02-25;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=77250
SANDOZ GLIMEPIRIDE;
02269589;
glimepiride 1 mg;
2005-08-04;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75494
SANDOZ GLIMEPIRIDE;
02269597;
glimepiride 2 mg;
2005-08-04;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75495
SANDOZ GLIMEPIRIDE;
02269619;
glimepiride 4 mg;
2005-08-04;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=75497
GLUCAGEN;
02333619;
glucagon (recombinant dna origin) (glucagon hydrochloride) 1 mg / vial;
2010-01-04;
Intramuscular;
Kit , Powder For Solution;
68:22.12 – GLYCOGENOLYTIC AGENTS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81923
GLUCAGEN HYPOKIT;
02333627;
glucagon (recombinant dna origin) (glucagon hydrochloride) 1 mg / vial;
2009-12-23;
Intramuscular;
Kit , Powder For Solution;
68:22.12 – GLYCOGENOLYTIC AGENTS;
Schedule D;
NOVO NORDISK CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81924
GLUCAGON;
02243297;
glucagon (recombinant dna origin) 1 mg / vial;
2002-05-27;
Intramuscular , Intravenous , Subcutaneous;
Kit , Powder For Solution;
68:22.12 – GLYCOGENOLYTIC AGENTS;
Schedule D;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=67195
BAQSIMI;
02492415;
glucagon 3 mg / container;
2019-11-20;
Nasal;
Powder;
68:22.12 – GLYCOGENOLYTIC AGENTS;
Ethical;
ELI LILLY CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=98243
APO GLYBURIDE TAB 2.5MG;
01913654;
glyburide 2.5 mg;
1991-12-31;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11728
TEVA-GLYBURIDE;
01913670;
glyburide 2.5 mg;
1991-12-31;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11780
GLYBURIDE;
01959352;
glyburide 2.5 mg;
1992-12-31;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=12865
GLYBURIDE;
02350459;
glyburide 2.5 mg;
2010-05-12;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83566
APO GLYBURIDE TAB 5MG;
01913662;
glyburide 5 mg;
1991-12-31;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11727
TEVA-GLYBURIDE;
01913689;
glyburide 5 mg;
1991-12-31;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11781
GLYBURIDE;
02350467;
glyburide 5 mg;
2010-05-12;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
SANIS HEALTH INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83567
GLYBURIDE;
02485664;
glyburide 5 mg;
2019-02-27;
Oral;
Tablet;
68:20.20 – SULFONYLUREAS;
Prescription;
PRO DOC LIMITEE
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97589
RAVICTI;
02453304;
glycerol phenylbutyrate 1.1 g / ml;
2016-11-03;
Oral;
Liquid;
-;
Prescription;
HORIZON THERAPEUTICS IRELAND DAC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93983
GLYCINE 1.5% IRRIGATION USP SOL;
00799955;
glycine 1.5 g / 100 ml;
1989-12-31;
Irrigation;
Liquid;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
BAXTER CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=9828
GLYCINE IRRIGATION USP;
00498793;
glycine 15 mg / ml;
1980-12-31;
Irrigation;
Solution;
40:36.00 – IRRIGATING SOLUTIONS;
Ethical;
ICU MEDICAL CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=3865
GLYCOPYRROLATE INJECTION USP;
02039508;
glycopyrrolate 0.2 mg / ml;
1993-12-31;
Intramuscular , Intravenous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
SANDOZ CANADA INCORPORATED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=14577
GLYCOPYRROLATE INJECTION MULTIDOSE;
02382849;
glycopyrrolate 0.2 mg / ml;
2012-07-13;
Intramuscular , Intravenous;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86865
GLYCOPYRROLATE INJECTION;
02382857;
glycopyrrolate 0.2 mg / ml;
2012-06-29;
Intramuscular , Intravenous;
Liquid;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Ethical;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86866
CUVPOSA;
02469332;
glycopyrrolate 1 mg / 5 ml;
2018-04-03;
Oral;
Solution;
12:08.08 – ANTIMUSCARINICS ANTISPASMODICS;
Prescription;
MEDEXUS PHARMACEUTICALS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95811
SEEBRI BREEZHALER;
02394936;
glycopyrronium (glycopyrronium bromide) 50 mcg;
2013-01-14;
Inhalation;
Capsule;
48:12.08 – ANTICHOLINERGIC AGENTS;
Prescription;
NOVARTIS PHARMACEUTICALS CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=88007
SIMPONI;
02413175;
golimumab 100 mg / 1.0 ml;
2013-10-03;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89785
SIMPONI;
02413183;
golimumab 100 mg / 1.0 ml;
2013-10-03;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89786
SIMPONI;
02324776;
golimumab 50 mg / 0.5 ml;
2009-06-22;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81020
SIMPONI;
02324784;
golimumab 50 mg / 0.5 ml;
2009-06-22;
Subcutaneous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=81021
SIMPONI I.V.;
02417472;
golimumab 50 mg / 4.0 ml;
2013-12-12;
Intravenous;
Solution;
92:36.00 – DISEASE-MODIFYING ANTIRHEUMATIC AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=90217
LUTREPULSE PWS 0.8MG/VIAL;
02046210;
gonadorelin acetate 0.8 mg / vial;
1994-12-31;
Intravenous , Subcutaneous;
Powder For Solution;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription;
FERRING INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16274
ZOLADEX LA;
02225905;
goserelin (goserelin acetate) 10.8 mg;
1996-08-28;
Subcutaneous;
Implant;
92:00.00 – MISCELLANEOUS THERAPEUTIC AGENTS;
Prescription;
TERSERA THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=43433
ZOLADEX;
02049325;
goserelin (goserelin acetate) 3.6 mg;
1994-12-31;
Subcutaneous;
Implant;
68:18.00 – GONADOTROPINS AND ANTIGONADOTROPINS;
Prescription;
TERSERA THERAPEUTICS LLC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=16216
APO-GRANISETRON;
02308894;
granisetron (granisetron hydrochloride) 1 mg;
2009-02-20;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
APOTEX INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=79450
NAT-GRANISETRON;
02452359;
granisetron (granisetron hydrochloride) 1 mg;
2016-03-01;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
NATCO PHARMA (CANADA) INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=93873
JAMP GRANISETRON;
02472686;
granisetron (granisetron hydrochloride) 1 mg;
2020-09-17;
Oral;
Tablet;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
JAMP PHARMA CORPORATION
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96198
GRANISETRON HYDROCHLORIDE INJECTION;
02322765;
granisetron (granisetron hydrochloride) 1 mg / ml;
2009-05-14;
Intravenous;
Liquid;
56:22.20 – 5-HT3 RECEPTOR ANTAGONISTS;
Prescription;
OMEGA LABORATORIES LTD
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=80824
ORALAIR;
02381885;
grass pollen allergen extract 100 unit;
2012-07-26;
Sublingual;
Tablet;
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
STALLERGENES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86772
ORALAIR;
02381893;
grass pollen allergen extract 300 unit;
2012-07-26;
Sublingual;
Tablet;
92:05.00* – ALLERGENIC EXTRACTS;
Prescription , Schedule D;
STALLERGENES CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=86773
ROBITUSSIN MUCUS & PHLEGM;
01931032;
guaifenesin 100 mg / 5 ml;
1991-12-31;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=11918
BRONCHOPHAN EXPECTORANT (SANS SUCROSE);
02121999;
guaifenesin 100 mg / 5 ml;
1999-03-10;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
LABORATOIRE ATLAS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=30557
BALMINIL EXPECTORANT;
00608920;
guaifenesin 100 mg / 5 ml;
1979-12-31;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41988
BALMINIL EXPECTORANT (SUCROSE FREE);
00609951;
guaifenesin 100 mg / 5 ml;
1979-12-31;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=41989
ROBITUSSIN EXTRA STRENGTH MUCUS AND PHLEGM;
02142783;
guaifenesin 200 mg / 5 ml;
1995-12-31;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=19044
EXPECTORANT (EXTRA STRENGTH) SYRUP;
02242892;
guaifenesin 200 mg / 5 ml;
2001-01-08;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=66724
MUCUS & PHLEGM RELIEF EXTRA STRENGTH;
02405865;
guaifenesin 200 mg / 5 ml;
2013-08-29;
Oral;
Syrup;
48:16.00 – EXPECTORANTS;
Otc;
TRILLIUM HEALTH CARE PRODUCTS INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89063
EXTRA STRENGTH MUCOUS RELIEF CHEST;
02353571;
guaifenesin 400 mg;
2011-05-17;
Oral;
Tablet;
48:16.00 – EXPECTORANTS;
Otc;
TEVA CANADA LIMITED
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=83879
MUCINEX CHEST CONGESTION;
02434725;
guaifenesin 600 mg;
2016-08-05;
Oral;
Tablet (Immediate And Extended Release);
48:16.00 – EXPECTORANTS;
Otc;
RB HEALTH (CANADA) INC.
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=91903
INTUNIV XR;
02409100;
guanfacine (guanfacine hydrochloride) 1 mg;
2013-08-06;
Oral;
Tablet (Extended-Release);
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89383
INTUNIV XR;
02409119;
guanfacine (guanfacine hydrochloride) 2 mg;
2013-08-06;
Oral;
Tablet (Extended-Release);
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89384
INTUNIV XR;
02409127;
guanfacine (guanfacine hydrochloride) 3 mg;
2013-08-06;
Oral;
Tablet (Extended-Release);
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89385
INTUNIV XR;
02409135;
guanfacine (guanfacine hydrochloride) 4 mg;
2013-08-06;
Oral;
Tablet (Extended-Release);
24:08.16 – CENTRAL ALPHA-AGONISTS;
Prescription;
TAKEDA CANADA INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=89386
TREMFYA;
02469758;
guselkumab 100 mg / 1 ml;
2017-11-27;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=95860
TREMFYA ONE-PRESS;
02487314;
guselkumab 100 mg / 1 ml;
2019-05-20;
Subcutaneous;
Solution;
84:92.00 – MISC. SKIN AND MUCOUS MEMBRANE AGENTS;
Prescription , Schedule D;
JANSSEN INC
https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=97748

NOTICE

This page contains a copy of information from Health Canada’s Drug Product Database.
The author of this website is not responsible for any incomplete or erroneous information that may be found in the Health Canada database and / or on this page.

The AHFS class of active ingredients is regularly reassigned. The information on this page doesn’t always reflect these changes.

© All rights reserved. Pharmaceuticals database and data extracts.
Health Canada. Adapted and reproduced with permission from the Minister of Health, 2019.

⇡ Return to top

AVIS

Cette page contient une copie des informations de la base de données sur les produits pharmaceutiques de Santé Canada.
L’auteure de ce site web n’est pas responsable des informations incomplètes ou erronées qui pourraient être trouvées dans la base de données de Santé Canada et/ou sur cette page.


La classe AHFS des ingrédients actifs fait régulièrement l’objet de réaffectations.
Les informations sur cette page ne reflète pas toujours ces changements;

© Tous droits réservés. Base de données sur les produits pharmaceutiques et extraits de données.
Santé Canada. Adapté et reproduit avec la permission du ministre de la Santé, 2019.

⇡ Retour en haut